,title,publish_time,journal,url,abstract,doi,cord_uid,words
2694,Internal control for real-time polymerase chain reaction based on MS2 bacteriophage for RNA viruses diagnostics,2017-04-06,Mem Inst Oswaldo Cruz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398160/,"BACKGROUND: Real-time reverse transcription polymerase chain reaction (RT-PCR) is routinely used to detect viral infections. In Brazil, it is mandatory the use of nucleic acid tests to detect hepatitis C virus (HCV), hepatitis B virus and human immunodeficiency virus in blood banks because of the immunological window. The use of an internal control (IC) is necessary to differentiate the true negative results from those consequent from a failure in some step of the nucleic acid test. OBJECTIVES: The aim of this study was the construction of virus-modified particles, based on MS2 bacteriophage, to be used as IC for the diagnosis of RNA viruses. METHODS: The MS2 genome was cloned into the pET47b(+) plasmid, generating pET47b(+)-MS2. MS2-like particles were produced through the synthesis of MS2 RNA genome by T7 RNA polymerase. These particles were used as non-competitive IC in assays for RNA virus diagnostics. In addition, a competitive control for HCV diagnosis was developed by cloning a mutated HCV sequence into the MS2 replicase gene of pET47b(+)-MS2, which produces a non-propagating MS2 particle. The utility of MS2-like particles as IC was evaluated in a one-step format multiplex real-time RT-PCR for HCV detection. FINDINGS: We demonstrated that both competitive and non-competitive IC could be successfully used to monitor the HCV amplification performance, including the extraction, reverse transcription, amplification and detection steps, without compromising the detection of samples with low target concentrations. In conclusion, MS2-like particles generated by this strategy proved to be useful IC for RNA virus diagnosis, with advantage that they are produced by a low cost protocol. An attractive feature of this system is that it allows the construction of a multicontrol by the insertion of sequences from more than one pathogen, increasing its applicability for diagnosing different RNA viruses.",10.1590/0074-02760160380,mtk3qxue,"['BACKGROUND', 'Real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'is', 'routinely', 'used', 'to', 'detect', 'viral', 'infections', 'In', 'Brazil', 'it', 'is', 'mandatory', 'the', 'use', 'of', 'nucleic', 'acid', 'tests', 'to', 'detect', 'hepatitis', 'C', 'virus', 'HCV', 'hepatitis', 'B', 'virus', 'and', 'human', 'immunodeficiency', 'virus', 'in', 'blood', 'banks', 'because', 'of', 'the', 'immunological', 'window', 'The', 'use', 'of', 'an', 'internal', 'control', 'IC', 'is', 'necessary', 'to', 'differentiate', 'the', 'true', 'negative', 'results', 'from', 'those', 'consequent', 'from', 'a', 'failure', 'in', 'some', 'step', 'of', 'the', 'nucleic', 'acid', 'test', 'OBJECTIVES', 'The', 'aim', 'of', 'this', 'study', 'was', 'the', 'construction', 'of', 'virus', 'modified', 'particles', 'based', 'on', 'MS2', 'bacteriophage', 'to', 'be', 'used', 'as', 'IC', 'for', 'the', 'diagnosis', 'of', 'RNA', 'viruses', 'METHODS', 'The', 'MS2', 'genome', 'was', 'cloned', 'into', 'the', 'pET47b', 'plasmid', 'generating', 'pET47b', 'MS2', 'MS2', 'like', 'particles', 'were', 'produced', 'through', 'the', 'synthesis', 'of', 'MS2', 'RNA', 'genome', 'by', 'T7', 'RNA', 'polymerase', 'These', 'particles', 'were', 'used', 'as', 'non', 'competitive', 'IC', 'in', 'assays', 'for', 'RNA', 'virus', 'diagnostics', 'In', 'addition', 'a', 'competitive', 'control', 'for', 'HCV', 'diagnosis', 'was', 'developed', 'by', 'cloning', 'a', 'mutated', 'HCV', 'sequence', 'into', 'the', 'MS2', 'replicase', 'gene', 'of', 'pET47b', 'MS2', 'which', 'produces', 'a', 'non', 'propagating', 'MS2', 'particle', 'The', 'utility', 'of', 'MS2', 'like', 'particles', 'as', 'IC', 'was', 'evaluated', 'in', 'a', 'one', 'step', 'format', 'multiplex', 'real', 'time', 'RT', 'PCR', 'for', 'HCV', 'detection', 'FINDINGS', 'We', 'demonstrated', 'that', 'both', 'competitive', 'and', 'non', 'competitive', 'IC', 'could', 'be', 'successfully', 'used', 'to', 'monitor', 'the', 'HCV', 'amplification', 'performance', 'including', 'the', 'extraction', 'reverse', 'transcription', 'amplification', 'and', 'detection', 'steps', 'without', 'compromising', 'the', 'detection', 'of', 'samples', 'with', 'low', 'target', 'concentrations', 'In', 'conclusion', 'MS2', 'like', 'particles', 'generated', 'by', 'this', 'strategy', 'proved', 'to', 'be', 'useful', 'IC', 'for', 'RNA', 'virus', 'diagnosis', 'with', 'advantage', 'that', 'they', 'are', 'produced', 'by', 'a', 'low', 'cost', 'protocol', 'An', 'attractive', 'feature', 'of', 'this', 'system', 'is', 'that', 'it', 'allows', 'the', 'construction', 'of', 'a', 'multicontrol', 'by', 'the', 'insertion', 'of', 'sequences', 'from', 'more', 'than', 'one', 'pathogen', 'increasing', 'its', 'applicability', 'for', 'diagnosing', 'different', 'RNA', 'viruses', '']"
2912,Development and evaluation of a rapid molecular diagnostic test for Zika virus infection by reverse transcription loop-mediated isothermal amplification,2017-10-18,Sci Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647432/,"The recent outbreak of Zika virus (ZIKV) disease caused an enormous number of infections in Central and South America, and the unusual increase in the number of infants born with microcephaly associated with ZIKV infection aroused global concern. Here, we developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay using a portable device for the detection of ZIKV. The assay specifically detected ZIKV strains of both Asian and African genotypes without cross-reactivity with other arboviruses, including Dengue and Chikungunya viruses. The assay detected viral RNA at 14.5 TCID(50)/mL in virus-spiked serum or urine samples within 15 min, although it was slightly less sensitive than reference real time RT-PCR assay. We then evaluated the utility of this assay as a molecular diagnostic test using 90 plasma or serum samples and 99 urine samples collected from 120 suspected cases of arbovirus infection in the states of Paraíba and Pernambuco, Brazil in 2016. The results of this assay were consistent with those of the reference RT-PCR test. This portable RT-LAMP assay was highly specific for ZIKV, and enable rapid diagnosis of the virus infection. Our results provide new insights into ZIKV molecular diagnostics and may improve preparedness for future outbreaks.",10.1038/s41598-017-13836-9,lrkscs71,"['The', 'recent', 'outbreak', 'of', 'Zika', 'virus', 'ZIKV', 'disease', 'caused', 'an', 'enormous', 'number', 'of', 'infections', 'in', 'Central', 'and', 'South', 'America', 'and', 'the', 'unusual', 'increase', 'in', 'the', 'number', 'of', 'infants', 'born', 'with', 'microcephaly', 'associated', 'with', 'ZIKV', 'infection', 'aroused', 'global', 'concern', 'Here', 'we', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'using', 'a', 'portable', 'device', 'for', 'the', 'detection', 'of', 'ZIKV', 'The', 'assay', 'specifically', 'detected', 'ZIKV', 'strains', 'of', 'both', 'Asian', 'and', 'African', 'genotypes', 'without', 'cross', 'reactivity', 'with', 'other', 'arboviruses', 'including', 'Dengue', 'and', 'Chikungunya', 'viruses', 'The', 'assay', 'detected', 'viral', 'RNA', 'at', '14', '5', 'TCID', '50', 'mL', 'in', 'virus', 'spiked', 'serum', 'or', 'urine', 'samples', 'within', '15', 'min', 'although', 'it', 'was', 'slightly', 'less', 'sensitive', 'than', 'reference', 'real', 'time', 'RT', 'PCR', 'assay', 'We', 'then', 'evaluated', 'the', 'utility', 'of', 'this', 'assay', 'as', 'a', 'molecular', 'diagnostic', 'test', 'using', '90', 'plasma', 'or', 'serum', 'samples', 'and', '99', 'urine', 'samples', 'collected', 'from', '120', 'suspected', 'cases', 'of', 'arbovirus', 'infection', 'in', 'the', 'states', 'of', 'Paraíba', 'and', 'Pernambuco', 'Brazil', 'in', '2016', 'The', 'results', 'of', 'this', 'assay', 'were', 'consistent', 'with', 'those', 'of', 'the', 'reference', 'RT', 'PCR', 'test', 'This', 'portable', 'RT', 'LAMP', 'assay', 'was', 'highly', 'specific', 'for', 'ZIKV', 'and', 'enable', 'rapid', 'diagnosis', 'of', 'the', 'virus', 'infection', 'Our', 'results', 'provide', 'new', 'insights', 'into', 'ZIKV', 'molecular', 'diagnostics', 'and', 'may', 'improve', 'preparedness', 'for', 'future', 'outbreaks', '']"
3715,Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease,2019-02-20,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407549/,"Crimean-Congo haemorrhagic fever (CCHF) is a widespread tickborne disease that circulates in wild and domestic animal hosts, and causes severe and often fatal haemorrhagic fever in infected humans. Due to the lack of treatment options or vaccines, and a high fatality rate, CCHF virus (CCHFV) is considered a high-priority pathogen according to the WHO R&D Blueprint. Several commercial reverse transcriptase PCR (RT-PCR) and serological diagnostic assays for CCHFV are already available, including febrile agent panels to distinguish CCHFV from other viral haemorrhagic fever agents; however, the majority of international laboratories use inhouse assays. As CCHFV has numerous amplifying animal hosts, a cross-sectoral ‘One Health’ approach to outbreak prevention is recommended to enhance notifications and enable early warning for genetic and epidemiological shifts in the human, animal and tick populations. However, a lack of guidance for surveillance in animals, harmonisation of case identification and validated serodiagnostic kits for animal testing hinders efforts to strengthen surveillance systems. Additionally, as RT-PCR tests tend to be lineage-specific for regional circulating strains, there is a need for pan-lineage sensitive diagnostics. Adaptation of existing tests to point-of-care molecular diagnostic platforms that can be implemented in clinic or field-based settings would be of value given the potential for CCHFV outbreaks in remote or low-resource areas. Finally, improved access to clinical specimens for validation of diagnostics would help to accelerate development of new tests. These gaps should be addressed by updated target product profiles for CCHFV diagnostics.",10.1136/bmjgh-2018-001114,u5tvbej3,"['Crimean', 'Congo', 'haemorrhagic', 'fever', 'CCHF', 'is', 'a', 'widespread', 'tickborne', 'disease', 'that', 'circulates', 'in', 'wild', 'and', 'domestic', 'animal', 'hosts', 'and', 'causes', 'severe', 'and', 'often', 'fatal', 'haemorrhagic', 'fever', 'in', 'infected', 'humans', 'Due', 'to', 'the', 'lack', 'of', 'treatment', 'options', 'or', 'vaccines', 'and', 'a', 'high', 'fatality', 'rate', 'CCHF', 'virus', 'CCHFV', 'is', 'considered', 'a', 'high', 'priority', 'pathogen', 'according', 'to', 'the', 'WHO', 'R', 'D', 'Blueprint', 'Several', 'commercial', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'and', 'serological', 'diagnostic', 'assays', 'for', 'CCHFV', 'are', 'already', 'available', 'including', 'febrile', 'agent', 'panels', 'to', 'distinguish', 'CCHFV', 'from', 'other', 'viral', 'haemorrhagic', 'fever', 'agents', 'however', 'the', 'majority', 'of', 'international', 'laboratories', 'use', 'inhouse', 'assays', 'As', 'CCHFV', 'has', 'numerous', 'amplifying', 'animal', 'hosts', 'a', 'cross', 'sectoral', 'One', 'Health', 'approach', 'to', 'outbreak', 'prevention', 'is', 'recommended', 'to', 'enhance', 'notifications', 'and', 'enable', 'early', 'warning', 'for', 'genetic', 'and', 'epidemiological', 'shifts', 'in', 'the', 'human', 'animal', 'and', 'tick', 'populations', 'However', 'a', 'lack', 'of', 'guidance', 'for', 'surveillance', 'in', 'animals', 'harmonisation', 'of', 'case', 'identification', 'and', 'validated', 'serodiagnostic', 'kits', 'for', 'animal', 'testing', 'hinders', 'efforts', 'to', 'strengthen', 'surveillance', 'systems', 'Additionally', 'as', 'RT', 'PCR', 'tests', 'tend', 'to', 'be', 'lineage', 'specific', 'for', 'regional', 'circulating', 'strains', 'there', 'is', 'a', 'need', 'for', 'pan', 'lineage', 'sensitive', 'diagnostics', 'Adaptation', 'of', 'existing', 'tests', 'to', 'point', 'of', 'care', 'molecular', 'diagnostic', 'platforms', 'that', 'can', 'be', 'implemented', 'in', 'clinic', 'or', 'field', 'based', 'settings', 'would', 'be', 'of', 'value', 'given', 'the', 'potential', 'for', 'CCHFV', 'outbreaks', 'in', 'remote', 'or', 'low', 'resource', 'areas', 'Finally', 'improved', 'access', 'to', 'clinical', 'specimens', 'for', 'validation', 'of', 'diagnostics', 'would', 'help', 'to', 'accelerate', 'development', 'of', 'new', 'tests', 'These', 'gaps', 'should', 'be', 'addressed', 'by', 'updated', 'target', 'product', 'profiles', 'for', 'CCHFV', 'diagnostics', '']"
5601,Detection of human viral RNA via a combined fluorescence and SERS molecular beacon assay,2007-05-03,Nanobiotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091242/,"A dual-mode molecular beacon on a multiplexed substrate has been developed and applied to the measurement of unlabeled human viral RNA. The detection system is based on a combined surface-enhanced Raman scattering (SERS) and fluorescent molecular beacon assay that is assembled on Nanobarcodes™ particles. In this assay, a molecular beacon probe terminated with a fluorescent Raman label dye is conjugated to the metallic Nanobarcodes™ particles. The molecular beacon probe is a single-stranded oligonucleotide that has been designed with a hairpin structure that holds the dye at 3′-end close to the particle surface when the probe is attached through a 5′-thiol group. In this configuration, the SERS spectrum of the label was obtained and its fluorescence quenched because the dye is in very close proximity to a noble metal surface with nanoscale features (Nanobarcodes™ particles). The SERS signal decreased and the fluorescence signal increased when target viral RNA was captured by this molecular beacon probe. In addition, a hepatitis C virus reverse transcriptase-polymerase chain reaction (HCV RT-PCR) product was detected using this dual-mode beacon. The development of a multiplexed, label-free assay system with the reassurance offered by detection of two distinctly separate signals offers significant benefits for rapid molecular diagnostics.",10.1007/s12030-007-0003-5,mkiz23c4,"['A', 'dual', 'mode', 'molecular', 'beacon', 'on', 'a', 'multiplexed', 'substrate', 'has', 'been', 'developed', 'and', 'applied', 'to', 'the', 'measurement', 'of', 'unlabeled', 'human', 'viral', 'RNA', 'The', 'detection', 'system', 'is', 'based', 'on', 'a', 'combined', 'surface', 'enhanced', 'Raman', 'scattering', 'SERS', 'and', 'fluorescent', 'molecular', 'beacon', 'assay', 'that', 'is', 'assembled', 'on', 'Nanobarcodes', 'particles', 'In', 'this', 'assay', 'a', 'molecular', 'beacon', 'probe', 'terminated', 'with', 'a', 'fluorescent', 'Raman', 'label', 'dye', 'is', 'conjugated', 'to', 'the', 'metallic', 'Nanobarcodes', 'particles', 'The', 'molecular', 'beacon', 'probe', 'is', 'a', 'single', 'stranded', 'oligonucleotide', 'that', 'has', 'been', 'designed', 'with', 'a', 'hairpin', 'structure', 'that', 'holds', 'the', 'dye', 'at', '3', 'end', 'close', 'to', 'the', 'particle', 'surface', 'when', 'the', 'probe', 'is', 'attached', 'through', 'a', '5', 'thiol', 'group', 'In', 'this', 'configuration', 'the', 'SERS', 'spectrum', 'of', 'the', 'label', 'was', 'obtained', 'and', 'its', 'fluorescence', 'quenched', 'because', 'the', 'dye', 'is', 'in', 'very', 'close', 'proximity', 'to', 'a', 'noble', 'metal', 'surface', 'with', 'nanoscale', 'features', 'Nanobarcodes', 'particles', 'The', 'SERS', 'signal', 'decreased', 'and', 'the', 'fluorescence', 'signal', 'increased', 'when', 'target', 'viral', 'RNA', 'was', 'captured', 'by', 'this', 'molecular', 'beacon', 'probe', 'In', 'addition', 'a', 'hepatitis', 'C', 'virus', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'HCV', 'RT', 'PCR', 'product', 'was', 'detected', 'using', 'this', 'dual', 'mode', 'beacon', 'The', 'development', 'of', 'a', 'multiplexed', 'label', 'free', 'assay', 'system', 'with', 'the', 'reassurance', 'offered', 'by', 'detection', 'of', 'two', 'distinctly', 'separate', 'signals', 'offers', 'significant', 'benefits', 'for', 'rapid', 'molecular', 'diagnostics', '']"
10596,"Development and validation of a portable, point-of-care canine distemper virus qPCR test",2020-04-22,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176111/,"Canine distemper virus (CDV) is a multi-host pathogen that can cause significant mortality in domestic, wild terrestrial and marine mammals. It is a major conservation threat in some endangered species. Infection can result in severe respiratory disease and fatal encephalitis. Diagnosis and disease monitoring in wildlife, and differentiation of CDV from rabies (a life-threatening zoonotic disease that can produce similar neurologic signs), would benefit from the availability of a portable, point-of-care (POC) diagnostic test. We therefore developed a quantitative RT-PCR assay for CDV using shelf-stable, lyophilized reagents and target-specific primers and probes for use with the handheld Biomeme two3(™) qPCR thermocycler. Biomeme’s extraction methodology, lyophilized reagents, and thermocycler were compared to our standard laboratory-based methods to assess sensitivity, efficiency and overall test performance. Results using a positive control plasmid for CDV showed comparable sensitivity (detection of 50 copies) and PCR efficiency between the two platforms, and CDV detection was similar between platforms when tested using a modified live CDV vaccine. Significantly higher Ct values (average Ct = 5.1 cycles) were observed using the Biomeme platform on known CDV positive animal samples. CDV detection using the Biomeme platform was similar in 25 of 26 samples from suspect CDV cases when compared to standard virology laboratory testing. One false positive was observed that was negative upon retest. The Biomeme methodology can be adapted for detection of specific targets, and this portable technology saves time by eliminating the need for local or international sample transport for laboratory-based diagnostics. However, results of our testing suggest that decreased diagnostic sensitivity (higher Ct values) relative to laboratory-based methods was observed using animal samples, so careful validation and optimization are essential. Portable qPCR platforms can empower biologists and wildlife health professionals in remote and low-resource settings, which will greatly improve our understanding of CDV disease ecology and associated conservation threats in wildlife.",10.1371/journal.pone.0232044,dgmoppg5,"['Canine', 'distemper', 'virus', 'CDV', 'is', 'a', 'multi', 'host', 'pathogen', 'that', 'can', 'cause', 'significant', 'mortality', 'in', 'domestic', 'wild', 'terrestrial', 'and', 'marine', 'mammals', 'It', 'is', 'a', 'major', 'conservation', 'threat', 'in', 'some', 'endangered', 'species', 'Infection', 'can', 'result', 'in', 'severe', 'respiratory', 'disease', 'and', 'fatal', 'encephalitis', 'Diagnosis', 'and', 'disease', 'monitoring', 'in', 'wildlife', 'and', 'differentiation', 'of', 'CDV', 'from', 'rabies', 'a', 'life', 'threatening', 'zoonotic', 'disease', 'that', 'can', 'produce', 'similar', 'neurologic', 'signs', 'would', 'benefit', 'from', 'the', 'availability', 'of', 'a', 'portable', 'point', 'of', 'care', 'POC', 'diagnostic', 'test', 'We', 'therefore', 'developed', 'a', 'quantitative', 'RT', 'PCR', 'assay', 'for', 'CDV', 'using', 'shelf', 'stable', 'lyophilized', 'reagents', 'and', 'target', 'specific', 'primers', 'and', 'probes', 'for', 'use', 'with', 'the', 'handheld', 'Biomeme', 'two3', 'qPCR', 'thermocycler', 'Biomeme', 's', 'extraction', 'methodology', 'lyophilized', 'reagents', 'and', 'thermocycler', 'were', 'compared', 'to', 'our', 'standard', 'laboratory', 'based', 'methods', 'to', 'assess', 'sensitivity', 'efficiency', 'and', 'overall', 'test', 'performance', 'Results', 'using', 'a', 'positive', 'control', 'plasmid', 'for', 'CDV', 'showed', 'comparable', 'sensitivity', 'detection', 'of', '50', 'copies', 'and', 'PCR', 'efficiency', 'between', 'the', 'two', 'platforms', 'and', 'CDV', 'detection', 'was', 'similar', 'between', 'platforms', 'when', 'tested', 'using', 'a', 'modified', 'live', 'CDV', 'vaccine', 'Significantly', 'higher', 'Ct', 'values', 'average', 'Ct', '5', '1', 'cycles', 'were', 'observed', 'using', 'the', 'Biomeme', 'platform', 'on', 'known', 'CDV', 'positive', 'animal', 'samples', 'CDV', 'detection', 'using', 'the', 'Biomeme', 'platform', 'was', 'similar', 'in', '25', 'of', '26', 'samples', 'from', 'suspect', 'CDV', 'cases', 'when', 'compared', 'to', 'standard', 'virology', 'laboratory', 'testing', 'One', 'false', 'positive', 'was', 'observed', 'that', 'was', 'negative', 'upon', 'retest', 'The', 'Biomeme', 'methodology', 'can', 'be', 'adapted', 'for', 'detection', 'of', 'specific', 'targets', 'and', 'this', 'portable', 'technology', 'saves', 'time', 'by', 'eliminating', 'the', 'need', 'for', 'local', 'or', 'international', 'sample', 'transport', 'for', 'laboratory', 'based', 'diagnostics', 'However', 'results', 'of', 'our', 'testing', 'suggest', 'that', 'decreased', 'diagnostic', 'sensitivity', 'higher', 'Ct', 'values', 'relative', 'to', 'laboratory', 'based', 'methods', 'was', 'observed', 'using', 'animal', 'samples', 'so', 'careful', 'validation', 'and', 'optimization', 'are', 'essential', 'Portable', 'qPCR', 'platforms', 'can', 'empower', 'biologists', 'and', 'wildlife', 'health', 'professionals', 'in', 'remote', 'and', 'low', 'resource', 'settings', 'which', 'will', 'greatly', 'improve', 'our', 'understanding', 'of', 'CDV', 'disease', 'ecology', 'and', 'associated', 'conservation', 'threats', 'in', 'wildlife', '']"
12646,739. Middle East Respiratory Syndrome Coronavirus Infection Profile in Qatar: A 7-Year Retrospective Study,2018-11-26,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255065/,"BACKGROUND: A deadly zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) had emerged over the last 7 years in the Arabian Peninsula. As of February 28, 2018, 2,182 cases of MERS-CoV infection (with 779 deaths) in 27 countries were reported to WHO worldwide. The objectives of this study were to identify the clinical and epidemiological characteristics of MERS-CoV infection as well as determine its clinical outcome. METHODS: This was a retrospective-observational study of all laboratory confirmed cases of MERS-CoV infection conducted at the main seven hospitals in the State of Qatar from January, 2012 to April 2018. We used the Fast Track diagnostics real-time reverse-transcription polymerase chain reaction (rRT-PCR), targeting the upE and ORF1a genes respectively. Demographics, clinical information, potential contacts and probable risk factors were collected and analyzed by standard statistical methods. RESULTS: The mean annual incidence was 1.7 per 100,0000 person-years. Among the 24 confirmed cases of of MERS-CoV, males constituted the vast majority of cases (23 males) with a median age of 52 years (range 22–74). Fifty percent of the cases were Qatari and 42% reside in the same region. 67% of the cases had contact with camels, and 21% had contact with MERS-CoV-infected patient. Thirty-eight had travel history within 2 weeks of symptoms onset to the Kingdom of Saudi Arabia. Fifty percent were smokers and 42% had comorbidities. The median symptoms duration was 4.5 days. Most of the patient presented with flu-like symptoms, were fever was the most common presentation, followed by cough, SOB, diarrhea, abdominal pain and headache, 96%, 83%, 33%, 8%, 8% and 4%, respectively. All patients were admitted to a tertiary hospital with a median hospital stay 41 days (8–97). Forty-five percent patients developed severe sepsis with multi-organ failure and needed ICU admission. Fifty percent patients developed acute kidney injury, 29% patients were on hemodialysis and 16% needed extra-corporeal membrane oxygenation. Thirty-three percent patients died. The rest of patients had recovered from the infection and discharged home. Among those who died all had one or more comorbidities. CONCLUSION: MERS-CoV infection is a rare infection in the State of Qatar, seen in both Qataris and expatriates with and without travel history. The infection in patients with comorbidities carries high mortality. DISCLOSURES: All authors: No reported disclosures.",10.1093/ofid/ofy210.746,2g0zq9dh,"['BACKGROUND', 'A', 'deadly', 'zoonotic', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'had', 'emerged', 'over', 'the', 'last', '7', 'years', 'in', 'the', 'Arabian', 'Peninsula', 'As', 'of', 'February', '28', '2018', '2', '182', 'cases', 'of', 'MERS', 'CoV', 'infection', 'with', '779', 'deaths', 'in', '27', 'countries', 'were', 'reported', 'to', 'WHO', 'worldwide', 'The', 'objectives', 'of', 'this', 'study', 'were', 'to', 'identify', 'the', 'clinical', 'and', 'epidemiological', 'characteristics', 'of', 'MERS', 'CoV', 'infection', 'as', 'well', 'as', 'determine', 'its', 'clinical', 'outcome', 'METHODS', 'This', 'was', 'a', 'retrospective', 'observational', 'study', 'of', 'all', 'laboratory', 'confirmed', 'cases', 'of', 'MERS', 'CoV', 'infection', 'conducted', 'at', 'the', 'main', 'seven', 'hospitals', 'in', 'the', 'State', 'of', 'Qatar', 'from', 'January', '2012', 'to', 'April', '2018', 'We', 'used', 'the', 'Fast', 'Track', 'diagnostics', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'targeting', 'the', 'upE', 'and', 'ORF1a', 'genes', 'respectively', 'Demographics', 'clinical', 'information', 'potential', 'contacts', 'and', 'probable', 'risk', 'factors', 'were', 'collected', 'and', 'analyzed', 'by', 'standard', 'statistical', 'methods', 'RESULTS', 'The', 'mean', 'annual', 'incidence', 'was', '1', '7', 'per', '100', '0000', 'person', 'years', 'Among', 'the', '24', 'confirmed', 'cases', 'of', 'of', 'MERS', 'CoV', 'males', 'constituted', 'the', 'vast', 'majority', 'of', 'cases', '23', 'males', 'with', 'a', 'median', 'age', 'of', '52', 'years', 'range', '22', '74', 'Fifty', 'percent', 'of', 'the', 'cases', 'were', 'Qatari', 'and', '42', 'reside', 'in', 'the', 'same', 'region', '67', 'of', 'the', 'cases', 'had', 'contact', 'with', 'camels', 'and', '21', 'had', 'contact', 'with', 'MERS', 'CoV', 'infected', 'patient', 'Thirty', 'eight', 'had', 'travel', 'history', 'within', '2', 'weeks', 'of', 'symptoms', 'onset', 'to', 'the', 'Kingdom', 'of', 'Saudi', 'Arabia', 'Fifty', 'percent', 'were', 'smokers', 'and', '42', 'had', 'comorbidities', 'The', 'median', 'symptoms', 'duration', 'was', '4', '5', 'days', 'Most', 'of', 'the', 'patient', 'presented', 'with', 'flu', 'like', 'symptoms', 'were', 'fever', 'was', 'the', 'most', 'common', 'presentation', 'followed', 'by', 'cough', 'SOB', 'diarrhea', 'abdominal', 'pain', 'and', 'headache', '96', '83', '33', '8', '8', 'and', '4', 'respectively', 'All', 'patients', 'were', 'admitted', 'to', 'a', 'tertiary', 'hospital', 'with', 'a', 'median', 'hospital', 'stay', '41', 'days', '8', '97', 'Forty', 'five', 'percent', 'patients', 'developed', 'severe', 'sepsis', 'with', 'multi', 'organ', 'failure', 'and', 'needed', 'ICU', 'admission', 'Fifty', 'percent', 'patients', 'developed', 'acute', 'kidney', 'injury', '29', 'patients', 'were', 'on', 'hemodialysis', 'and', '16', 'needed', 'extra', 'corporeal', 'membrane', 'oxygenation', 'Thirty', 'three', 'percent', 'patients', 'died', 'The', 'rest', 'of', 'patients', 'had', 'recovered', 'from', 'the', 'infection', 'and', 'discharged', 'home', 'Among', 'those', 'who', 'died', 'all', 'had', 'one', 'or', 'more', 'comorbidities', 'CONCLUSION', 'MERS', 'CoV', 'infection', 'is', 'a', 'rare', 'infection', 'in', 'the', 'State', 'of', 'Qatar', 'seen', 'in', 'both', 'Qataris', 'and', 'expatriates', 'with', 'and', 'without', 'travel', 'history', 'The', 'infection', 'in', 'patients', 'with', 'comorbidities', 'carries', 'high', 'mortality', 'DISCLOSURES', 'All', 'authors', 'No', 'reported', 'disclosures', '']"
16701,Quantitative Reverse Transcriptase Polymerase Chain Reaction,2007,Basic Science Techniques in Clinical Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123628/,"Since the first documentation of real-time polymerase chain reaction (PCR),(1) it has been used for an increasing and diverse number of applications, including mRNA expression studies, DNA copy number measurements in genomic or viral DNAs,(2–7) allelic discrimination assays,(8,9) expression analysis of specific splice variants of genes(10–13) and gene expression in paraffin-embedded tissues,(14,15) and laser captured microdissected cells.(13,16–19) Therefore, quantitative reverse transcriptase polymerase chain reaction (Q-RT-PCR) is now essential in molecular diagnostics to quantitatively assess the level of RNA or DNA in a given specimen. QRT-PCR enables the detection and quantification of very small amounts of DNA, cDNA, or RNA, even down to a single copy. It is based on the detection of fluorescence produced by reporter probes, which varies with reaction cycle number. Only during the exponential phase of the conventional PCR reaction is it possible to extrapolate back in order to determine the quantity of initial template sequence. The “real-time” nature of this technology pertains to the constant monitoring of fluorescence from specially designed reporter probes during each cycle. Due to inhibitors of the polymerase reaction found with the template, reagent limitation or accumulation of pyrophosphate molecules, the PCR reaction eventually ceases to generate template at an exponential rate (i.e., the plateau phase), making the end point quantitation of PCR products unreliable in all but the exponential phase.",10.1007/978-1-84628-740-4_8,8f0e8zn2,"['Since', 'the', 'first', 'documentation', 'of', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', '1', 'it', 'has', 'been', 'used', 'for', 'an', 'increasing', 'and', 'diverse', 'number', 'of', 'applications', 'including', 'mRNA', 'expression', 'studies', 'DNA', 'copy', 'number', 'measurements', 'in', 'genomic', 'or', 'viral', 'DNAs', '2', '7', 'allelic', 'discrimination', 'assays', '8', '9', 'expression', 'analysis', 'of', 'specific', 'splice', 'variants', 'of', 'genes', '10', '13', 'and', 'gene', 'expression', 'in', 'paraffin', 'embedded', 'tissues', '14', '15', 'and', 'laser', 'captured', 'microdissected', 'cells', '13', '16', '19', 'Therefore', 'quantitative', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'Q', 'RT', 'PCR', 'is', 'now', 'essential', 'in', 'molecular', 'diagnostics', 'to', 'quantitatively', 'assess', 'the', 'level', 'of', 'RNA', 'or', 'DNA', 'in', 'a', 'given', 'specimen', 'QRT', 'PCR', 'enables', 'the', 'detection', 'and', 'quantification', 'of', 'very', 'small', 'amounts', 'of', 'DNA', 'cDNA', 'or', 'RNA', 'even', 'down', 'to', 'a', 'single', 'copy', 'It', 'is', 'based', 'on', 'the', 'detection', 'of', 'fluorescence', 'produced', 'by', 'reporter', 'probes', 'which', 'varies', 'with', 'reaction', 'cycle', 'number', 'Only', 'during', 'the', 'exponential', 'phase', 'of', 'the', 'conventional', 'PCR', 'reaction', 'is', 'it', 'possible', 'to', 'extrapolate', 'back', 'in', 'order', 'to', 'determine', 'the', 'quantity', 'of', 'initial', 'template', 'sequence', 'The', 'real', 'time', 'nature', 'of', 'this', 'technology', 'pertains', 'to', 'the', 'constant', 'monitoring', 'of', 'fluorescence', 'from', 'specially', 'designed', 'reporter', 'probes', 'during', 'each', 'cycle', 'Due', 'to', 'inhibitors', 'of', 'the', 'polymerase', 'reaction', 'found', 'with', 'the', 'template', 'reagent', 'limitation', 'or', 'accumulation', 'of', 'pyrophosphate', 'molecules', 'the', 'PCR', 'reaction', 'eventually', 'ceases', 'to', 'generate', 'template', 'at', 'an', 'exponential', 'rate', 'i', 'e', 'the', 'plateau', 'phase', 'making', 'the', 'end', 'point', 'quantitation', 'of', 'PCR', 'products', 'unreliable', 'in', 'all', 'but', 'the', 'exponential', 'phase', '']"
35921,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.,2020-05-26,Viruses,https://doi.org/10.3390/v12060582; https://www.ncbi.nlm.nih.gov/pubmed/32466458/,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",10.3390/v12060582,h2mloxuh,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
39123,Clinical Molecular Genetics Evaluation in Women with Reproductive Failures.,2020-07-25,American journal of reproductive immunology,https://doi.org/10.1111/aji.13313; https://www.ncbi.nlm.nih.gov/pubmed/32710571/,"Molecular diagnostics is a rapidly growing branch of the clinical laboratory and has accelerated the advance of personalized medicine in the fields of pharmacogenomics, pharmacogenetics, and nutrigenomics. The versatility of molecular biology allows it to be effective in several medical fields that include reproduction, immunogenetics and virology. Implementation of molecular and sequencing technology in reproductive medicine can add another layer of understanding to better define the causes behind infertility and recurrent reproductive loss. In the following we examine current molecular methods for probing factors behind reproductive pregnancy loss including reverse transcription PCR (RT-PCR), and Next Generation Sequencing (NGS). We review several current and potential genetic (DNA) and transcriptional (RNA) based parameters in women with infertility that can be significant in diagnosis and treatment. These molecular factors can be inferred either from genomic DNA, or RNA locally within the endometrium. Furthermore, we consider infection-based abnormalities such as Human Herpes Virus-6 (HHV-6), and Severe acute respiratory syndrome coronavirus-2 (SARS CoV-2). Finally, we present future directions as well as data demonstrating the potential role of Human Endogenous Retroviruses (HERV) in pregnancy loss. We hope these discussions will assist the clinician in delineating some of the intricate molecular factors that can contribute to infertility and recurrent reproductive failures.",10.1111/aji.13313,zhklwsit,"['Molecular', 'diagnostics', 'is', 'a', 'rapidly', 'growing', 'branch', 'of', 'the', 'clinical', 'laboratory', 'and', 'has', 'accelerated', 'the', 'advance', 'of', 'personalized', 'medicine', 'in', 'the', 'fields', 'of', 'pharmacogenomics', 'pharmacogenetics', 'and', 'nutrigenomics', 'The', 'versatility', 'of', 'molecular', 'biology', 'allows', 'it', 'to', 'be', 'effective', 'in', 'several', 'medical', 'fields', 'that', 'include', 'reproduction', 'immunogenetics', 'and', 'virology', 'Implementation', 'of', 'molecular', 'and', 'sequencing', 'technology', 'in', 'reproductive', 'medicine', 'can', 'add', 'another', 'layer', 'of', 'understanding', 'to', 'better', 'define', 'the', 'causes', 'behind', 'infertility', 'and', 'recurrent', 'reproductive', 'loss', 'In', 'the', 'following', 'we', 'examine', 'current', 'molecular', 'methods', 'for', 'probing', 'factors', 'behind', 'reproductive', 'pregnancy', 'loss', 'including', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'and', 'Next', 'Generation', 'Sequencing', 'NGS', 'We', 'review', 'several', 'current', 'and', 'potential', 'genetic', 'DNA', 'and', 'transcriptional', 'RNA', 'based', 'parameters', 'in', 'women', 'with', 'infertility', 'that', 'can', 'be', 'significant', 'in', 'diagnosis', 'and', 'treatment', 'These', 'molecular', 'factors', 'can', 'be', 'inferred', 'either', 'from', 'genomic', 'DNA', 'or', 'RNA', 'locally', 'within', 'the', 'endometrium', 'Furthermore', 'we', 'consider', 'infection', 'based', 'abnormalities', 'such', 'as', 'Human', 'Herpes', 'Virus', '6', 'HHV', '6', 'and', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'Finally', 'we', 'present', 'future', 'directions', 'as', 'well', 'as', 'data', 'demonstrating', 'the', 'potential', 'role', 'of', 'Human', 'Endogenous', 'Retroviruses', 'HERV', 'in', 'pregnancy', 'loss', 'We', 'hope', 'these', 'discussions', 'will', 'assist', 'the', 'clinician', 'in', 'delineating', 'some', 'of', 'the', 'intricate', 'molecular', 'factors', 'that', 'can', 'contribute', 'to', 'infertility', 'and', 'recurrent', 'reproductive', 'failures', '']"
44349,Markers of Borna disease virus infection in cats with staggering disease.,2012,Journal of feline medicine and surgery,https://doi.org/10.1177/1098612x12446638; https://www.ncbi.nlm.nih.gov/pubmed/22553310/,"Borna disease virus (BDV) is a RNA-virus causing neurological disorders in a wide range of mammals. In cats, BDV infection may cause staggering disease. Presently, staggering disease is a tentative clinical diagnosis, only confirmed at necropsy. In this study, cats with staggering disease were investigated to study markers of BDV infection aiming for improvement of current diagnostics. Nineteen cats fulfilled the inclusion criteria based on neurological signs and pathological findings. In 17/19 cats, BDV infection markers (BDV-specific antibodies and/or BDV-RNA) were found, and antibodies in serum (13/16, 81%) were the most common marker. BDV-RNA was found in 11/19 cats (58%). In a reference population without neurological signs, 4/25 cats were seropositive (16%). The clinical history and neurological signs in combination with presence of BDV infection markers, where serology and rRT-PCR on blood can be helpful tools, improve the diagnostic accuracy in the living cat.",10.1177/1098612x12446638,vw6t0alg,"['Borna', 'disease', 'virus', 'BDV', 'is', 'a', 'RNA', 'virus', 'causing', 'neurological', 'disorders', 'in', 'a', 'wide', 'range', 'of', 'mammals', 'In', 'cats', 'BDV', 'infection', 'may', 'cause', 'staggering', 'disease', 'Presently', 'staggering', 'disease', 'is', 'a', 'tentative', 'clinical', 'diagnosis', 'only', 'confirmed', 'at', 'necropsy', 'In', 'this', 'study', 'cats', 'with', 'staggering', 'disease', 'were', 'investigated', 'to', 'study', 'markers', 'of', 'BDV', 'infection', 'aiming', 'for', 'improvement', 'of', 'current', 'diagnostics', 'Nineteen', 'cats', 'fulfilled', 'the', 'inclusion', 'criteria', 'based', 'on', 'neurological', 'signs', 'and', 'pathological', 'findings', 'In', '17', '19', 'cats', 'BDV', 'infection', 'markers', 'BDV', 'specific', 'antibodies', 'and', 'or', 'BDV', 'RNA', 'were', 'found', 'and', 'antibodies', 'in', 'serum', '13', '16', '81', 'were', 'the', 'most', 'common', 'marker', 'BDV', 'RNA', 'was', 'found', 'in', '11', '19', 'cats', '58', 'In', 'a', 'reference', 'population', 'without', 'neurological', 'signs', '4', '25', 'cats', 'were', 'seropositive', '16', 'The', 'clinical', 'history', 'and', 'neurological', 'signs', 'in', 'combination', 'with', 'presence', 'of', 'BDV', 'infection', 'markers', 'where', 'serology', 'and', 'rRT', 'PCR', 'on', 'blood', 'can', 'be', 'helpful', 'tools', 'improve', 'the', 'diagnostic', 'accuracy', 'in', 'the', 'living', 'cat', '']"
48177,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay.",2020-07-20,Journal of clinical microbiology,https://doi.org/10.1128/jcm.01598-20; https://www.ncbi.nlm.nih.gov/pubmed/32690547/,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",10.1128/jcm.01598-20,lpoelp91,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
58205,"Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives.",2015,Journal of infection in developing countries,https://doi.org/10.3855/jidc.6197; https://www.ncbi.nlm.nih.gov/pubmed/25989163/,"Humans constantly encounter threats from many infectious, zoonotic, and devastating pathogens. Outbreaks of severe acute respiratory syndrome (SARS), bird flu, and swine flu posing pandemic threats have compelled health agencies to follow global preparedness for combating the emerging deadly pathogens. The outbreak in West Africa of highly contagious Ebola viral disease (EVD) that started in Guinea in December 2013, assumed global proportions to become the largest outbreak of EVD and the most prominent international health concern. With fatality rates of nearly 50%-90%, it has claimed, as of 11 April 2015, 10,619 human lives out of a total of 25,626 cases reported worldwide. Ebola virus (EBOV), a member of Filoviridae family, is associated with severe, often lethal, hemorrhagic fever disease in humans and animals. The animal hosts, including non-human primates and reservoir hosts (fruit bats), play a significant role in transmission and maintenance of EBOV in nature. Although no approved vaccine for the prevention of EVD currently exists, disease control can be greatly enhanced by timely laboratory confirmation through blood tests using enzyme-linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR). Adherence to strict sanitary and hygienic measures, monitoring and surveillance of EBOV, as well as quarantine checks on international trade, transport, and visitors from affected countries are mandatory to prevent and control the spread of EVD. This review describes the salient properties of EBOV and the development of novel diagnostics, vaccines, and control strategies for this emerging disease of high public health concern and international emergency.",10.3855/jidc.6197,2l7f22fl,"['Humans', 'constantly', 'encounter', 'threats', 'from', 'many', 'infectious', 'zoonotic', 'and', 'devastating', 'pathogens', 'Outbreaks', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'bird', 'flu', 'and', 'swine', 'flu', 'posing', 'pandemic', 'threats', 'have', 'compelled', 'health', 'agencies', 'to', 'follow', 'global', 'preparedness', 'for', 'combating', 'the', 'emerging', 'deadly', 'pathogens', 'The', 'outbreak', 'in', 'West', 'Africa', 'of', 'highly', 'contagious', 'Ebola', 'viral', 'disease', 'EVD', 'that', 'started', 'in', 'Guinea', 'in', 'December', '2013', 'assumed', 'global', 'proportions', 'to', 'become', 'the', 'largest', 'outbreak', 'of', 'EVD', 'and', 'the', 'most', 'prominent', 'international', 'health', 'concern', 'With', 'fatality', 'rates', 'of', 'nearly', '50', '90', 'it', 'has', 'claimed', 'as', 'of', '11', 'April', '2015', '10', '619', 'human', 'lives', 'out', 'of', 'a', 'total', 'of', '25', '626', 'cases', 'reported', 'worldwide', 'Ebola', 'virus', 'EBOV', 'a', 'member', 'of', 'Filoviridae', 'family', 'is', 'associated', 'with', 'severe', 'often', 'lethal', 'hemorrhagic', 'fever', 'disease', 'in', 'humans', 'and', 'animals', 'The', 'animal', 'hosts', 'including', 'non', 'human', 'primates', 'and', 'reservoir', 'hosts', 'fruit', 'bats', 'play', 'a', 'significant', 'role', 'in', 'transmission', 'and', 'maintenance', 'of', 'EBOV', 'in', 'nature', 'Although', 'no', 'approved', 'vaccine', 'for', 'the', 'prevention', 'of', 'EVD', 'currently', 'exists', 'disease', 'control', 'can', 'be', 'greatly', 'enhanced', 'by', 'timely', 'laboratory', 'confirmation', 'through', 'blood', 'tests', 'using', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'and', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'Adherence', 'to', 'strict', 'sanitary', 'and', 'hygienic', 'measures', 'monitoring', 'and', 'surveillance', 'of', 'EBOV', 'as', 'well', 'as', 'quarantine', 'checks', 'on', 'international', 'trade', 'transport', 'and', 'visitors', 'from', 'affected', 'countries', 'are', 'mandatory', 'to', 'prevent', 'and', 'control', 'the', 'spread', 'of', 'EVD', 'This', 'review', 'describes', 'the', 'salient', 'properties', 'of', 'EBOV', 'and', 'the', 'development', 'of', 'novel', 'diagnostics', 'vaccines', 'and', 'control', 'strategies', 'for', 'this', 'emerging', 'disease', 'of', 'high', 'public', 'health', 'concern', 'and', 'international', 'emergency', '']"
71608,Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays,2020-04-20,,https://doi.org/10.1101/2020.04.15.20066407,"Background: The SARS-CoV-2 pandemic caused >1 million infections during January-March 2020. There is an urgent need for robust antibody detection approaches to support diagnostics, vaccine development, safe individual release from quarantine and population lock-down exit strategies. The early promise of lateral flow immunoassay (LFIA) devices has been questioned following concerns about sensitivity and specificity. Methods: We used a panel of plasma samples designated SARS-CoV-2 positive (from SARS-CoV-2 RT-PCR-positive individuals; n=40) and negative (samples banked in the UK prior to December-2019 (n=142)). We tested plasma for SARS-Cov-2 IgM and IgG antibodies by ELISA and using nine different commercially available LFIA devices. Results: ELISA detected SARS-CoV-2 IgM or IgG in 34/40 individuals with an RT-PCR-confirmed diagnosis of SARS-CoV-2 infection (sensitivity 85%, 95%CI 70-94%), vs 0/50 pre-pandemic controls (specificity 100% [95%CI 93-100%]). IgG levels were detected in 31/31 RT-PCR-positive individuals tested ≥10 days after symptom onset (sensitivity 100%, 95%CI 89-100%). IgG titres rose during the 3 weeks post symptom onset and began to fall by 8 weeks, but remained above the detection threshold. Point estimates for the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively. Within the limits of the study size, the performance of most LFIA devices was similar. Conclusions: The performance of current LFIA devices is inadequate for most individual patient applications. ELISA can be calibrated to be specific for detecting and quantifying SARS-CoV-2 IgM and IgG and is highly sensitive for IgG from 10 days following symptoms onset.",10.1101/2020.04.15.20066407,5trox1i5,"['Background', 'The', 'SARS', 'CoV', '2', 'pandemic', 'caused', '1', 'million', 'infections', 'during', 'January', 'March', '2020', 'There', 'is', 'an', 'urgent', 'need', 'for', 'robust', 'antibody', 'detection', 'approaches', 'to', 'support', 'diagnostics', 'vaccine', 'development', 'safe', 'individual', 'release', 'from', 'quarantine', 'and', 'population', 'lock', 'down', 'exit', 'strategies', 'The', 'early', 'promise', 'of', 'lateral', 'flow', 'immunoassay', 'LFIA', 'devices', 'has', 'been', 'questioned', 'following', 'concerns', 'about', 'sensitivity', 'and', 'specificity', 'Methods', 'We', 'used', 'a', 'panel', 'of', 'plasma', 'samples', 'designated', 'SARS', 'CoV', '2', 'positive', 'from', 'SARS', 'CoV', '2', 'RT', 'PCR', 'positive', 'individuals', 'n', '40', 'and', 'negative', 'samples', 'banked', 'in', 'the', 'UK', 'prior', 'to', 'December', '2019', 'n', '142', 'We', 'tested', 'plasma', 'for', 'SARS', 'Cov', '2', 'IgM', 'and', 'IgG', 'antibodies', 'by', 'ELISA', 'and', 'using', 'nine', 'different', 'commercially', 'available', 'LFIA', 'devices', 'Results', 'ELISA', 'detected', 'SARS', 'CoV', '2', 'IgM', 'or', 'IgG', 'in', '34', '40', 'individuals', 'with', 'an', 'RT', 'PCR', 'confirmed', 'diagnosis', 'of', 'SARS', 'CoV', '2', 'infection', 'sensitivity', '85', '95', 'CI', '70', '94', 'vs', '0', '50', 'pre', 'pandemic', 'controls', 'specificity', '100', '95', 'CI', '93', '100', 'IgG', 'levels', 'were', 'detected', 'in', '31', '31', 'RT', 'PCR', 'positive', 'individuals', 'tested', '10', 'days', 'after', 'symptom', 'onset', 'sensitivity', '100', '95', 'CI', '89', '100', 'IgG', 'titres', 'rose', 'during', 'the', '3', 'weeks', 'post', 'symptom', 'onset', 'and', 'began', 'to', 'fall', 'by', '8', 'weeks', 'but', 'remained', 'above', 'the', 'detection', 'threshold', 'Point', 'estimates', 'for', 'the', 'sensitivity', 'of', 'LFIA', 'devices', 'ranged', 'from', '55', '70', 'versus', 'RT', 'PCR', 'and', '65', '85', 'versus', 'ELISA', 'with', 'specificity', '95', '100', 'and', '93', '100', 'respectively', 'Within', 'the', 'limits', 'of', 'the', 'study', 'size', 'the', 'performance', 'of', 'most', 'LFIA', 'devices', 'was', 'similar', 'Conclusions', 'The', 'performance', 'of', 'current', 'LFIA', 'devices', 'is', 'inadequate', 'for', 'most', 'individual', 'patient', 'applications', 'ELISA', 'can', 'be', 'calibrated', 'to', 'be', 'specific', 'for', 'detecting', 'and', 'quantifying', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'and', 'is', 'highly', 'sensitive', 'for', 'IgG', 'from', '10', 'days', 'following', 'symptoms', 'onset', '']"
71965,Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia,2020-06-04,,http://medrxiv.org/cgi/content/short/2020.06.02.20120782v1?rss=1,"Introduction: SARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemics. The virus crossed the species barrier and established in the human population due to its ability to exploit the ACE receptor for virus entry, which is present and abundant in several tissues, including the lung and respiratory tract, gastrointestinal tract and hearth. Virus interaction with the cellular receptor is mediated by the surface protein, known as Spike. Another structural protein of major importance in the Nucleocapsid, directly interacting with the viral RNA to form the ribonucleocapsid, considered a multifunctional protein, and being the target of the most molecular diagnostics assays. Objective: To describe the frequency of substitutions in spike and nucleocapsid proteins of SARS-CoV-2 circulating in Colombia and evaluate the frequency of these substitutions in SARS-CoV-2 sequences from other countries of South America. Materials and methods: Samples of 43 patients were included for viral RNA detection by real-time RT-PCR using the Charite-Berlin protocol for the amplification of the SARS-CoV-2 E and RdRp genes. Genome sequences were obtained through the Oxford Nanopore and Illumina MiSeq technologies, following the artic.network ""nCoV-2019 sequencing protocol"". Available genomes were consulted from GISAID, GenBank, and Genome sequence archive (GSA) and a total of 371 genomes sequences from South America were included. The genome sequences were aligned with the Muscle tool using the MEGA X software. Substitution matrices of the Colombian sequences respect to the reference genome (NC_045512) at the nucleotide and amino acid levels were generated for the spike and nucleocapsid gene. Results: substitution D614G in the amino acid sequence of spike protein was found in 86.7% of the Colombian sequences; substitutions G181V and D936Y in 2.3%, respectively. Five substitutions were found in the nucleocapsid protein, with substitution R203K and G204R being the most frequent (13.95 %) in Colombia. The substitutions D614G in Spike and R203K-G204R in nucleocapsid have a frequency of 83% and 28% respectively in sequences from South America. Conclusion: Non-synonymous substitutions were found in the spike and nucleocapsid proteins in Colombian genomes, the most frequent being D614G in Spike and R203K-G204R in nucleocapsid. These substitutions are frequent in the genomes reported for other South American countries. It is necessary to continue with genomic surveillance of the changes in Spike and Nucleocapsid proteins during the SARS-CoV-2 pandemic in Colombia and South America, even more considering that these proteins are the most commonly used antigen in serological tests.",10.1101/2020.06.02.20120782,zb034sbv,"['Introduction', 'SARS', 'CoV', '2', 'is', 'a', 'new', 'member', 'of', 'the', 'genus', 'Betacoronavirus', 'responsible', 'for', 'the', 'COVID', '19', 'pandemics', 'The', 'virus', 'crossed', 'the', 'species', 'barrier', 'and', 'established', 'in', 'the', 'human', 'population', 'due', 'to', 'its', 'ability', 'to', 'exploit', 'the', 'ACE', 'receptor', 'for', 'virus', 'entry', 'which', 'is', 'present', 'and', 'abundant', 'in', 'several', 'tissues', 'including', 'the', 'lung', 'and', 'respiratory', 'tract', 'gastrointestinal', 'tract', 'and', 'hearth', 'Virus', 'interaction', 'with', 'the', 'cellular', 'receptor', 'is', 'mediated', 'by', 'the', 'surface', 'protein', 'known', 'as', 'Spike', 'Another', 'structural', 'protein', 'of', 'major', 'importance', 'in', 'the', 'Nucleocapsid', 'directly', 'interacting', 'with', 'the', 'viral', 'RNA', 'to', 'form', 'the', 'ribonucleocapsid', 'considered', 'a', 'multifunctional', 'protein', 'and', 'being', 'the', 'target', 'of', 'the', 'most', 'molecular', 'diagnostics', 'assays', 'Objective', 'To', 'describe', 'the', 'frequency', 'of', 'substitutions', 'in', 'spike', 'and', 'nucleocapsid', 'proteins', 'of', 'SARS', 'CoV', '2', 'circulating', 'in', 'Colombia', 'and', 'evaluate', 'the', 'frequency', 'of', 'these', 'substitutions', 'in', 'SARS', 'CoV', '2', 'sequences', 'from', 'other', 'countries', 'of', 'South', 'America', 'Materials', 'and', 'methods', 'Samples', 'of', '43', 'patients', 'were', 'included', 'for', 'viral', 'RNA', 'detection', 'by', 'real', 'time', 'RT', 'PCR', 'using', 'the', 'Charite', 'Berlin', 'protocol', 'for', 'the', 'amplification', 'of', 'the', 'SARS', 'CoV', '2', 'E', 'and', 'RdRp', 'genes', 'Genome', 'sequences', 'were', 'obtained', 'through', 'the', 'Oxford', 'Nanopore', 'and', 'Illumina', 'MiSeq', 'technologies', 'following', 'the', 'artic', 'network', 'nCoV', '2019', 'sequencing', 'protocol', 'Available', 'genomes', 'were', 'consulted', 'from', 'GISAID', 'GenBank', 'and', 'Genome', 'sequence', 'archive', 'GSA', 'and', 'a', 'total', 'of', '371', 'genomes', 'sequences', 'from', 'South', 'America', 'were', 'included', 'The', 'genome', 'sequences', 'were', 'aligned', 'with', 'the', 'Muscle', 'tool', 'using', 'the', 'MEGA', 'X', 'software', 'Substitution', 'matrices', 'of', 'the', 'Colombian', 'sequences', 'respect', 'to', 'the', 'reference', 'genome', 'NC', '045512', 'at', 'the', 'nucleotide', 'and', 'amino', 'acid', 'levels', 'were', 'generated', 'for', 'the', 'spike', 'and', 'nucleocapsid', 'gene', 'Results', 'substitution', 'D614G', 'in', 'the', 'amino', 'acid', 'sequence', 'of', 'spike', 'protein', 'was', 'found', 'in', '86', '7', 'of', 'the', 'Colombian', 'sequences', 'substitutions', 'G181V', 'and', 'D936Y', 'in', '2', '3', 'respectively', 'Five', 'substitutions', 'were', 'found', 'in', 'the', 'nucleocapsid', 'protein', 'with', 'substitution', 'R203K', 'and', 'G204R', 'being', 'the', 'most', 'frequent', '13', '95', 'in', 'Colombia', 'The', 'substitutions', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'have', 'a', 'frequency', 'of', '83', 'and', '28', 'respectively', 'in', 'sequences', 'from', 'South', 'America', 'Conclusion', 'Non', 'synonymous', 'substitutions', 'were', 'found', 'in', 'the', 'spike', 'and', 'nucleocapsid', 'proteins', 'in', 'Colombian', 'genomes', 'the', 'most', 'frequent', 'being', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'These', 'substitutions', 'are', 'frequent', 'in', 'the', 'genomes', 'reported', 'for', 'other', 'South', 'American', 'countries', 'It', 'is', 'necessary', 'to', 'continue', 'with', 'genomic', 'surveillance', 'of', 'the', 'changes', 'in', 'Spike', 'and', 'Nucleocapsid', 'proteins', 'during', 'the', 'SARS', 'CoV', '2', 'pandemic', 'in', 'Colombia', 'and', 'South', 'America', 'even', 'more', 'considering', 'that', 'these', 'proteins', 'are', 'the', 'most', 'commonly', 'used', 'antigen', 'in', 'serological', 'tests', '']"
71995,Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care,2020-07-24,bioRxiv,https://doi.org/10.1101/2020.07.22.215251,"Most methods applied to nucleic acids’ detection at the point-of-care require either expensive and mostly bench-top instruments or simpler inexpensive systems providing qualitative results. Truly decentralized approaches to reliable, quantitative and affordable diagnostics are still missing. Here, we report the development of real-time quantitative colorimetric LAMP based on a portable and cost-effective device, the use of which requires minimal training. Main advantages of the method are the rapid analysis time (<30min); quantification over a large dynamic range (9 log units); ability to work with crude samples (saliva, tissue); demonstrated low detection limit (1-10 copies); smartphone-operation and fast prototyping (3D-printing). The system’s broad detection capability is demonstrated during infectious diseases-testing for COVID-19 and pharmacogenetics for BRAF V600E mutation testing. Validation studies showed 97.4% and 100% agreement with qRT-PCR for SARS-CoV-2 RNA detection extracted from positive and negative patients’ samples (89), respectively; and 100% agreement with ddPCR and Sanger sequencing for BRAF V600E mutation detection from 12 clinical biopsy samples. The new methodology provides a needed solution for affordable healthcare at the point-of-care, with emphasis on global diagnostics.",10.1101/2020.07.22.215251,e0krtdfy,"['Most', 'methods', 'applied', 'to', 'nucleic', 'acids', 'detection', 'at', 'the', 'point', 'of', 'care', 'require', 'either', 'expensive', 'and', 'mostly', 'bench', 'top', 'instruments', 'or', 'simpler', 'inexpensive', 'systems', 'providing', 'qualitative', 'results', 'Truly', 'decentralized', 'approaches', 'to', 'reliable', 'quantitative', 'and', 'affordable', 'diagnostics', 'are', 'still', 'missing', 'Here', 'we', 'report', 'the', 'development', 'of', 'real', 'time', 'quantitative', 'colorimetric', 'LAMP', 'based', 'on', 'a', 'portable', 'and', 'cost', 'effective', 'device', 'the', 'use', 'of', 'which', 'requires', 'minimal', 'training', 'Main', 'advantages', 'of', 'the', 'method', 'are', 'the', 'rapid', 'analysis', 'time', '30min', 'quantification', 'over', 'a', 'large', 'dynamic', 'range', '9', 'log', 'units', 'ability', 'to', 'work', 'with', 'crude', 'samples', 'saliva', 'tissue', 'demonstrated', 'low', 'detection', 'limit', '1', '10', 'copies', 'smartphone', 'operation', 'and', 'fast', 'prototyping', '3D', 'printing', 'The', 'system', 's', 'broad', 'detection', 'capability', 'is', 'demonstrated', 'during', 'infectious', 'diseases', 'testing', 'for', 'COVID', '19', 'and', 'pharmacogenetics', 'for', 'BRAF', 'V600E', 'mutation', 'testing', 'Validation', 'studies', 'showed', '97', '4', 'and', '100', 'agreement', 'with', 'qRT', 'PCR', 'for', 'SARS', 'CoV', '2', 'RNA', 'detection', 'extracted', 'from', 'positive', 'and', 'negative', 'patients', 'samples', '89', 'respectively', 'and', '100', 'agreement', 'with', 'ddPCR', 'and', 'Sanger', 'sequencing', 'for', 'BRAF', 'V600E', 'mutation', 'detection', 'from', '12', 'clinical', 'biopsy', 'samples', 'The', 'new', 'methodology', 'provides', 'a', 'needed', 'solution', 'for', 'affordable', 'healthcare', 'at', 'the', 'point', 'of', 'care', 'with', 'emphasis', 'on', 'global', 'diagnostics', '']"
72639,Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context.,2020-04-29,,http://medrxiv.org/cgi/content/short/2020.04.24.20077776v1?rss=1,"Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine decisions. In this Original Research article, we describe the conception, the analytical and clinical performances as well as the risk management of implementing the COVID-19 Ag Respi-Strip in a diagnostic decision algorithm. Materials and Methods: Development of the COVID-19 Ag Respi-Strip resulted in a ready-to-use ICT assay based on a membrane technology with colloidal gold nanoparticles using monoclonal antibodies directed against the SARS-CoV and SARS-CoV-2 highly conserved nucleoprotein antigen. Four hundred observations were recorded for the analytical performance study and thirty tests were analysed for the cross-reactivity study. The clinical performance study was performed in a retrospective multi-centric evaluation on aliquots of 328 nasopharyngeal samples. COVID-19 Ag Respi-Strip results were compared with qRT-PCR as golden standard for COVID-19 diagnostics. Results: In the analytical performance study, the reproducibility showed a between-observer disagreement of 1.7%, a robustness of 98%, an overall satisfying user friendliness and no cross-reactivity with other virus-infected nasopharyngeal samples. In the clinical performance study performed in three different clinical laboratories we found an overall sensitivity and specificity of 57.6% and 99.5% respectively with an accuracy of 82.6%. The cut-off of the assay was found at Ct<22. User-friendliness analysis and risk management assessment through Ishikawa diagram demonstrate that COVID-19 Ag Respi-Strip may be implemented in clinical laboratories according to biosafety recommendations. Conclusion: The COVID-19 Ag Respi-Strip represents a promising rapid SARS-CoV-2 antigen assay for the first-line diagnosis of COVID-19 in 15 minutes. Its role in the proposed diagnostic algorithm is complementary to the currently-used molecular techniques.",10.1101/2020.04.24.20077776,812st0np,"['Introduction', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'an', 'immunochromatographic', 'ICT', 'assay', 'for', 'the', 'rapid', 'detection', 'of', 'SARS', 'CoV', '2', 'antigen', 'on', 'nasopharyngeal', 'specimen', 'has', 'been', 'developed', 'to', 'identify', 'positive', 'COVID', '19', 'patients', 'allowing', 'prompt', 'clinical', 'and', 'quarantine', 'decisions', 'In', 'this', 'Original', 'Research', 'article', 'we', 'describe', 'the', 'conception', 'the', 'analytical', 'and', 'clinical', 'performances', 'as', 'well', 'as', 'the', 'risk', 'management', 'of', 'implementing', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'in', 'a', 'diagnostic', 'decision', 'algorithm', 'Materials', 'and', 'Methods', 'Development', 'of', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'resulted', 'in', 'a', 'ready', 'to', 'use', 'ICT', 'assay', 'based', 'on', 'a', 'membrane', 'technology', 'with', 'colloidal', 'gold', 'nanoparticles', 'using', 'monoclonal', 'antibodies', 'directed', 'against', 'the', 'SARS', 'CoV', 'and', 'SARS', 'CoV', '2', 'highly', 'conserved', 'nucleoprotein', 'antigen', 'Four', 'hundred', 'observations', 'were', 'recorded', 'for', 'the', 'analytical', 'performance', 'study', 'and', 'thirty', 'tests', 'were', 'analysed', 'for', 'the', 'cross', 'reactivity', 'study', 'The', 'clinical', 'performance', 'study', 'was', 'performed', 'in', 'a', 'retrospective', 'multi', 'centric', 'evaluation', 'on', 'aliquots', 'of', '328', 'nasopharyngeal', 'samples', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'results', 'were', 'compared', 'with', 'qRT', 'PCR', 'as', 'golden', 'standard', 'for', 'COVID', '19', 'diagnostics', 'Results', 'In', 'the', 'analytical', 'performance', 'study', 'the', 'reproducibility', 'showed', 'a', 'between', 'observer', 'disagreement', 'of', '1', '7', 'a', 'robustness', 'of', '98', 'an', 'overall', 'satisfying', 'user', 'friendliness', 'and', 'no', 'cross', 'reactivity', 'with', 'other', 'virus', 'infected', 'nasopharyngeal', 'samples', 'In', 'the', 'clinical', 'performance', 'study', 'performed', 'in', 'three', 'different', 'clinical', 'laboratories', 'we', 'found', 'an', 'overall', 'sensitivity', 'and', 'specificity', 'of', '57', '6', 'and', '99', '5', 'respectively', 'with', 'an', 'accuracy', 'of', '82', '6', 'The', 'cut', 'off', 'of', 'the', 'assay', 'was', 'found', 'at', 'Ct', '22', 'User', 'friendliness', 'analysis', 'and', 'risk', 'management', 'assessment', 'through', 'Ishikawa', 'diagram', 'demonstrate', 'that', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'may', 'be', 'implemented', 'in', 'clinical', 'laboratories', 'according', 'to', 'biosafety', 'recommendations', 'Conclusion', 'The', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'represents', 'a', 'promising', 'rapid', 'SARS', 'CoV', '2', 'antigen', 'assay', 'for', 'the', 'first', 'line', 'diagnosis', 'of', 'COVID', '19', 'in', '15', 'minutes', 'Its', 'role', 'in', 'the', 'proposed', 'diagnostic', 'algorithm', 'is', 'complementary', 'to', 'the', 'currently', 'used', 'molecular', 'techniques', '']"
72719,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020-04-11,,https://doi.org/10.1101/2020.04.07.20056234,"The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated (sample to result) RT-PCR platform offering random-access capabilities and good clinical performance for SARS-CoV-2 testing.",10.1101/2020.04.07.20056234,rkkhv4mw,"['The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'sample', 'to', 'result', 'RT', 'PCR', 'platform', 'offering', 'random', 'access', 'capabilities', 'and', 'good', 'clinical', 'performance', 'for', 'SARS', 'CoV', '2', 'testing', '']"
72823,Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution,2020-06-08,,http://medrxiv.org/cgi/content/short/2020.06.05.20109637v1?rss=1,"An epidemic caused by an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019 has since rapidly spread internationally, requiring urgent response from the clinical diagnostics community. We present a detailed overview of the clinical validation and implementation of the first laboratory-developed real-time reverse-transcription-PCR (rRT-PCR) test offered in the NewYork-Presbyterian Hospital system following the emergency use authority (EUA) guidance issued by the US Food and Drug Administration. Validation was performed on nasopharyngeal and sputum specimens (n=124) using newly designed dual-target rRT-PCR (altona RealStar SARS-CoV-2 Reagent) for detecting of SARS-CoV-2 in upper respiratory and lower respiratory tract specimens, including bronchoalveolar lavage and tracheal aspirates. Accuracy testing demonstrated excellent assay agreement between expected and observed values. The limit of detection (LOD) was 2.7 and 23.0 gene copies/reaction for nasopharyngeal and sputum specimens, respectively. Retrospective analysis of 1,694 tests from 1,571 patients revealed increased positivity in older patients and males compared to females, and an increasing positivity rate from approximately 20% at the start of testing to 50% at the end of testing three weeks later. Our findings demonstrate that the assay accurately and sensitively identifies SARS-CoV-2 in multiple specimen types in the clinical setting and summarizes clinical data from early in the epidemic in New York City.",10.1101/2020.06.05.20109637,mb784dam,"['An', 'epidemic', 'caused', 'by', 'an', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'in', 'China', 'in', 'December', '2019', 'has', 'since', 'rapidly', 'spread', 'internationally', 'requiring', 'urgent', 'response', 'from', 'the', 'clinical', 'diagnostics', 'community', 'We', 'present', 'a', 'detailed', 'overview', 'of', 'the', 'clinical', 'validation', 'and', 'implementation', 'of', 'the', 'first', 'laboratory', 'developed', 'real', 'time', 'reverse', 'transcription', 'PCR', 'rRT', 'PCR', 'test', 'offered', 'in', 'the', 'NewYork', 'Presbyterian', 'Hospital', 'system', 'following', 'the', 'emergency', 'use', 'authority', 'EUA', 'guidance', 'issued', 'by', 'the', 'US', 'Food', 'and', 'Drug', 'Administration', 'Validation', 'was', 'performed', 'on', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'n', '124', 'using', 'newly', 'designed', 'dual', 'target', 'rRT', 'PCR', 'altona', 'RealStar', 'SARS', 'CoV', '2', 'Reagent', 'for', 'detecting', 'of', 'SARS', 'CoV', '2', 'in', 'upper', 'respiratory', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'including', 'bronchoalveolar', 'lavage', 'and', 'tracheal', 'aspirates', 'Accuracy', 'testing', 'demonstrated', 'excellent', 'assay', 'agreement', 'between', 'expected', 'and', 'observed', 'values', 'The', 'limit', 'of', 'detection', 'LOD', 'was', '2', '7', 'and', '23', '0', 'gene', 'copies', 'reaction', 'for', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'respectively', 'Retrospective', 'analysis', 'of', '1', '694', 'tests', 'from', '1', '571', 'patients', 'revealed', 'increased', 'positivity', 'in', 'older', 'patients', 'and', 'males', 'compared', 'to', 'females', 'and', 'an', 'increasing', 'positivity', 'rate', 'from', 'approximately', '20', 'at', 'the', 'start', 'of', 'testing', 'to', '50', 'at', 'the', 'end', 'of', 'testing', 'three', 'weeks', 'later', 'Our', 'findings', 'demonstrate', 'that', 'the', 'assay', 'accurately', 'and', 'sensitively', 'identifies', 'SARS', 'CoV', '2', 'in', 'multiple', 'specimen', 'types', 'in', 'the', 'clinical', 'setting', 'and', 'summarizes', 'clinical', 'data', 'from', 'early', 'in', 'the', 'epidemic', 'in', 'New', 'York', 'City', '']"
73021,The UCSC SARS-CoV-2 Genome Browser,2020-05-04,bioRxiv,https://doi.org/10.1101/2020.05.04.075945,"Background Researchers are generating molecular data pertaining to the SARS-CoV-2 RNA genome and its proteins at an unprecedented rate during the COVID-19 pandemic. As a result, there is a critical need for rapid and continuously updated access to the latest molecular data in a format in which all data can be quickly cross-referenced and compared. We adapted our genome browser visualization tool to the viral genome for this purpose. Molecular data, curated from published studies or from database submissions, are mapped to the viral genome and grouped together into “annotation tracks” where they can be visualized along the linear map of the viral genome sequence and programmatically downloaded in standard format for analysis. Results The UCSC Genome Browser for SARS-CoV-2 (https://genome.ucsc.edu/covid19.html) provides continuously updated access to the mutations in the many thousands of SARS-CoV-2 genomes deposited in GISAID and the international nucleotide sequencing databases, displayed alongside phylogenetic trees. These data are augmented with alignments of bat, pangolin, and other animal and human coronavirus genomes, including per-base evolutionary rate analysis. All available annotations are cross-referenced on the virus genome, including those from major databases (PDB, RFAM, IEDB, UniProt) as well as up-to-date individual results from preprints. Annotated data include predicted and validated immune epitopes, promising antibodies, RT-PCR and sequencing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of interaction between human and viral genes. As a community resource, any user can add manual annotations which are quality checked and shared publicly on the browser the next day. Conclusions We invite all investigators to contribute additional data and annotations to this resource to accelerate research and development activities globally. Contact us at genome-www@soe.ucsc.edu with data suggestions or requests for support for adding data. Rapid sharing of data will accelerate SARS-CoV-2 research, especially when researchers take time to integrate their data with those from other labs on a widely-used community browser platform with standardized machine-readable data formats, such as the SARS-CoV-2 Genome Browser.",10.1101/2020.05.04.075945,gmk4qo4i,"['Background', 'Researchers', 'are', 'generating', 'molecular', 'data', 'pertaining', 'to', 'the', 'SARS', 'CoV', '2', 'RNA', 'genome', 'and', 'its', 'proteins', 'at', 'an', 'unprecedented', 'rate', 'during', 'the', 'COVID', '19', 'pandemic', 'As', 'a', 'result', 'there', 'is', 'a', 'critical', 'need', 'for', 'rapid', 'and', 'continuously', 'updated', 'access', 'to', 'the', 'latest', 'molecular', 'data', 'in', 'a', 'format', 'in', 'which', 'all', 'data', 'can', 'be', 'quickly', 'cross', 'referenced', 'and', 'compared', 'We', 'adapted', 'our', 'genome', 'browser', 'visualization', 'tool', 'to', 'the', 'viral', 'genome', 'for', 'this', 'purpose', 'Molecular', 'data', 'curated', 'from', 'published', 'studies', 'or', 'from', 'database', 'submissions', 'are', 'mapped', 'to', 'the', 'viral', 'genome', 'and', 'grouped', 'together', 'into', 'annotation', 'tracks', 'where', 'they', 'can', 'be', 'visualized', 'along', 'the', 'linear', 'map', 'of', 'the', 'viral', 'genome', 'sequence', 'and', 'programmatically', 'downloaded', 'in', 'standard', 'format', 'for', 'analysis', 'Results', 'The', 'UCSC', 'Genome', 'Browser', 'for', 'SARS', 'CoV', '2', 'https', 'genome', 'ucsc', 'edu', 'covid19', 'html', 'provides', 'continuously', 'updated', 'access', 'to', 'the', 'mutations', 'in', 'the', 'many', 'thousands', 'of', 'SARS', 'CoV', '2', 'genomes', 'deposited', 'in', 'GISAID', 'and', 'the', 'international', 'nucleotide', 'sequencing', 'databases', 'displayed', 'alongside', 'phylogenetic', 'trees', 'These', 'data', 'are', 'augmented', 'with', 'alignments', 'of', 'bat', 'pangolin', 'and', 'other', 'animal', 'and', 'human', 'coronavirus', 'genomes', 'including', 'per', 'base', 'evolutionary', 'rate', 'analysis', 'All', 'available', 'annotations', 'are', 'cross', 'referenced', 'on', 'the', 'virus', 'genome', 'including', 'those', 'from', 'major', 'databases', 'PDB', 'RFAM', 'IEDB', 'UniProt', 'as', 'well', 'as', 'up', 'to', 'date', 'individual', 'results', 'from', 'preprints', 'Annotated', 'data', 'include', 'predicted', 'and', 'validated', 'immune', 'epitopes', 'promising', 'antibodies', 'RT', 'PCR', 'and', 'sequencing', 'primers', 'CRISPR', 'guides', 'from', 'research', 'diagnostics', 'vaccines', 'and', 'therapies', 'and', 'points', 'of', 'interaction', 'between', 'human', 'and', 'viral', 'genes', 'As', 'a', 'community', 'resource', 'any', 'user', 'can', 'add', 'manual', 'annotations', 'which', 'are', 'quality', 'checked', 'and', 'shared', 'publicly', 'on', 'the', 'browser', 'the', 'next', 'day', 'Conclusions', 'We', 'invite', 'all', 'investigators', 'to', 'contribute', 'additional', 'data', 'and', 'annotations', 'to', 'this', 'resource', 'to', 'accelerate', 'research', 'and', 'development', 'activities', 'globally', 'Contact', 'us', 'at', 'genome', 'www', 'soe', 'ucsc', 'edu', 'with', 'data', 'suggestions', 'or', 'requests', 'for', 'support', 'for', 'adding', 'data', 'Rapid', 'sharing', 'of', 'data', 'will', 'accelerate', 'SARS', 'CoV', '2', 'research', 'especially', 'when', 'researchers', 'take', 'time', 'to', 'integrate', 'their', 'data', 'with', 'those', 'from', 'other', 'labs', 'on', 'a', 'widely', 'used', 'community', 'browser', 'platform', 'with', 'standardized', 'machine', 'readable', 'data', 'formats', 'such', 'as', 'the', 'SARS', 'CoV', '2', 'Genome', 'Browser', '']"
74114,Failure of the cobas(R) SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome,2020-05-03,,http://medrxiv.org/cgi/content/short/2020.04.28.20083337v1?rss=1,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of RT-PCR tests have been developed to identify SARS-CoV-2, targeting multiple regions in the viral genome. In comparison to other RNA viruses the mutation rate of SARS-CoV-2 is moderate, however given the large number of transmission chains it is prudent to monitor circulating viruses for mutations that might compromise these tests. Here we report the identification of a C-to-T transition at position 26340 of the SARS-CoV-2 genome which is associated with failure of the cobas(R) SARS-CoV-2 E-gene assay. This variant was detected in four health care workers from the same team. Whole genome sequencing of SARS-CoV-2 showed all four to carry genetically identical viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently on three occasions. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect the RT-PCRs used in diagnostics. Additionally, it argues that two regions in the SARS-CoV-2 should be targeted in RT-PCRs to avoid false negatives.",10.1101/2020.04.28.20083337,vd62r8qu,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'RT', 'PCR', 'tests', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'regions', 'in', 'the', 'viral', 'genome', 'In', 'comparison', 'to', 'other', 'RNA', 'viruses', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'however', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'mutations', 'that', 'might', 'compromise', 'these', 'tests', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'T', 'transition', 'at', 'position', '26340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'R', 'SARS', 'CoV', '2', 'E', 'gene', 'assay', 'This', 'variant', 'was', 'detected', 'in', 'four', 'health', 'care', 'workers', 'from', 'the', 'same', 'team', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'four', 'to', 'carry', 'genetically', 'identical', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'on', 'three', 'occasions', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'the', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'in', 'RT', 'PCRs', 'to', 'avoid', 'false', 'negatives', '']"
74274,Optimized qRT-PCR approach for the detection of intra- and extra-cellular SARS-CoV-2 RNAs,2020-04-25,bioRxiv,https://doi.org/10.1101/2020.04.20.052258,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19 which has become a global concern due to its rapid spread. Meanwhile, increased demand in testing has led to shortage of reagents, supplies, and compromised the performance of diagnostic laboratories in many countries. Both the world health organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate interpretation of the test results especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in the diagnostics as well as in research labs using a low cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infection and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.1101/2020.04.20.052258,t9jaspf2,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'in', 'testing', 'has', 'led', 'to', 'shortage', 'of', 'reagents', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'world', 'health', 'organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'the', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
74792,Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus,2020-02-23,,https://doi.org/10.1101/2020.02.22.20025460,"Background: The recent outbreak of infections by the 2019 novel coronavirus (2019-nCoV), the third zoonotic CoV has raised great public health concern. The demand for rapid and accurate diagnosis of this novel pathogen brought significant clinical and technological challenges. Currently, metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) are the most widely used molecular diagnostics. Methods: 2019-nCoV infections were confirmed in 52 specimens by mNGS. Genomic information was analyzed and used for the design and development of an isothermal, CRISPR-based diagnostic for this novel virus. The diagnostic performance of CRISPR-nCoV was assessed and compared across three technology platforms (mNGS, RT-PCR and CRISPR). Results: 2019-nCoVs sequenced in our study were conserved with the Wuhan strain, and shared certain genetic similarity with SARS-CoV. A high degree of variation in the level of viral RNA was observed in clinical specimens. CRISPR-nCoV demonstrated a near single-copy sensitivity and great clinical sensitivity with a shorter turn-around time than RT-PCR. Conclusion: CRISPR-nCoV presents as a promising diagnostic option for the emerging pathogen.",10.1101/2020.02.22.20025460,hth8f5sn,"['Background', 'The', 'recent', 'outbreak', 'of', 'infections', 'by', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'the', 'third', 'zoonotic', 'CoV', 'has', 'raised', 'great', 'public', 'health', 'concern', 'The', 'demand', 'for', 'rapid', 'and', 'accurate', 'diagnosis', 'of', 'this', 'novel', 'pathogen', 'brought', 'significant', 'clinical', 'and', 'technological', 'challenges', 'Currently', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'and', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'are', 'the', 'most', 'widely', 'used', 'molecular', 'diagnostics', 'Methods', '2019', 'nCoV', 'infections', 'were', 'confirmed', 'in', '52', 'specimens', 'by', 'mNGS', 'Genomic', 'information', 'was', 'analyzed', 'and', 'used', 'for', 'the', 'design', 'and', 'development', 'of', 'an', 'isothermal', 'CRISPR', 'based', 'diagnostic', 'for', 'this', 'novel', 'virus', 'The', 'diagnostic', 'performance', 'of', 'CRISPR', 'nCoV', 'was', 'assessed', 'and', 'compared', 'across', 'three', 'technology', 'platforms', 'mNGS', 'RT', 'PCR', 'and', 'CRISPR', 'Results', '2019', 'nCoVs', 'sequenced', 'in', 'our', 'study', 'were', 'conserved', 'with', 'the', 'Wuhan', 'strain', 'and', 'shared', 'certain', 'genetic', 'similarity', 'with', 'SARS', 'CoV', 'A', 'high', 'degree', 'of', 'variation', 'in', 'the', 'level', 'of', 'viral', 'RNA', 'was', 'observed', 'in', 'clinical', 'specimens', 'CRISPR', 'nCoV', 'demonstrated', 'a', 'near', 'single', 'copy', 'sensitivity', 'and', 'great', 'clinical', 'sensitivity', 'with', 'a', 'shorter', 'turn', 'around', 'time', 'than', 'RT', 'PCR', 'Conclusion', 'CRISPR', 'nCoV', 'presents', 'as', 'a', 'promising', 'diagnostic', 'option', 'for', 'the', 'emerging', 'pathogen', '']"
75239,In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19,2020-06-02,bioRxiv,https://doi.org/10.1101/2020.05.22.111526,"Rapid generation of diagnostics is paramount to understand epidemiology and to control the spread of emerging infectious diseases such as COVID-19. Computational methods to predict serodiagnostic epitopes that are specific for the pathogen could help accelerate the development of new diagnostics. A systematic survey of 27 SARS-CoV-2 proteins was conducted to assess whether existing B-cell epitope prediction methods, combined with comprehensive mining of sequence databases and structural data, could predict whether a particular protein would be suitable for serodiagnosis. Nine of the predictions were validated with recombinant SARS-CoV-2 proteins in the ELISA format using plasma and sera from patients with SARS-CoV-2 infection, and a further 11 predictions were compared to the recent literature. Results appeared to be in agreement with 12 of the predictions, in disagreement with 3, while a further 5 were deemed inconclusive. We showed that two of our top five candidates, the N-terminal fragment of the nucleoprotein and the receptor-binding domain of the spike protein, have the highest sensitivity and specificity and signal-to-noise ratio for detecting COVID-19 sera/plasma by ELISA. Mixing the two antigens together for coating ELISA plates led to a sensitivity of 94% (N=80 samples from persons with RT-PCR confirmed SARS-CoV2 infection), and a specificity of 97.2% (N=106 control samples).",10.1101/2020.05.22.111526,90a9rhsh,"['Rapid', 'generation', 'of', 'diagnostics', 'is', 'paramount', 'to', 'understand', 'epidemiology', 'and', 'to', 'control', 'the', 'spread', 'of', 'emerging', 'infectious', 'diseases', 'such', 'as', 'COVID', '19', 'Computational', 'methods', 'to', 'predict', 'serodiagnostic', 'epitopes', 'that', 'are', 'specific', 'for', 'the', 'pathogen', 'could', 'help', 'accelerate', 'the', 'development', 'of', 'new', 'diagnostics', 'A', 'systematic', 'survey', 'of', '27', 'SARS', 'CoV', '2', 'proteins', 'was', 'conducted', 'to', 'assess', 'whether', 'existing', 'B', 'cell', 'epitope', 'prediction', 'methods', 'combined', 'with', 'comprehensive', 'mining', 'of', 'sequence', 'databases', 'and', 'structural', 'data', 'could', 'predict', 'whether', 'a', 'particular', 'protein', 'would', 'be', 'suitable', 'for', 'serodiagnosis', 'Nine', 'of', 'the', 'predictions', 'were', 'validated', 'with', 'recombinant', 'SARS', 'CoV', '2', 'proteins', 'in', 'the', 'ELISA', 'format', 'using', 'plasma', 'and', 'sera', 'from', 'patients', 'with', 'SARS', 'CoV', '2', 'infection', 'and', 'a', 'further', '11', 'predictions', 'were', 'compared', 'to', 'the', 'recent', 'literature', 'Results', 'appeared', 'to', 'be', 'in', 'agreement', 'with', '12', 'of', 'the', 'predictions', 'in', 'disagreement', 'with', '3', 'while', 'a', 'further', '5', 'were', 'deemed', 'inconclusive', 'We', 'showed', 'that', 'two', 'of', 'our', 'top', 'five', 'candidates', 'the', 'N', 'terminal', 'fragment', 'of', 'the', 'nucleoprotein', 'and', 'the', 'receptor', 'binding', 'domain', 'of', 'the', 'spike', 'protein', 'have', 'the', 'highest', 'sensitivity', 'and', 'specificity', 'and', 'signal', 'to', 'noise', 'ratio', 'for', 'detecting', 'COVID', '19', 'sera', 'plasma', 'by', 'ELISA', 'Mixing', 'the', 'two', 'antigens', 'together', 'for', 'coating', 'ELISA', 'plates', 'led', 'to', 'a', 'sensitivity', 'of', '94', 'N', '80', 'samples', 'from', 'persons', 'with', 'RT', 'PCR', 'confirmed', 'SARS', 'CoV2', 'infection', 'and', 'a', 'specificity', 'of', '97', '2', 'N', '106', 'control', 'samples', '']"
76436,Dog Savior: Immediate Scent-Detection of SARS-COV-2 by Trained Dogs,2020-06-19,bioRxiv,https://doi.org/10.1101/2020.06.17.158105,"Molecular tests for viral diagnostics are essential to confront the COVID-19 pandemic, but their production and distribution cannot satisfy the current high demand. Early identification of infected people and their contacts is the key to being able to isolate them and prevent the dissemination of the pathogen; unfortunately, most countries are unable to do this due to the lack of diagnostic tools. Dogs can identify, with a high rate of precision, unique odors of volatile organic compounds generated during an infection; as a result, dogs can diagnose infectious agents by smelling specimens and, sometimes, the body of an infected individual. We trained six dogs of three different breeds to detect SARS-CoV-2 in respiratory secretions of infected patients and evaluated their performance experimentally, comparing it against the gold standard (rRT-PCR). Here we show that viral detection takes one second per specimen. After scent-interrogating 9,200 samples, our six dogs achieved independently and as a group very high sensitivity, specificity, predictive values, accuracy, and likelihood ratio, with very narrow confidence intervals. The highest metric was the negative predictive value, indicating that with a disease prevalence of 7.6%, 99.9% of the specimens indicated as negative by the dogs did not carry the virus. These findings demonstrate that dogs could be useful to track viral infection in humans, allowing COVID-19 free people to return to work safely.",10.1101/2020.06.17.158105,ywuj9gu7,"['Molecular', 'tests', 'for', 'viral', 'diagnostics', 'are', 'essential', 'to', 'confront', 'the', 'COVID', '19', 'pandemic', 'but', 'their', 'production', 'and', 'distribution', 'cannot', 'satisfy', 'the', 'current', 'high', 'demand', 'Early', 'identification', 'of', 'infected', 'people', 'and', 'their', 'contacts', 'is', 'the', 'key', 'to', 'being', 'able', 'to', 'isolate', 'them', 'and', 'prevent', 'the', 'dissemination', 'of', 'the', 'pathogen', 'unfortunately', 'most', 'countries', 'are', 'unable', 'to', 'do', 'this', 'due', 'to', 'the', 'lack', 'of', 'diagnostic', 'tools', 'Dogs', 'can', 'identify', 'with', 'a', 'high', 'rate', 'of', 'precision', 'unique', 'odors', 'of', 'volatile', 'organic', 'compounds', 'generated', 'during', 'an', 'infection', 'as', 'a', 'result', 'dogs', 'can', 'diagnose', 'infectious', 'agents', 'by', 'smelling', 'specimens', 'and', 'sometimes', 'the', 'body', 'of', 'an', 'infected', 'individual', 'We', 'trained', 'six', 'dogs', 'of', 'three', 'different', 'breeds', 'to', 'detect', 'SARS', 'CoV', '2', 'in', 'respiratory', 'secretions', 'of', 'infected', 'patients', 'and', 'evaluated', 'their', 'performance', 'experimentally', 'comparing', 'it', 'against', 'the', 'gold', 'standard', 'rRT', 'PCR', 'Here', 'we', 'show', 'that', 'viral', 'detection', 'takes', 'one', 'second', 'per', 'specimen', 'After', 'scent', 'interrogating', '9', '200', 'samples', 'our', 'six', 'dogs', 'achieved', 'independently', 'and', 'as', 'a', 'group', 'very', 'high', 'sensitivity', 'specificity', 'predictive', 'values', 'accuracy', 'and', 'likelihood', 'ratio', 'with', 'very', 'narrow', 'confidence', 'intervals', 'The', 'highest', 'metric', 'was', 'the', 'negative', 'predictive', 'value', 'indicating', 'that', 'with', 'a', 'disease', 'prevalence', 'of', '7', '6', '99', '9', 'of', 'the', 'specimens', 'indicated', 'as', 'negative', 'by', 'the', 'dogs', 'did', 'not', 'carry', 'the', 'virus', 'These', 'findings', 'demonstrate', 'that', 'dogs', 'could', 'be', 'useful', 'to', 'track', 'viral', 'infection', 'in', 'humans', 'allowing', 'COVID', '19', 'free', 'people', 'to', 'return', 'to', 'work', 'safely', '']"
76548,Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic,2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20085068v1?rss=1,"ABSTRACT Background: Antibody diagnostics play an important role in disease detection and can potentially aid in monitoring of the immune responses to see if an individual has developed immunity. Developing high throughput diagnostics which does not involve handling of infectious material becomes imperative in the case of pandemics such as the recent outbreak of SARS-CoV2. Methods: A protein microarray technology was used to detect the plurality of antibody response to four novel antigens namely S1 glycoprotein, Receptor binding domain (RBD), S2 glycoprotein and Nucleoprotein of the novel coronavirus named SARS-CoV2 using serum samples. A DBS card was additionally used to compare its performance with a venipuncture-based serum separator tube (SST) draw. Results: The three main subclasses of antibodies IgM, IgA and IgG were analyzed to see the variations in immune responses in the affected population and compared to their microbial RT-PCR based NP swab results. The clinical sensitivity and specificity were determined to be 98.1% and 98.6%. In the matrix comparison study, which would enable patients to test without risk of transmitting the virus, DBS matched with higher than 98% accuracy to a venipuncture-based SST collection. Conclusion: Multiplex testing enables higher sensitivity and specificity which is essential while establishing exposure on a population scale. This flexible platform along with a discrete collection methodology would be crucial and broadly useful to scale up testing in current and future pandemics. Minimum sample volume that can be collected using DBS cards can be processed in this multiplex pillar plate format enabling the capacity to provide the reliability of high throughput analyzers while having the ease of collection similar to rapid tests. Keywords: COVID19, SARS-CoV2, Antibody, Multiplex, serology, biomarker, immune modulation, prevalence, high sensitivity, high specificity, Dried blood spot, pandemic, venipuncture",10.1101/2020.04.29.20085068,8uu10t4p,"['ABSTRACT', 'Background', 'Antibody', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'disease', 'detection', 'and', 'can', 'potentially', 'aid', 'in', 'monitoring', 'of', 'the', 'immune', 'responses', 'to', 'see', 'if', 'an', 'individual', 'has', 'developed', 'immunity', 'Developing', 'high', 'throughput', 'diagnostics', 'which', 'does', 'not', 'involve', 'handling', 'of', 'infectious', 'material', 'becomes', 'imperative', 'in', 'the', 'case', 'of', 'pandemics', 'such', 'as', 'the', 'recent', 'outbreak', 'of', 'SARS', 'CoV2', 'Methods', 'A', 'protein', 'microarray', 'technology', 'was', 'used', 'to', 'detect', 'the', 'plurality', 'of', 'antibody', 'response', 'to', 'four', 'novel', 'antigens', 'namely', 'S1', 'glycoprotein', 'Receptor', 'binding', 'domain', 'RBD', 'S2', 'glycoprotein', 'and', 'Nucleoprotein', 'of', 'the', 'novel', 'coronavirus', 'named', 'SARS', 'CoV2', 'using', 'serum', 'samples', 'A', 'DBS', 'card', 'was', 'additionally', 'used', 'to', 'compare', 'its', 'performance', 'with', 'a', 'venipuncture', 'based', 'serum', 'separator', 'tube', 'SST', 'draw', 'Results', 'The', 'three', 'main', 'subclasses', 'of', 'antibodies', 'IgM', 'IgA', 'and', 'IgG', 'were', 'analyzed', 'to', 'see', 'the', 'variations', 'in', 'immune', 'responses', 'in', 'the', 'affected', 'population', 'and', 'compared', 'to', 'their', 'microbial', 'RT', 'PCR', 'based', 'NP', 'swab', 'results', 'The', 'clinical', 'sensitivity', 'and', 'specificity', 'were', 'determined', 'to', 'be', '98', '1', 'and', '98', '6', 'In', 'the', 'matrix', 'comparison', 'study', 'which', 'would', 'enable', 'patients', 'to', 'test', 'without', 'risk', 'of', 'transmitting', 'the', 'virus', 'DBS', 'matched', 'with', 'higher', 'than', '98', 'accuracy', 'to', 'a', 'venipuncture', 'based', 'SST', 'collection', 'Conclusion', 'Multiplex', 'testing', 'enables', 'higher', 'sensitivity', 'and', 'specificity', 'which', 'is', 'essential', 'while', 'establishing', 'exposure', 'on', 'a', 'population', 'scale', 'This', 'flexible', 'platform', 'along', 'with', 'a', 'discrete', 'collection', 'methodology', 'would', 'be', 'crucial', 'and', 'broadly', 'useful', 'to', 'scale', 'up', 'testing', 'in', 'current', 'and', 'future', 'pandemics', 'Minimum', 'sample', 'volume', 'that', 'can', 'be', 'collected', 'using', 'DBS', 'cards', 'can', 'be', 'processed', 'in', 'this', 'multiplex', 'pillar', 'plate', 'format', 'enabling', 'the', 'capacity', 'to', 'provide', 'the', 'reliability', 'of', 'high', 'throughput', 'analyzers', 'while', 'having', 'the', 'ease', 'of', 'collection', 'similar', 'to', 'rapid', 'tests', 'Keywords', 'COVID19', 'SARS', 'CoV2', 'Antibody', 'Multiplex', 'serology', 'biomarker', 'immune', 'modulation', 'prevalence', 'high', 'sensitivity', 'high', 'specificity', 'Dried', 'blood', 'spot', 'pandemic', 'venipuncture']"
76565,Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs,2020-04-22,,http://medrxiv.org/cgi/content/short/2020.04.16.20067835v1?rss=1,"Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs. Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches. Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies. To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards. When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing.",10.1101/2020.04.16.20067835,lt7qsxxh,"['Rapid', 'and', 'accurate', 'SARS', 'CoV', '2', 'diagnostic', 'testing', 'is', 'essential', 'for', 'controlling', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'The', 'current', 'gold', 'standard', 'for', 'COVID', '19', 'diagnosis', 'is', 'real', 'time', 'RT', 'PCR', 'detection', 'of', 'SARS', 'CoV', '2', 'from', 'nasopharyngeal', 'swabs', 'Low', 'sensitivity', 'exposure', 'risks', 'to', 'healthcare', 'workers', 'and', 'global', 'shortages', 'of', 'swabs', 'and', 'personal', 'protective', 'equipment', 'however', 'necessitate', 'the', 'validation', 'of', 'new', 'diagnostic', 'approaches', 'Saliva', 'is', 'a', 'promising', 'candidate', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'because', '1', 'collection', 'is', 'minimally', 'invasive', 'and', 'can', 'reliably', 'be', 'self', 'administered', 'and', '2', 'saliva', 'has', 'exhibited', 'comparable', 'sensitivity', 'to', 'nasopharyngeal', 'swabs', 'in', 'detection', 'of', 'other', 'respiratory', 'pathogens', 'including', 'endemic', 'human', 'coronaviruses', 'in', 'previous', 'studies', 'To', 'validate', 'the', 'use', 'of', 'saliva', 'for', 'SARS', 'CoV', '2', 'detection', 'we', 'tested', 'nasopharyngeal', 'and', 'saliva', 'samples', 'from', 'confirmed', 'COVID', '19', 'patients', 'and', 'self', 'collected', 'samples', 'from', 'healthcare', 'workers', 'on', 'COVID', '19', 'wards', 'When', 'we', 'compared', 'SARS', 'CoV', '2', 'detection', 'from', 'patient', 'matched', 'nasopharyngeal', 'and', 'saliva', 'samples', 'we', 'found', 'that', 'saliva', 'yielded', 'greater', 'detection', 'sensitivity', 'and', 'consistency', 'throughout', 'the', 'course', 'of', 'infection', 'Furthermore', 'we', 'report', 'less', 'variability', 'in', 'self', 'sample', 'collection', 'of', 'saliva', 'Taken', 'together', 'our', 'findings', 'demonstrate', 'that', 'saliva', 'is', 'a', 'viable', 'and', 'more', 'sensitive', 'alternative', 'to', 'nasopharyngeal', 'swabs', 'and', 'could', 'enable', 'at', 'home', 'self', 'administered', 'sample', 'collection', 'for', 'accurate', 'large', 'scale', 'SARS', 'CoV', '2', 'testing', '']"
77421,A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry,2020-07-29,,http://medrxiv.org/cgi/content/short/2020.07.27.20161836v1?rss=1,"In the last few months, there has been a global catastrophic outbreak of severe acute respiratory syndrome disease caused by the novel corona virus SARS-CoV-2 affecting millions of people worldwide. Early diagnosis and isolation is key to contain the rapid spread of the virus. Towards this goal, we report a simple, sensitive and rapid method to detect the virus using a targeted mass spectrometric approach, which can directly detect the presence of virus from naso-oropharyngeal swabs. Using a multiple reaction monitoring we can detect the presence of two peptides specific to SARS-CoV-2 in a 2.3 minute gradient run with 100% specificity and 90.4 % sensitivity when compared to RT-PCR. Importantly, we further show that these peptides could be detected even in the patients who have recovered from the symptoms and have tested negative for the virus by RT-PCR highlighting the sensitivity of the technique. This method has the translational potential of in terms of the rapid diagnostics of symptomatic and asymptomatic COVID-19 and can augment current methods available for diagnosis of SARS-CoV-2.",10.1101/2020.07.27.20161836,h1ovifuq,"['In', 'the', 'last', 'few', 'months', 'there', 'has', 'been', 'a', 'global', 'catastrophic', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'disease', 'caused', 'by', 'the', 'novel', 'corona', 'virus', 'SARS', 'CoV', '2', 'affecting', 'millions', 'of', 'people', 'worldwide', 'Early', 'diagnosis', 'and', 'isolation', 'is', 'key', 'to', 'contain', 'the', 'rapid', 'spread', 'of', 'the', 'virus', 'Towards', 'this', 'goal', 'we', 'report', 'a', 'simple', 'sensitive', 'and', 'rapid', 'method', 'to', 'detect', 'the', 'virus', 'using', 'a', 'targeted', 'mass', 'spectrometric', 'approach', 'which', 'can', 'directly', 'detect', 'the', 'presence', 'of', 'virus', 'from', 'naso', 'oropharyngeal', 'swabs', 'Using', 'a', 'multiple', 'reaction', 'monitoring', 'we', 'can', 'detect', 'the', 'presence', 'of', 'two', 'peptides', 'specific', 'to', 'SARS', 'CoV', '2', 'in', 'a', '2', '3', 'minute', 'gradient', 'run', 'with', '100', 'specificity', 'and', '90', '4', 'sensitivity', 'when', 'compared', 'to', 'RT', 'PCR', 'Importantly', 'we', 'further', 'show', 'that', 'these', 'peptides', 'could', 'be', 'detected', 'even', 'in', 'the', 'patients', 'who', 'have', 'recovered', 'from', 'the', 'symptoms', 'and', 'have', 'tested', 'negative', 'for', 'the', 'virus', 'by', 'RT', 'PCR', 'highlighting', 'the', 'sensitivity', 'of', 'the', 'technique', 'This', 'method', 'has', 'the', 'translational', 'potential', 'of', 'in', 'terms', 'of', 'the', 'rapid', 'diagnostics', 'of', 'symptomatic', 'and', 'asymptomatic', 'COVID', '19', 'and', 'can', 'augment', 'current', 'methods', 'available', 'for', 'diagnosis', 'of', 'SARS', 'CoV', '2', '']"
78488,Pushing beyond specifications: Evaluation of linearity and clinical performance of a fully automated SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations,2020-05-30,,http://medrxiv.org/cgi/content/short/2020.05.28.20115469v1?rss=1,"Background: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In this study we evaluate clinical performance and linear range for the SARS-CoV-2 IVD (cobas6800/8800 system, a fully automated sample-to-result platform) in different clinically relevant matrix materials outside official specifications. Methods: Assay performance was assessed in human plasma, BAL/BL and transport medium following chemical inactivation. For analytical evaluation, respective matrix materials were spiked with SARS-CoV-2 RNA in ten-fold dilution series. The efficacy of chemical inactivation by guanidine hydrochloride solution was confirmed in cell culture infectivity experiments. For correlation, a total of 235 predetermined clinical samples including respiratory swabs, plasma and BAL/BL were subjected to the SARS-CoV-2 IVD test and results were compared. Results: The SARS-CoV-2 IVD showed excellent linearity over five to seven log steps depending on matrix material. Chemical inactivation resulted in a reduction in plaque forming units of at least 3.5 log steps, while having no significant impact on assay performance. Inter-run consistency from three different testing sites demonstrated excellent comparability of RT-PCR results (maximum deviation was 1.53 CT). Clinical evaluation for respiratory swabs showed very good agreement with the comparator assay (Positive agreement 95.7%, negative agreement 98.9%). Conclusion: The SARS-CoV-2 IVD test for the cobas6800/8800 systems offers excellent linear range and inter-run consistency for quantification of SARS-CoV-2 RNA in different matrices outside official specifications.",10.1101/2020.05.28.20115469,c9dwvhk3,"['Background', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'to', 'diagnostic', 'laboratories', 'There', 'are', 'preliminary', 'studies', 'correlating', 'qRT', 'PCR', 'results', 'from', 'different', 'materials', 'to', 'clinical', 'outcomes', 'yet', 'comparability', 'is', 'limited', 'due', 'to', 'the', 'plethora', 'of', 'different', 'assays', 'used', 'for', 'diagnostics', 'In', 'this', 'study', 'we', 'evaluate', 'clinical', 'performance', 'and', 'linear', 'range', 'for', 'the', 'SARS', 'CoV', '2', 'IVD', 'cobas6800', '8800', 'system', 'a', 'fully', 'automated', 'sample', 'to', 'result', 'platform', 'in', 'different', 'clinically', 'relevant', 'matrix', 'materials', 'outside', 'official', 'specifications', 'Methods', 'Assay', 'performance', 'was', 'assessed', 'in', 'human', 'plasma', 'BAL', 'BL', 'and', 'transport', 'medium', 'following', 'chemical', 'inactivation', 'For', 'analytical', 'evaluation', 'respective', 'matrix', 'materials', 'were', 'spiked', 'with', 'SARS', 'CoV', '2', 'RNA', 'in', 'ten', 'fold', 'dilution', 'series', 'The', 'efficacy', 'of', 'chemical', 'inactivation', 'by', 'guanidine', 'hydrochloride', 'solution', 'was', 'confirmed', 'in', 'cell', 'culture', 'infectivity', 'experiments', 'For', 'correlation', 'a', 'total', 'of', '235', 'predetermined', 'clinical', 'samples', 'including', 'respiratory', 'swabs', 'plasma', 'and', 'BAL', 'BL', 'were', 'subjected', 'to', 'the', 'SARS', 'CoV', '2', 'IVD', 'test', 'and', 'results', 'were', 'compared', 'Results', 'The', 'SARS', 'CoV', '2', 'IVD', 'showed', 'excellent', 'linearity', 'over', 'five', 'to', 'seven', 'log', 'steps', 'depending', 'on', 'matrix', 'material', 'Chemical', 'inactivation', 'resulted', 'in', 'a', 'reduction', 'in', 'plaque', 'forming', 'units', 'of', 'at', 'least', '3', '5', 'log', 'steps', 'while', 'having', 'no', 'significant', 'impact', 'on', 'assay', 'performance', 'Inter', 'run', 'consistency', 'from', 'three', 'different', 'testing', 'sites', 'demonstrated', 'excellent', 'comparability', 'of', 'RT', 'PCR', 'results', 'maximum', 'deviation', 'was', '1', '53', 'CT', 'Clinical', 'evaluation', 'for', 'respiratory', 'swabs', 'showed', 'very', 'good', 'agreement', 'with', 'the', 'comparator', 'assay', 'Positive', 'agreement', '95', '7', 'negative', 'agreement', '98', '9', 'Conclusion', 'The', 'SARS', 'CoV', '2', 'IVD', 'test', 'for', 'the', 'cobas6800', '8800', 'systems', 'offers', 'excellent', 'linear', 'range', 'and', 'inter', 'run', 'consistency', 'for', 'quantification', 'of', 'SARS', 'CoV', '2', 'RNA', 'in', 'different', 'matrices', 'outside', 'official', 'specifications', '']"
78638,A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities,2020-04-17,bioRxiv,https://doi.org/10.1101/2020.04.14.041319,"The COVID-19 pandemic is expanding at an unprecedented rate. As a result, diagnostic services are stretched to their limit, and there is a clear need for the provision of additional diagnostic capacity. Academic laboratories, many of which are closed due to governmental lockdowns, may be in a position to support local screening capacity by adapting their current laboratory practices. Here, we describe the process of developing a SARS-Cov2 diagnostic workflow in a conventional academic Containment Level 2 (CL2) laboratory. Our outline includes simple SARS-Cov2 deactivation upon contact, the methods for a quantitative real-time reverse transcriptase PCR (qRT-PCR) detecting SARS-Cov2, a description of process establishment and validation, and some considerations for establishing a similar workflow elsewhere. This was achieved under challenging circumstances through the collaborative efforts of scientists, clinical staff, and diagnostic staff to mitigate to the ongoing crisis. Within 14 days, we created a validated COVID-19 diagnostics service for healthcare workers in our local hospital. The described methods are not exhaustive, but we hope may offer support to other academic groups aiming to set up something comparable in a short time frame.",10.1101/2020.04.14.041319,xyzu4b47,"['The', 'COVID', '19', 'pandemic', 'is', 'expanding', 'at', 'an', 'unprecedented', 'rate', 'As', 'a', 'result', 'diagnostic', 'services', 'are', 'stretched', 'to', 'their', 'limit', 'and', 'there', 'is', 'a', 'clear', 'need', 'for', 'the', 'provision', 'of', 'additional', 'diagnostic', 'capacity', 'Academic', 'laboratories', 'many', 'of', 'which', 'are', 'closed', 'due', 'to', 'governmental', 'lockdowns', 'may', 'be', 'in', 'a', 'position', 'to', 'support', 'local', 'screening', 'capacity', 'by', 'adapting', 'their', 'current', 'laboratory', 'practices', 'Here', 'we', 'describe', 'the', 'process', 'of', 'developing', 'a', 'SARS', 'Cov2', 'diagnostic', 'workflow', 'in', 'a', 'conventional', 'academic', 'Containment', 'Level', '2', 'CL2', 'laboratory', 'Our', 'outline', 'includes', 'simple', 'SARS', 'Cov2', 'deactivation', 'upon', 'contact', 'the', 'methods', 'for', 'a', 'quantitative', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'qRT', 'PCR', 'detecting', 'SARS', 'Cov2', 'a', 'description', 'of', 'process', 'establishment', 'and', 'validation', 'and', 'some', 'considerations', 'for', 'establishing', 'a', 'similar', 'workflow', 'elsewhere', 'This', 'was', 'achieved', 'under', 'challenging', 'circumstances', 'through', 'the', 'collaborative', 'efforts', 'of', 'scientists', 'clinical', 'staff', 'and', 'diagnostic', 'staff', 'to', 'mitigate', 'to', 'the', 'ongoing', 'crisis', 'Within', '14', 'days', 'we', 'created', 'a', 'validated', 'COVID', '19', 'diagnostics', 'service', 'for', 'healthcare', 'workers', 'in', 'our', 'local', 'hospital', 'The', 'described', 'methods', 'are', 'not', 'exhaustive', 'but', 'we', 'hope', 'may', 'offer', 'support', 'to', 'other', 'academic', 'groups', 'aiming', 'to', 'set', 'up', 'something', 'comparable', 'in', 'a', 'short', 'time', 'frame', '']"
79819,Comparison of commercial RT-PCR diagnostic kits for COVID-19,2020-04-24,bioRxiv,https://doi.org/10.1101/2020.04.22.056747,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95% limit of detection (LOD95%). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n=16) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n=6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was ≥96% for all assays and the estimated LOD95% varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",10.1101/2020.04.22.056747,dpk3fqqj,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '16', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
80526,Real-time RT-PCR diagnostics of virus causing COVID-19,2020,Farmakoekonomika,https://doi.org/10.17749/2070-4909.2020.13.1.52-63,"Aim: the study was aimed to develop a reagent kit for the real-time RT-PCR diagnostics of virus causing COVID-19 Materials and Methods Three target sites were chosen in the genome SARS-CoV-2 The testing included 220 samples, 48 artificially created positive samples (made from patients' biomaterial) and 172 clinical samples (scrapes from nasal and pharyngeal cavities, bronchoalveolar lavage, expectoration, endotracheal/nasopharyngeal aspirate, feces, post-mortem material), obtained from two medical centers Preliminary, the obtained biomaterial was analyzed with a reagent kit of comparison The evaluation was performed with a confidential interval CI 95% The calculation of CI for the sensitivity and specificity was made based on the distribution of χ2 Results The authors developed a technology of novel coronavirus infection (COVID-19) real-time RT-PCR diagnostics for the application in practical healthcare and proposed the variants of testing at all the stages (preanalytical, analytical, and post-analytical, including automated results processing) The proposed reagent kit meets the requirements of the World Health Organization and the Ministry of Healthcare of the Russian Federation The study results demonstrated high sensitivity and specificity The sensitivity was 100% (95% CI) 95 6-100%;the specificity was 100% (95% CI) 96 7-100% Conclusion The proposed reagent kit was registered in the RF as a medical product;the registration certificate No RZN 2020/9948 dated 01 04 2020 The application of the reagent kit in network laboratories will provide patients with access to testing for the virus causing COVID-19 and contribute to quick differential diagnostics, improvement of pandemic control, and accurate statistics on the spread of the virus",10.17749/2070-4909.2020.13.1.52-63,5wqirhd1,"['Aim', 'the', 'study', 'was', 'aimed', 'to', 'develop', 'a', 'reagent', 'kit', 'for', 'the', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'of', 'virus', 'causing', 'COVID', '19', 'Materials', 'and', 'Methods', 'Three', 'target', 'sites', 'were', 'chosen', 'in', 'the', 'genome', 'SARS', 'CoV', '2', 'The', 'testing', 'included', '220', 'samples', '48', 'artificially', 'created', 'positive', 'samples', 'made', 'from', 'patients', 'biomaterial', 'and', '172', 'clinical', 'samples', 'scrapes', 'from', 'nasal', 'and', 'pharyngeal', 'cavities', 'bronchoalveolar', 'lavage', 'expectoration', 'endotracheal', 'nasopharyngeal', 'aspirate', 'feces', 'post', 'mortem', 'material', 'obtained', 'from', 'two', 'medical', 'centers', 'Preliminary', 'the', 'obtained', 'biomaterial', 'was', 'analyzed', 'with', 'a', 'reagent', 'kit', 'of', 'comparison', 'The', 'evaluation', 'was', 'performed', 'with', 'a', 'confidential', 'interval', 'CI', '95', 'The', 'calculation', 'of', 'CI', 'for', 'the', 'sensitivity', 'and', 'specificity', 'was', 'made', 'based', 'on', 'the', 'distribution', 'of', 'χ2', 'Results', 'The', 'authors', 'developed', 'a', 'technology', 'of', 'novel', 'coronavirus', 'infection', 'COVID', '19', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'for', 'the', 'application', 'in', 'practical', 'healthcare', 'and', 'proposed', 'the', 'variants', 'of', 'testing', 'at', 'all', 'the', 'stages', 'preanalytical', 'analytical', 'and', 'post', 'analytical', 'including', 'automated', 'results', 'processing', 'The', 'proposed', 'reagent', 'kit', 'meets', 'the', 'requirements', 'of', 'the', 'World', 'Health', 'Organization', 'and', 'the', 'Ministry', 'of', 'Healthcare', 'of', 'the', 'Russian', 'Federation', 'The', 'study', 'results', 'demonstrated', 'high', 'sensitivity', 'and', 'specificity', 'The', 'sensitivity', 'was', '100', '95', 'CI', '95', '6', '100', 'the', 'specificity', 'was', '100', '95', 'CI', '96', '7', '100', 'Conclusion', 'The', 'proposed', 'reagent', 'kit', 'was', 'registered', 'in', 'the', 'RF', 'as', 'a', 'medical', 'product', 'the', 'registration', 'certificate', 'No', 'RZN', '2020', '9948', 'dated', '01', '04', '2020', 'The', 'application', 'of', 'the', 'reagent', 'kit', 'in', 'network', 'laboratories', 'will', 'provide', 'patients', 'with', 'access', 'to', 'testing', 'for', 'the', 'virus', 'causing', 'COVID', '19', 'and', 'contribute', 'to', 'quick', 'differential', 'diagnostics', 'improvement', 'of', 'pandemic', 'control', 'and', 'accurate', 'statistics', 'on', 'the', 'spread', 'of', 'the', 'virus']"
82843,Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).,2008,"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",https://www.ncbi.nlm.nih.gov/pubmed/19203466/,"PURPOSE The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance. METHODS This review describes the specific molecular targets for diagnostics and therapeutics of viral infection. RESULTS The three major diagnostic methods available for SARS includes viral RNA detection by reverse transcription polymerase chain reaction (RT-PCR), virus induced antibodies by immunofluorescence assay (IFA) or by enzyme linked immunosorbant assay (ELISA) of nucleocapsid protein (NP). The spike glycoprotein of SARS-CoV is the major inducer of neutralizing antibodies. The receptor binding domain (RBD) in the S1 region of the spike glycoprotein contains multiple conformational epitopes that induces highly potent neutralizing antibodies. The genetically engineered attenuated form of the virus or viral vector vaccine encoding for the SARS-CoV spike glycoprotein has been shown to elicit protective immunity in vaccinated animals. CONCLUSION NP is the preferred target for routine detection of SARS-CoV infection by ELISA which is an economical method compared to other methods. The RBD of the spike glycoprotein is both a functional domain for cell receptor binding and also a major neutralizing determinant of SARS-CoV. The progress in evaluating a therapeutic or vaccine would depend on the avail ability of clinically relevant animal model.",,qxiyo47f,"['PURPOSE', 'The', 'large', 'number', 'of', 'deaths', 'in', 'a', 'short', 'period', 'of', 'time', 'due', 'to', 'the', 'spread', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'infection', 'led', 'to', 'the', 'unparalleled', 'collaborative', 'efforts', 'world', 'wide', 'to', 'determine', 'and', 'characterize', 'the', 'new', 'coronavirus', 'SARS', 'CoV', 'The', 'full', 'genome', 'sequence', 'was', 'determined', 'within', 'weeks', 'of', 'the', 'first', 'outbreak', 'by', 'the', 'Canadian', 'group', 'with', 'international', 'collaboration', 'As', 'per', 'the', 'World', 'Health', 'Organization', 'WHO', 'the', 'continual', 'lack', 'of', 'a', 'rapid', 'laboratory', 'test', 'to', 'aid', 'the', 'early', 'diagnosis', 'of', 'suspected', 'cases', 'of', 'SARS', 'makes', 'this', 'area', 'a', 'priority', 'for', 'future', 'research', 'To', 'prevent', 'deaths', 'in', 'the', 'future', 'early', 'diagnosis', 'and', 'therapy', 'of', 'this', 'infectious', 'disease', 'is', 'of', 'paramount', 'importance', 'METHODS', 'This', 'review', 'describes', 'the', 'specific', 'molecular', 'targets', 'for', 'diagnostics', 'and', 'therapeutics', 'of', 'viral', 'infection', 'RESULTS', 'The', 'three', 'major', 'diagnostic', 'methods', 'available', 'for', 'SARS', 'includes', 'viral', 'RNA', 'detection', 'by', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'virus', 'induced', 'antibodies', 'by', 'immunofluorescence', 'assay', 'IFA', 'or', 'by', 'enzyme', 'linked', 'immunosorbant', 'assay', 'ELISA', 'of', 'nucleocapsid', 'protein', 'NP', 'The', 'spike', 'glycoprotein', 'of', 'SARS', 'CoV', 'is', 'the', 'major', 'inducer', 'of', 'neutralizing', 'antibodies', 'The', 'receptor', 'binding', 'domain', 'RBD', 'in', 'the', 'S1', 'region', 'of', 'the', 'spike', 'glycoprotein', 'contains', 'multiple', 'conformational', 'epitopes', 'that', 'induces', 'highly', 'potent', 'neutralizing', 'antibodies', 'The', 'genetically', 'engineered', 'attenuated', 'form', 'of', 'the', 'virus', 'or', 'viral', 'vector', 'vaccine', 'encoding', 'for', 'the', 'SARS', 'CoV', 'spike', 'glycoprotein', 'has', 'been', 'shown', 'to', 'elicit', 'protective', 'immunity', 'in', 'vaccinated', 'animals', 'CONCLUSION', 'NP', 'is', 'the', 'preferred', 'target', 'for', 'routine', 'detection', 'of', 'SARS', 'CoV', 'infection', 'by', 'ELISA', 'which', 'is', 'an', 'economical', 'method', 'compared', 'to', 'other', 'methods', 'The', 'RBD', 'of', 'the', 'spike', 'glycoprotein', 'is', 'both', 'a', 'functional', 'domain', 'for', 'cell', 'receptor', 'binding', 'and', 'also', 'a', 'major', 'neutralizing', 'determinant', 'of', 'SARS', 'CoV', 'The', 'progress', 'in', 'evaluating', 'a', 'therapeutic', 'or', 'vaccine', 'would', 'depend', 'on', 'the', 'avail', 'ability', 'of', 'clinically', 'relevant', 'animal', 'model', '']"
86712,The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.,2004,The Clinical biochemist. Reviews,https://www.ncbi.nlm.nih.gov/pubmed/18458711/,"The 2003 pandemic of Severe Acute Respiratory Syndrome (SARS) profiled the ability of modern diagnostic microbiology and molecular biology to identify, isolate and characterize, within weeks, a previously unknown viral infectious pathogen. The culprit, SARS coronavirus (SARS-CoV), was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction (RT-PCR) targeting the polymerase 1 B region of the genome. In addition, serologic assays were rapidly developed, and the genome of this large virus was sequenced within one month of its spread to North America. At the present time, diagnostics have progressed to the point that RT-PCR has a sensitivity approaching 80% within the first few days of onset of illness, while serology has a sensitivity close to 100% on convalescent sera taken >21 days after illness onset. Viral culture remains a method confined to biosafety level III laboratories. The specificity of RT-PCR and serology remains to be conclusively defined, but in most studies to date seems to be >90%. Serologic cross-reactivity with human coronaviruses causing the common cold may be a problem with some serologic assays. The early development of SARS-CoV diagnostics is now being replaced by refinement and optimization of these assays. Although at the present time we do not have a test that will definitively rule in or rule out SARS at the time of initial presentation of a patient with a respiratory infection, modifications of existing assays will hopefully result in our ability to make this diagnosis with a high degree of accuracy in the future.",,ycch15k8,"['The', '2003', 'pandemic', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'profiled', 'the', 'ability', 'of', 'modern', 'diagnostic', 'microbiology', 'and', 'molecular', 'biology', 'to', 'identify', 'isolate', 'and', 'characterize', 'within', 'weeks', 'a', 'previously', 'unknown', 'viral', 'infectious', 'pathogen', 'The', 'culprit', 'SARS', 'coronavirus', 'SARS', 'CoV', 'was', 'detected', 'in', 'patient', 'specimens', 'by', 'traditional', 'cell', 'culture', 'using', 'an', 'unusual', 'cell', 'line', 'for', 'respiratory', 'viruses', 'Vero', 'E6', 'and', 'by', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'targeting', 'the', 'polymerase', '1', 'B', 'region', 'of', 'the', 'genome', 'In', 'addition', 'serologic', 'assays', 'were', 'rapidly', 'developed', 'and', 'the', 'genome', 'of', 'this', 'large', 'virus', 'was', 'sequenced', 'within', 'one', 'month', 'of', 'its', 'spread', 'to', 'North', 'America', 'At', 'the', 'present', 'time', 'diagnostics', 'have', 'progressed', 'to', 'the', 'point', 'that', 'RT', 'PCR', 'has', 'a', 'sensitivity', 'approaching', '80', 'within', 'the', 'first', 'few', 'days', 'of', 'onset', 'of', 'illness', 'while', 'serology', 'has', 'a', 'sensitivity', 'close', 'to', '100', 'on', 'convalescent', 'sera', 'taken', '21', 'days', 'after', 'illness', 'onset', 'Viral', 'culture', 'remains', 'a', 'method', 'confined', 'to', 'biosafety', 'level', 'III', 'laboratories', 'The', 'specificity', 'of', 'RT', 'PCR', 'and', 'serology', 'remains', 'to', 'be', 'conclusively', 'defined', 'but', 'in', 'most', 'studies', 'to', 'date', 'seems', 'to', 'be', '90', 'Serologic', 'cross', 'reactivity', 'with', 'human', 'coronaviruses', 'causing', 'the', 'common', 'cold', 'may', 'be', 'a', 'problem', 'with', 'some', 'serologic', 'assays', 'The', 'early', 'development', 'of', 'SARS', 'CoV', 'diagnostics', 'is', 'now', 'being', 'replaced', 'by', 'refinement', 'and', 'optimization', 'of', 'these', 'assays', 'Although', 'at', 'the', 'present', 'time', 'we', 'do', 'not', 'have', 'a', 'test', 'that', 'will', 'definitively', 'rule', 'in', 'or', 'rule', 'out', 'SARS', 'at', 'the', 'time', 'of', 'initial', 'presentation', 'of', 'a', 'patient', 'with', 'a', 'respiratory', 'infection', 'modifications', 'of', 'existing', 'assays', 'will', 'hopefully', 'result', 'in', 'our', 'ability', 'to', 'make', 'this', 'diagnosis', 'with', 'a', 'high', 'degree', 'of', 'accuracy', 'in', 'the', 'future', '']"
87782,Native nucleic acid electrophoresis as an efficient alternative for genotyping method of influenza virus.,2014,Acta biochimica Polonica,https://www.ncbi.nlm.nih.gov/pubmed/25180222/,"Influenza viruses are the worldwide major causative agents of human and animal acute respiratory infections. Some of the influenza subtypes have caused epidemics and pandemics among humans. The varieties of methods are available for the rapid isolation and identification of influenza viruses in clinical and environmental samples. Since nucleic acids amplification techniques such as RT-PCR have been adapted, fast and sensitive influenza type and subtype determination is possible. However, in some ambiguous cases other, more detailed assay might be desired. The genetic material of influenza virus is highly unstable and constantly mutates. It is known that single nucleotide polymorphisms (SNPs) results in resistance to commercially available anti-viral drugs. The genetic drift of the virus could also result in weakening of immune response to infection. Finally, in a substantial number of patients co-infection with various virus strains or types has been confirmed. Although the detection of co-infection or presence of minor genetic variants within flu-infected patients is not a routine procedure, a rapid and wide spectrum diagnostics of influenza virus infections could reveal an accurate picture of the disease and more importantly, is crucial for choosing the appropriate therapeutics and virus monitoring. Herein we present the evidences that native gel electrophoresis and MSSCP--a method based on multitemperature single strand conformation polymorphism could furnish a useful technique for minor variants, which escape discovery by conventional diagnostic assays.",,uu2edrfg,"['Influenza', 'viruses', 'are', 'the', 'worldwide', 'major', 'causative', 'agents', 'of', 'human', 'and', 'animal', 'acute', 'respiratory', 'infections', 'Some', 'of', 'the', 'influenza', 'subtypes', 'have', 'caused', 'epidemics', 'and', 'pandemics', 'among', 'humans', 'The', 'varieties', 'of', 'methods', 'are', 'available', 'for', 'the', 'rapid', 'isolation', 'and', 'identification', 'of', 'influenza', 'viruses', 'in', 'clinical', 'and', 'environmental', 'samples', 'Since', 'nucleic', 'acids', 'amplification', 'techniques', 'such', 'as', 'RT', 'PCR', 'have', 'been', 'adapted', 'fast', 'and', 'sensitive', 'influenza', 'type', 'and', 'subtype', 'determination', 'is', 'possible', 'However', 'in', 'some', 'ambiguous', 'cases', 'other', 'more', 'detailed', 'assay', 'might', 'be', 'desired', 'The', 'genetic', 'material', 'of', 'influenza', 'virus', 'is', 'highly', 'unstable', 'and', 'constantly', 'mutates', 'It', 'is', 'known', 'that', 'single', 'nucleotide', 'polymorphisms', 'SNPs', 'results', 'in', 'resistance', 'to', 'commercially', 'available', 'anti', 'viral', 'drugs', 'The', 'genetic', 'drift', 'of', 'the', 'virus', 'could', 'also', 'result', 'in', 'weakening', 'of', 'immune', 'response', 'to', 'infection', 'Finally', 'in', 'a', 'substantial', 'number', 'of', 'patients', 'co', 'infection', 'with', 'various', 'virus', 'strains', 'or', 'types', 'has', 'been', 'confirmed', 'Although', 'the', 'detection', 'of', 'co', 'infection', 'or', 'presence', 'of', 'minor', 'genetic', 'variants', 'within', 'flu', 'infected', 'patients', 'is', 'not', 'a', 'routine', 'procedure', 'a', 'rapid', 'and', 'wide', 'spectrum', 'diagnostics', 'of', 'influenza', 'virus', 'infections', 'could', 'reveal', 'an', 'accurate', 'picture', 'of', 'the', 'disease', 'and', 'more', 'importantly', 'is', 'crucial', 'for', 'choosing', 'the', 'appropriate', 'therapeutics', 'and', 'virus', 'monitoring', 'Herein', 'we', 'present', 'the', 'evidences', 'that', 'native', 'gel', 'electrophoresis', 'and', 'MSSCP', 'a', 'method', 'based', 'on', 'multitemperature', 'single', 'strand', 'conformation', 'polymorphism', 'could', 'furnish', 'a', 'useful', 'technique', 'for', 'minor', 'variants', 'which', 'escape', 'discovery', 'by', 'conventional', 'diagnostic', 'assays', '']"
88286,Simple enzymatic means to neutralize DNA contamination in nucleic acid amplification.,2005,BioTechniques,https://www.ncbi.nlm.nih.gov/pubmed/16060371/,"Reverse transcription PCR (RT-PCR) is prone to false positives when contaminating DNA molecules are present at the start of a reaction. Contaminants that derive from earlier work using a given primer pair (carryover PCR products) are of particular concern when those primers are used routinely, as in clinical diagnostics or environmental monitoring. In addition, contamination by genomic DNA can significantly interfere with quantitative and qualitative analysis of RNAs by RT-PCR. Here we describe contaminant restriction (ConR), a method that can be used to neutralize carryover and genomic DNA contamination in RT-PCR studies. Restriction enzymes (REs) added to the amplification cocktail cleave contaminant DNA molecules while sparing the intended target nucleic acid. Restriction, reverse transcription, and amplification steps all take place in the same sealed vessel, thus avoiding any danger of recontamination. ConR eliminates carryover contamination in PCR without compromising target sequence amplification. Because the method is effective against both genomic and carryover contamination, it can be employed routinely in one-step RT-PCR, whatever the RNA target or the nature of the potential DNA contaminant. A variation of this decontamination method, amplicon primer site restriction (APSR), is effective specifically against carryover contamination. APSR, unlike ConR, can be applied during PCR-based amplification of DNA target molecules.",,p92h8av7,"['Reverse', 'transcription', 'PCR', 'RT', 'PCR', 'is', 'prone', 'to', 'false', 'positives', 'when', 'contaminating', 'DNA', 'molecules', 'are', 'present', 'at', 'the', 'start', 'of', 'a', 'reaction', 'Contaminants', 'that', 'derive', 'from', 'earlier', 'work', 'using', 'a', 'given', 'primer', 'pair', 'carryover', 'PCR', 'products', 'are', 'of', 'particular', 'concern', 'when', 'those', 'primers', 'are', 'used', 'routinely', 'as', 'in', 'clinical', 'diagnostics', 'or', 'environmental', 'monitoring', 'In', 'addition', 'contamination', 'by', 'genomic', 'DNA', 'can', 'significantly', 'interfere', 'with', 'quantitative', 'and', 'qualitative', 'analysis', 'of', 'RNAs', 'by', 'RT', 'PCR', 'Here', 'we', 'describe', 'contaminant', 'restriction', 'ConR', 'a', 'method', 'that', 'can', 'be', 'used', 'to', 'neutralize', 'carryover', 'and', 'genomic', 'DNA', 'contamination', 'in', 'RT', 'PCR', 'studies', 'Restriction', 'enzymes', 'REs', 'added', 'to', 'the', 'amplification', 'cocktail', 'cleave', 'contaminant', 'DNA', 'molecules', 'while', 'sparing', 'the', 'intended', 'target', 'nucleic', 'acid', 'Restriction', 'reverse', 'transcription', 'and', 'amplification', 'steps', 'all', 'take', 'place', 'in', 'the', 'same', 'sealed', 'vessel', 'thus', 'avoiding', 'any', 'danger', 'of', 'recontamination', 'ConR', 'eliminates', 'carryover', 'contamination', 'in', 'PCR', 'without', 'compromising', 'target', 'sequence', 'amplification', 'Because', 'the', 'method', 'is', 'effective', 'against', 'both', 'genomic', 'and', 'carryover', 'contamination', 'it', 'can', 'be', 'employed', 'routinely', 'in', 'one', 'step', 'RT', 'PCR', 'whatever', 'the', 'RNA', 'target', 'or', 'the', 'nature', 'of', 'the', 'potential', 'DNA', 'contaminant', 'A', 'variation', 'of', 'this', 'decontamination', 'method', 'amplicon', 'primer', 'site', 'restriction', 'APSR', 'is', 'effective', 'specifically', 'against', 'carryover', 'contamination', 'APSR', 'unlike', 'ConR', 'can', 'be', 'applied', 'during', 'PCR', 'based', 'amplification', 'of', 'DNA', 'target', 'molecules', '']"
92286,Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis.,2005,Clinical science,https://www.ncbi.nlm.nih.gov/pubmed/16171460/,"qRT-PCR (real-time reverse transcription-PCR) has become the benchmark for the detection and quantification of RNA targets and is being utilized increasingly in novel clinical diagnostic assays. Quantitative results obtained by this technology are not only more informative than qualitative data, but simplify assay standardization and quality management. qRT-PCR assays are most established for the detection of viral load and therapy monitoring, and the development of SARS (severe acute respiratory syndrome)-associated coronavirus qRT-PCR assays provide a textbook example of the value of this technology for clinical diagnostics. The widespread use of qRT-PCR assays for diagnosis and the detection of disease-specific prognostic markers in leukaemia patients provide further examples of their usefulness. Their value for the detection of disease-associated mRNA expressed by circulating tumour cells in patients with solid malignancies is far less apparent, and the clinical significance of results obtained from such tests remains unclear. This is because of conceptual reservations as well as technical limitations that can interfere with the diagnostic specificity of qRT-PCR assays. Therefore, although it is evident that qRT-PCR assay has become a useful and important technology in the clinical diagnostic laboratory, it must be used appropriately and it is essential to be aware of its limitations if it is to fulfil its potential.",,z1d8i5em,"['qRT', 'PCR', 'real', 'time', 'reverse', 'transcription', 'PCR', 'has', 'become', 'the', 'benchmark', 'for', 'the', 'detection', 'and', 'quantification', 'of', 'RNA', 'targets', 'and', 'is', 'being', 'utilized', 'increasingly', 'in', 'novel', 'clinical', 'diagnostic', 'assays', 'Quantitative', 'results', 'obtained', 'by', 'this', 'technology', 'are', 'not', 'only', 'more', 'informative', 'than', 'qualitative', 'data', 'but', 'simplify', 'assay', 'standardization', 'and', 'quality', 'management', 'qRT', 'PCR', 'assays', 'are', 'most', 'established', 'for', 'the', 'detection', 'of', 'viral', 'load', 'and', 'therapy', 'monitoring', 'and', 'the', 'development', 'of', 'SARS', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'qRT', 'PCR', 'assays', 'provide', 'a', 'textbook', 'example', 'of', 'the', 'value', 'of', 'this', 'technology', 'for', 'clinical', 'diagnostics', 'The', 'widespread', 'use', 'of', 'qRT', 'PCR', 'assays', 'for', 'diagnosis', 'and', 'the', 'detection', 'of', 'disease', 'specific', 'prognostic', 'markers', 'in', 'leukaemia', 'patients', 'provide', 'further', 'examples', 'of', 'their', 'usefulness', 'Their', 'value', 'for', 'the', 'detection', 'of', 'disease', 'associated', 'mRNA', 'expressed', 'by', 'circulating', 'tumour', 'cells', 'in', 'patients', 'with', 'solid', 'malignancies', 'is', 'far', 'less', 'apparent', 'and', 'the', 'clinical', 'significance', 'of', 'results', 'obtained', 'from', 'such', 'tests', 'remains', 'unclear', 'This', 'is', 'because', 'of', 'conceptual', 'reservations', 'as', 'well', 'as', 'technical', 'limitations', 'that', 'can', 'interfere', 'with', 'the', 'diagnostic', 'specificity', 'of', 'qRT', 'PCR', 'assays', 'Therefore', 'although', 'it', 'is', 'evident', 'that', 'qRT', 'PCR', 'assay', 'has', 'become', 'a', 'useful', 'and', 'important', 'technology', 'in', 'the', 'clinical', 'diagnostic', 'laboratory', 'it', 'must', 'be', 'used', 'appropriately', 'and', 'it', 'is', 'essential', 'to', 'be', 'aware', 'of', 'its', 'limitations', 'if', 'it', 'is', 'to', 'fulfil', 'its', 'potential', '']"
92433,"Identification of viral agents associated with diarrhea in young children during a winter season in Beijing, China.",2006,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,https://www.ncbi.nlm.nih.gov/pubmed/15998600/,"BACKGROUND Viral diarrhea remains a major cause of childhood morbidity and mortality worldwide. Although rotavirus was extensively studied in China, few comprehensive studies of all viral agents related to diarrhea in children have been conducted. OBJECTIVES Our study was performed to investigate the role of enteric viruses in acute diarrhea in our country and to evaluate methods that could be used in routine diagnostics. STUDY DESIGN One hundred stool samples were collected from children under 5 years of age seeking medical care for acute diarrhea during the winter season 2000/2001 in Beijing Children's Hospital. All specimens were initially screened microscopically for leucocytes/red blood cells. Samples with negative results were analyzed for virus presence using commercial EIAs and/or in-house RT-PCRs. RESULTS At least one viral agent was found in 67% of the specimens. The frequency of rotavirus, astrovirus, norovirus and enteric adenovirus was 59%, 8%, 6% and 2%, respectively. Dual infections were found in 9.0% (6/67) of the positive samples. The results from rotavirus and astrovirus EIAs were concordant with those of rotavirus and astrovirus RT-PCRs. CONCLUSIONS Enteric viruses play an important role in pediatric diarrhea during the winter season in China. A combination of microscopic examination of stool samples with specific EIA assays to detect virus antigen in stool specimens may be suitable for routine diagnostics.",,vfje1hpq,"['BACKGROUND', 'Viral', 'diarrhea', 'remains', 'a', 'major', 'cause', 'of', 'childhood', 'morbidity', 'and', 'mortality', 'worldwide', 'Although', 'rotavirus', 'was', 'extensively', 'studied', 'in', 'China', 'few', 'comprehensive', 'studies', 'of', 'all', 'viral', 'agents', 'related', 'to', 'diarrhea', 'in', 'children', 'have', 'been', 'conducted', 'OBJECTIVES', 'Our', 'study', 'was', 'performed', 'to', 'investigate', 'the', 'role', 'of', 'enteric', 'viruses', 'in', 'acute', 'diarrhea', 'in', 'our', 'country', 'and', 'to', 'evaluate', 'methods', 'that', 'could', 'be', 'used', 'in', 'routine', 'diagnostics', 'STUDY', 'DESIGN', 'One', 'hundred', 'stool', 'samples', 'were', 'collected', 'from', 'children', 'under', '5', 'years', 'of', 'age', 'seeking', 'medical', 'care', 'for', 'acute', 'diarrhea', 'during', 'the', 'winter', 'season', '2000', '2001', 'in', 'Beijing', 'Children', 's', 'Hospital', 'All', 'specimens', 'were', 'initially', 'screened', 'microscopically', 'for', 'leucocytes', 'red', 'blood', 'cells', 'Samples', 'with', 'negative', 'results', 'were', 'analyzed', 'for', 'virus', 'presence', 'using', 'commercial', 'EIAs', 'and', 'or', 'in', 'house', 'RT', 'PCRs', 'RESULTS', 'At', 'least', 'one', 'viral', 'agent', 'was', 'found', 'in', '67', 'of', 'the', 'specimens', 'The', 'frequency', 'of', 'rotavirus', 'astrovirus', 'norovirus', 'and', 'enteric', 'adenovirus', 'was', '59', '8', '6', 'and', '2', 'respectively', 'Dual', 'infections', 'were', 'found', 'in', '9', '0', '6', '67', 'of', 'the', 'positive', 'samples', 'The', 'results', 'from', 'rotavirus', 'and', 'astrovirus', 'EIAs', 'were', 'concordant', 'with', 'those', 'of', 'rotavirus', 'and', 'astrovirus', 'RT', 'PCRs', 'CONCLUSIONS', 'Enteric', 'viruses', 'play', 'an', 'important', 'role', 'in', 'pediatric', 'diarrhea', 'during', 'the', 'winter', 'season', 'in', 'China', 'A', 'combination', 'of', 'microscopic', 'examination', 'of', 'stool', 'samples', 'with', 'specific', 'EIA', 'assays', 'to', 'detect', 'virus', 'antigen', 'in', 'stool', 'specimens', 'may', 'be', 'suitable', 'for', 'routine', 'diagnostics', '']"
93124,Comparison of seven commercial RT-PCR diagnostic kits for COVID-19,2020,J Clin Virol,,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was &#8805;96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",,u5gjsvq8,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '8805', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
93125,Comparison of seven commercial RT-PCR diagnostic kits for COVID-19,2020,J Clin Virol,,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was &#8805;96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",,ce4ukaua,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '8805', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
93219,Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma,2020,Clin Chim Acta,,"BACKGROUND: Besides SARS-CoV-2 RT-PCR testing, serological testing is emerging as additional option in COVID-19 diagnostics. Aim of this study was to evaluate novel immunoassays for detection of SARS-CoV-2 antibodies in human plasma. METHODS: Using EDITM Novel Coronavirus COVID-19 Enzyme Linked Immunosorbent Assays (ELISAs), we measured SARS-CoV-2 IgM and IgG antibodies in 64 SARS-CoV-2 RT-PCR confirmed COVID-19 patients with serial blood samples (n = 104) collected at different time points from symptom onset. Blood samples from 200 healthy blood donors and 256 intensive care unit (ICU) patients collected before the COVID-19 outbreak were also used. RESULTS: The positivity rates in the COVID-19 patients were 5.9% for IgM and 2.9% for IgG &#8804; 5 days after symptom onset; Between day 5 and day 10 the positivity rates were 37.1% for IgM and 37.1% for IgG and rose to 76.4% for IgM and 82.4% for IgG after > 10-15 days. After 15-22 days the ""true"" positivity rates were 94.4% for IgM and 100% for IgG. The ""false"" positivity rates were 0.5% for IgM and 1.0% for IgG in the healthy blood donors, 1.6% for IgM and 1.2% for IgG in ICU patients. CONCLUSIONS: This study shows high ""true"" vs. low ""false"" positivity rates for the EDITM SARS-CoV-2 IgM and IgG ELISAs.",,zvj00qjj,"['BACKGROUND', 'Besides', 'SARS', 'CoV', '2', 'RT', 'PCR', 'testing', 'serological', 'testing', 'is', 'emerging', 'as', 'additional', 'option', 'in', 'COVID', '19', 'diagnostics', 'Aim', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'novel', 'immunoassays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'antibodies', 'in', 'human', 'plasma', 'METHODS', 'Using', 'EDITM', 'Novel', 'Coronavirus', 'COVID', '19', 'Enzyme', 'Linked', 'Immunosorbent', 'Assays', 'ELISAs', 'we', 'measured', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'in', '64', 'SARS', 'CoV', '2', 'RT', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'with', 'serial', 'blood', 'samples', 'n', '104', 'collected', 'at', 'different', 'time', 'points', 'from', 'symptom', 'onset', 'Blood', 'samples', 'from', '200', 'healthy', 'blood', 'donors', 'and', '256', 'intensive', 'care', 'unit', 'ICU', 'patients', 'collected', 'before', 'the', 'COVID', '19', 'outbreak', 'were', 'also', 'used', 'RESULTS', 'The', 'positivity', 'rates', 'in', 'the', 'COVID', '19', 'patients', 'were', '5', '9', 'for', 'IgM', 'and', '2', '9', 'for', 'IgG', '8804', '5', 'days', 'after', 'symptom', 'onset', 'Between', 'day', '5', 'and', 'day', '10', 'the', 'positivity', 'rates', 'were', '37', '1', 'for', 'IgM', 'and', '37', '1', 'for', 'IgG', 'and', 'rose', 'to', '76', '4', 'for', 'IgM', 'and', '82', '4', 'for', 'IgG', 'after', '10', '15', 'days', 'After', '15', '22', 'days', 'the', 'true', 'positivity', 'rates', 'were', '94', '4', 'for', 'IgM', 'and', '100', 'for', 'IgG', 'The', 'false', 'positivity', 'rates', 'were', '0', '5', 'for', 'IgM', 'and', '1', '0', 'for', 'IgG', 'in', 'the', 'healthy', 'blood', 'donors', '1', '6', 'for', 'IgM', 'and', '1', '2', 'for', 'IgG', 'in', 'ICU', 'patients', 'CONCLUSIONS', 'This', 'study', 'shows', 'high', 'true', 'vs', 'low', 'false', 'positivity', 'rates', 'for', 'the', 'EDITM', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'ELISAs', '']"
101264,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2,2020,Viruses,,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",,nm8a3jxt,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
101670,"Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned",2020,Emerg Microbes Infect,,"Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT-PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT-PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP.",,em12jvad,"['Unexplained', 'pneumonia', 'UP', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'emerged', 'in', 'China', 'in', 'late', 'December', '2019', 'and', 'has', 'infected', 'more', 'than', '9000', 'cases', 'by', '31', 'January', '2020', 'Shanghai', 'reported', 'the', 'first', 'imported', 'case', 'of', 'COVID', '19', 'Coronavirus', 'Disease', '2019', 'in', '20', 'January', '2020', 'A', 'combinative', 'approach', 'of', 'real', 'time', 'RT', 'PCR', 'CRISPR', 'based', 'assay', 'and', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'were', 'used', 'to', 'diagnose', 'this', 'unexplained', 'pneumonia', 'patient', 'Real', 'time', 'RT', 'PCR', 'and', 'CRISPR', 'based', 'assay', 'both', 'reported', 'positive', 'This', 'sample', 'belonged', 'to', 'Betacoronavirus', 'and', 'shared', 'a', 'more', 'than', '99', 'nucleotide', 'nt', 'identity', 'with', 'the', 'Wuhan', 'SARS', 'CoV', '2', 'isolates', 'We', 'further', 'compared', 'pros', 'and', 'cons', 'of', 'common', 'molecular', 'diagnostics', 'in', 'UP', 'In', 'this', 'study', 'we', 'illustrated', 'the', 'importance', 'of', 'combining', 'molecular', 'diagnostics', 'to', 'rule', 'out', 'common', 'pathogens', 'and', 'performed', 'mNGS', 'to', 'obtain', 'unbiased', 'potential', 'pathogen', 'result', 'for', 'the', 'diagnosis', 'of', 'UP', '']"
102034,SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro,2020,Mem Inst Oswaldo Cruz,,"Corona virus disease (COVID-19) presents a serious threat to global health. A historical timeline of early molecular diagnostics from government alert (January 22) (D) was presented. After in silico analysis, Brazilian Army Institute of Biology (IBEx-RJ) tested samples in house using real-time reverse transcriptase polymerase chain reaction (RT-PCR) (fast mode) based on Centers for Disease Control and Prevention (CDC) recommendations. First cases from Brazil, Rio de Janeiro, IBEx, and diagnosis team were reported in D36, D44, D66, and D74 respectively. Therefore, after 1300 tests, we recommend N1/N2 primer sets (CDC) for preliminary and Charité protocol confirmation in case of positive results. Moreover, every professional should be tested before starting work, in addition to weekly tests for everyone involved.",,fzf8tefr,"['Corona', 'virus', 'disease', 'COVID', '19', 'presents', 'a', 'serious', 'threat', 'to', 'global', 'health', 'A', 'historical', 'timeline', 'of', 'early', 'molecular', 'diagnostics', 'from', 'government', 'alert', 'January', '22', 'D', 'was', 'presented', 'After', 'in', 'silico', 'analysis', 'Brazilian', 'Army', 'Institute', 'of', 'Biology', 'IBEx', 'RJ', 'tested', 'samples', 'in', 'house', 'using', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'fast', 'mode', 'based', 'on', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommendations', 'First', 'cases', 'from', 'Brazil', 'Rio', 'de', 'Janeiro', 'IBEx', 'and', 'diagnosis', 'team', 'were', 'reported', 'in', 'D36', 'D44', 'D66', 'and', 'D74', 'respectively', 'Therefore', 'after', '1300', 'tests', 'we', 'recommend', 'N1', 'N2', 'primer', 'sets', 'CDC', 'for', 'preliminary', 'and', 'Charité', 'protocol', 'confirmation', 'in', 'case', 'of', 'positive', 'results', 'Moreover', 'every', 'professional', 'should', 'be', 'tested', 'before', 'starting', 'work', 'in', 'addition', 'to', 'weekly', 'tests', 'for', 'everyone', 'involved', '']"
102539,Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis,2020,Biosens Bioelectron,,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to detect target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ~50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",,pfb0ozy6,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'detect', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'quantitative', 'RT', 'PCR', 'RT', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'RT', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
102540,Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis,2020,Biosens Bioelectron,,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to detect target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ~50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",,b5izy2tn,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'detect', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'quantitative', 'RT', 'PCR', 'RT', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'RT', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
106203,COVID-19 pandemic-a focused review for clinicians,2020,Clin Microbiol Infect,,"BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019, and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments in the virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and the clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains patient density. However, accurate diagnosis as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",,f33f0868,"['BACKGROUND', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'OBJECTIVES', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'in', 'the', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'SOURCES', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'CONTENT', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'IMPLICATIONS', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'patient', 'density', 'However', 'accurate', 'diagnosis', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
107264,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,d08pnq1u,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
107265,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,2svdhayy,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
112936,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020,Emerg Microbes Infect,,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 102 RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30â min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",,77jpm4o0,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '102', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30â', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
115076,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,l0cm3mae,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115077,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,4nq2ok89,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115078,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,ltvpbxp4,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115219,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay",2020,J. clin. microbiol,,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",,uwrps3x3,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
117936,Momentum Contrastive Learning for Few-Shot COVID-19 Diagnosis from Chest CT Images,2020-06-16,,https://arxiv.org/pdf/2006.13276v1.pdf,"The current pandemic, caused by the outbreak of a novel coronavirus (COVID-19) in December 2019, has led to a global emergency that has significantly impacted economies, healthcare systems and personal wellbeing all around the world. Controlling the rapidly evolving disease requires highly sensitive and specific diagnostics. While real-time RT-PCR is the most commonly used, these can take up to 8 hours, and require significant effort from healthcare professionals. As such, there is a critical need for a quick and automatic diagnostic system. Diagnosis from chest CT images is a promising direction. However, current studies are limited by the lack of sufficient training samples, as acquiring annotated CT images is time-consuming. To this end, we propose a new deep learning algorithm for the automated diagnosis of COVID-19, which only requires a few samples for training. Specifically, we use contrastive learning to train an encoder which can capture expressive feature representations on large and publicly available lung datasets and adopt the prototypical network for classification. We validate the efficacy of the proposed model in comparison with other competing methods on two publicly available and annotated COVID-19 CT datasets. Our results demonstrate the superior performance of our model for the accurate diagnosis of COVID-19 based on chest CT images.",,724br56j,"['The', 'current', 'pandemic', 'caused', 'by', 'the', 'outbreak', 'of', 'a', 'novel', 'coronavirus', 'COVID', '19', 'in', 'December', '2019', 'has', 'led', 'to', 'a', 'global', 'emergency', 'that', 'has', 'significantly', 'impacted', 'economies', 'healthcare', 'systems', 'and', 'personal', 'wellbeing', 'all', 'around', 'the', 'world', 'Controlling', 'the', 'rapidly', 'evolving', 'disease', 'requires', 'highly', 'sensitive', 'and', 'specific', 'diagnostics', 'While', 'real', 'time', 'RT', 'PCR', 'is', 'the', 'most', 'commonly', 'used', 'these', 'can', 'take', 'up', 'to', '8', 'hours', 'and', 'require', 'significant', 'effort', 'from', 'healthcare', 'professionals', 'As', 'such', 'there', 'is', 'a', 'critical', 'need', 'for', 'a', 'quick', 'and', 'automatic', 'diagnostic', 'system', 'Diagnosis', 'from', 'chest', 'CT', 'images', 'is', 'a', 'promising', 'direction', 'However', 'current', 'studies', 'are', 'limited', 'by', 'the', 'lack', 'of', 'sufficient', 'training', 'samples', 'as', 'acquiring', 'annotated', 'CT', 'images', 'is', 'time', 'consuming', 'To', 'this', 'end', 'we', 'propose', 'a', 'new', 'deep', 'learning', 'algorithm', 'for', 'the', 'automated', 'diagnosis', 'of', 'COVID', '19', 'which', 'only', 'requires', 'a', 'few', 'samples', 'for', 'training', 'Specifically', 'we', 'use', 'contrastive', 'learning', 'to', 'train', 'an', 'encoder', 'which', 'can', 'capture', 'expressive', 'feature', 'representations', 'on', 'large', 'and', 'publicly', 'available', 'lung', 'datasets', 'and', 'adopt', 'the', 'prototypical', 'network', 'for', 'classification', 'We', 'validate', 'the', 'efficacy', 'of', 'the', 'proposed', 'model', 'in', 'comparison', 'with', 'other', 'competing', 'methods', 'on', 'two', 'publicly', 'available', 'and', 'annotated', 'COVID', '19', 'CT', 'datasets', 'Our', 'results', 'demonstrate', 'the', 'superior', 'performance', 'of', 'our', 'model', 'for', 'the', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'based', 'on', 'chest', 'CT', 'images', '']"
120409,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,wzd51alu,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120410,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,jkiqhwap,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120411,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,dxqb10r5,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120412,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,wmd4ehfx,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
124164,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020,J Clin Virol,,"BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for highly urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated device performing extraction and real-time PCR. METHODS: A publicly available SARS-CoV-2 RT-PCR assay was adapted for the automated system. Analytical performance was evaluated using in-vitro transcribed RNA and clinical performance was compared to the cobas 6800-based reference assay within the lab. RESULTS: The Envelope (E) Gene-LDT displayed good analytical performance with an LoD of 95.55 cp/mL and no false positives during evaluation of cross-reactivity. A total of 176 patient samples were tested with both the E-Gene-LDT and the reference assay. Positive and negative agreement were 100 % and 99.2 % respectively. Invalid-rate was 6.3 %. CONCLUSION: The E-Gene-LDT showed analytical and clinical performance comparable to the cobas6800-based reference assay. Due to its random-access workflow concept and rapid time-to-result of about 80 min, the system is very well suited for providing fast-tracked SARS-CoV-2 diagnostics for urgent clinical samples in the hospital setting.",,v5gtgh0o,"['BACKGROUND', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'highly', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'device', 'performing', 'extraction', 'and', 'real', 'time', 'PCR', 'METHODS', 'A', 'publicly', 'available', 'SARS', 'CoV', '2', 'RT', 'PCR', 'assay', 'was', 'adapted', 'for', 'the', 'automated', 'system', 'Analytical', 'performance', 'was', 'evaluated', 'using', 'in', 'vitro', 'transcribed', 'RNA', 'and', 'clinical', 'performance', 'was', 'compared', 'to', 'the', 'cobas', '6800', 'based', 'reference', 'assay', 'within', 'the', 'lab', 'RESULTS', 'The', 'Envelope', 'E', 'Gene', 'LDT', 'displayed', 'good', 'analytical', 'performance', 'with', 'an', 'LoD', 'of', '95', '55', 'cp', 'mL', 'and', 'no', 'false', 'positives', 'during', 'evaluation', 'of', 'cross', 'reactivity', 'A', 'total', 'of', '176', 'patient', 'samples', 'were', 'tested', 'with', 'both', 'the', 'E', 'Gene', 'LDT', 'and', 'the', 'reference', 'assay', 'Positive', 'and', 'negative', 'agreement', 'were', '100', 'and', '99', '2', 'respectively', 'Invalid', 'rate', 'was', '6', '3', 'CONCLUSION', 'The', 'E', 'Gene', 'LDT', 'showed', 'analytical', 'and', 'clinical', 'performance', 'comparable', 'to', 'the', 'cobas6800', 'based', 'reference', 'assay', 'Due', 'to', 'its', 'random', 'access', 'workflow', 'concept', 'and', 'rapid', 'time', 'to', 'result', 'of', 'about', '80', 'min', 'the', 'system', 'is', 'very', 'well', 'suited', 'for', 'providing', 'fast', 'tracked', 'SARS', 'CoV', '2', 'diagnostics', 'for', 'urgent', 'clinical', 'samples', 'in', 'the', 'hospital', 'setting', '']"
129250,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020,Biosens Bioelectron,,"The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",,u9s272m5,"['The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
141010,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020,,,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",,m95bmi9t,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
143733,Sensitive Commercial NASBA Assay for the Detection of Respiratory Syncytial Virus in Clinical Specimen,2007-12-26,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/18159240/,"The aim of the study was to evaluate the usability of three diagnostic procedures for the detection of respiratory syncytial virus in clinical samples. Therefore, the FDA cleared CE marked NOW® RSV ELISA, the NucliSENS® EasyQ RSV A+B NASBA, and a literature based inhouse RT-PCR protocol were compared for their relative sensitivities. Thereby, NASBA turned out to be the most sensitive method with a total number of 80 RSV positive samples out of a cohort of 251 nasopharyngeal washings from patients suffering from clinical symptoms, followed by the inhouse RT-PCR (62/251) and ELISA (52/251). Thus, NASBA may serve as a rapid and highly sensitive alternative for RSV diagnostics.",10.1371/journal.pone.0001357,3xab3yxc,"['The', 'aim', 'of', 'the', 'study', 'was', 'to', 'evaluate', 'the', 'usability', 'of', 'three', 'diagnostic', 'procedures', 'for', 'the', 'detection', 'of', 'respiratory', 'syncytial', 'virus', 'in', 'clinical', 'samples', 'Therefore', 'the', 'FDA', 'cleared', 'CE', 'marked', 'NOW', 'RSV', 'ELISA', 'the', 'NucliSENS', 'EasyQ', 'RSV', 'A', 'B', 'NASBA', 'and', 'a', 'literature', 'based', 'inhouse', 'RT', 'PCR', 'protocol', 'were', 'compared', 'for', 'their', 'relative', 'sensitivities', 'Thereby', 'NASBA', 'turned', 'out', 'to', 'be', 'the', 'most', 'sensitive', 'method', 'with', 'a', 'total', 'number', 'of', '80', 'RSV', 'positive', 'samples', 'out', 'of', 'a', 'cohort', 'of', '251', 'nasopharyngeal', 'washings', 'from', 'patients', 'suffering', 'from', 'clinical', 'symptoms', 'followed', 'by', 'the', 'inhouse', 'RT', 'PCR', '62', '251', 'and', 'ELISA', '52', '251', 'Thus', 'NASBA', 'may', 'serve', 'as', 'a', 'rapid', 'and', 'highly', 'sensitive', 'alternative', 'for', 'RSV', 'diagnostics', '']"
144723,Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection,2020-05-27,J Clin Virol,https://api.elsevier.com/content/article/pii/S1386653220302183; https://www.sciencedirect.com/science/article/pii/S1386653220302183?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32516739/; https://doi.org/10.1016/j.jcv.2020.104476,"BACKGROUND: Rapid and sensitive diagnostic assays for SARS-CoV-2 detection are required for prompt patient management and infection control. The analytical and clinical performances of LightMix® Modular SARS and Wuhan CoV E-gene kit, a widely used commercial assay for SARS-CoV-2 detection, have not been well studied. OBJECTIVE: To evaluate the performance characteristics of the LightMix® E-gene kit in comparison with well-validated in-house developed tests. STUDY DESIGN: Serial dilutions of SARS-CoV-2 culture isolate extracts were used for analytical sensitivity evaluation. A total of 289 clinical specimens from 186 patients with suspected COVID-19 and 8 proficiency testing (PT) samples were used to evaluate the diagnostic performance of the LightMix® E-gene kit against in-house developed COVID-19-RdRp/Hel and COVID-19-N RT-PCR assays. RESULTS: The LightMix® E-gene kit had a limit-of-detection of 1.8 × 10(-1) TCID(50)/mL, which was one log(10) lower than those of the two in-house RT-PCR assays. The LightMix® E-gene kit (149/289 [51.6%]) had higher diagnostic sensitivity than the in-house assays (144/289 [49.8%] for RdRp/Hel and 146/289 [50.5%] for N). All three assays gave correct results for all the PT samples. Cycle threshold (Cp) values of the LightMix® E-gene kit and in-house assays showed excellent correlation. Reproducibility of the Cp values was satisfactory with intra- and inter-assay coefficient of variation values <5%. Importantly, the LightMix® E-gene kit, when used as a stand-alone assay, was equally sensitive as testing algorithms using multiple SARS-CoV-2 assays. CONCLUSIONS: The LightMix® E-gene kit is a rapid and sensitive assay for SARS-CoV-2 diagnostics, with fewer verification requirements compared to laboratory-developed tests",10.1016/j.jcv.2020.104476,i8u0j87l,"['BACKGROUND', 'Rapid', 'and', 'sensitive', 'diagnostic', 'assays', 'for', 'SARS', 'CoV', '2', 'detection', 'are', 'required', 'for', 'prompt', 'patient', 'management', 'and', 'infection', 'control', 'The', 'analytical', 'and', 'clinical', 'performances', 'of', 'LightMix', 'Modular', 'SARS', 'and', 'Wuhan', 'CoV', 'E', 'gene', 'kit', 'a', 'widely', 'used', 'commercial', 'assay', 'for', 'SARS', 'CoV', '2', 'detection', 'have', 'not', 'been', 'well', 'studied', 'OBJECTIVE', 'To', 'evaluate', 'the', 'performance', 'characteristics', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'in', 'comparison', 'with', 'well', 'validated', 'in', 'house', 'developed', 'tests', 'STUDY', 'DESIGN', 'Serial', 'dilutions', 'of', 'SARS', 'CoV', '2', 'culture', 'isolate', 'extracts', 'were', 'used', 'for', 'analytical', 'sensitivity', 'evaluation', 'A', 'total', 'of', '289', 'clinical', 'specimens', 'from', '186', 'patients', 'with', 'suspected', 'COVID', '19', 'and', '8', 'proficiency', 'testing', 'PT', 'samples', 'were', 'used', 'to', 'evaluate', 'the', 'diagnostic', 'performance', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'against', 'in', 'house', 'developed', 'COVID', '19', 'RdRp', 'Hel', 'and', 'COVID', '19', 'N', 'RT', 'PCR', 'assays', 'RESULTS', 'The', 'LightMix', 'E', 'gene', 'kit', 'had', 'a', 'limit', 'of', 'detection', 'of', '1', '8', '10', '1', 'TCID', '50', 'mL', 'which', 'was', 'one', 'log', '10', 'lower', 'than', 'those', 'of', 'the', 'two', 'in', 'house', 'RT', 'PCR', 'assays', 'The', 'LightMix', 'E', 'gene', 'kit', '149', '289', '51', '6', 'had', 'higher', 'diagnostic', 'sensitivity', 'than', 'the', 'in', 'house', 'assays', '144', '289', '49', '8', 'for', 'RdRp', 'Hel', 'and', '146', '289', '50', '5', 'for', 'N', 'All', 'three', 'assays', 'gave', 'correct', 'results', 'for', 'all', 'the', 'PT', 'samples', 'Cycle', 'threshold', 'Cp', 'values', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'and', 'in', 'house', 'assays', 'showed', 'excellent', 'correlation', 'Reproducibility', 'of', 'the', 'Cp', 'values', 'was', 'satisfactory', 'with', 'intra', 'and', 'inter', 'assay', 'coefficient', 'of', 'variation', 'values', '5', 'Importantly', 'the', 'LightMix', 'E', 'gene', 'kit', 'when', 'used', 'as', 'a', 'stand', 'alone', 'assay', 'was', 'equally', 'sensitive', 'as', 'testing', 'algorithms', 'using', 'multiple', 'SARS', 'CoV', '2', 'assays', 'CONCLUSIONS', 'The', 'LightMix', 'E', 'gene', 'kit', 'is', 'a', 'rapid', 'and', 'sensitive', 'assay', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'with', 'fewer', 'verification', 'requirements', 'compared', 'to', 'laboratory', 'developed', 'tests']"
145353,Evaluation of ViroCyt(®) Virus Counter for Rapid Filovirus Quantitation,2015-02-20,Viruses,https://doi.org/10.3390/v7030857; https://www.ncbi.nlm.nih.gov/pubmed/25710889/,"Development and evaluation of medical countermeasures for diagnostics, vaccines, and therapeutics requires production of standardized, reproducible, and well characterized virus preparations. For filoviruses this includes plaque assay for quantitation of infectious virus, transmission electron microscopy (TEM) for morphology and quantitation of virus particles, and real-time reverse transcription PCR for quantitation of viral RNA (qRT-PCR). The ViroCyt(®) Virus Counter (VC) 2100 (ViroCyt, Boulder, CO, USA) is a flow-based instrument capable of quantifying virus particles in solution. Using a proprietary combination of fluorescent dyes that stain both nucleic acid and protein in a single 30 min step, rapid, reproducible, and cost-effective quantification of filovirus particles was demonstrated. Using a seed stock of Ebola virus variant Kikwit, the linear range of the instrument was determined to be 2.8E+06 to 1.0E+09 virus particles per mL with coefficient of variation ranging from 9.4% to 31.5% for samples tested in triplicate. VC particle counts for various filovirus stocks were within one log of TEM particle counts. A linear relationship was established between the plaque assay, qRT-PCR, and the VC. VC results significantly correlated with both plaque assay and qRT-PCR. These results demonstrated that the VC is an easy, fast, and consistent method to quantify filoviruses in stock preparations.",10.3390/v7030857,ic3r2g7s,"['Development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'for', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'requires', 'production', 'of', 'standardized', 'reproducible', 'and', 'well', 'characterized', 'virus', 'preparations', 'For', 'filoviruses', 'this', 'includes', 'plaque', 'assay', 'for', 'quantitation', 'of', 'infectious', 'virus', 'transmission', 'electron', 'microscopy', 'TEM', 'for', 'morphology', 'and', 'quantitation', 'of', 'virus', 'particles', 'and', 'real', 'time', 'reverse', 'transcription', 'PCR', 'for', 'quantitation', 'of', 'viral', 'RNA', 'qRT', 'PCR', 'The', 'ViroCyt', 'Virus', 'Counter', 'VC', '2100', 'ViroCyt', 'Boulder', 'CO', 'USA', 'is', 'a', 'flow', 'based', 'instrument', 'capable', 'of', 'quantifying', 'virus', 'particles', 'in', 'solution', 'Using', 'a', 'proprietary', 'combination', 'of', 'fluorescent', 'dyes', 'that', 'stain', 'both', 'nucleic', 'acid', 'and', 'protein', 'in', 'a', 'single', '30', 'min', 'step', 'rapid', 'reproducible', 'and', 'cost', 'effective', 'quantification', 'of', 'filovirus', 'particles', 'was', 'demonstrated', 'Using', 'a', 'seed', 'stock', 'of', 'Ebola', 'virus', 'variant', 'Kikwit', 'the', 'linear', 'range', 'of', 'the', 'instrument', 'was', 'determined', 'to', 'be', '2', '8E', '06', 'to', '1', '0E', '09', 'virus', 'particles', 'per', 'mL', 'with', 'coefficient', 'of', 'variation', 'ranging', 'from', '9', '4', 'to', '31', '5', 'for', 'samples', 'tested', 'in', 'triplicate', 'VC', 'particle', 'counts', 'for', 'various', 'filovirus', 'stocks', 'were', 'within', 'one', 'log', 'of', 'TEM', 'particle', 'counts', 'A', 'linear', 'relationship', 'was', 'established', 'between', 'the', 'plaque', 'assay', 'qRT', 'PCR', 'and', 'the', 'VC', 'VC', 'results', 'significantly', 'correlated', 'with', 'both', 'plaque', 'assay', 'and', 'qRT', 'PCR', 'These', 'results', 'demonstrated', 'that', 'the', 'VC', 'is', 'an', 'easy', 'fast', 'and', 'consistent', 'method', 'to', 'quantify', 'filoviruses', 'in', 'stock', 'preparations', '']"
146836,Ultra-sensitive and high-throughput CRISPR-Powered COVID-19 diagnosis,2020-05-23,Biosens Bioelectron,https://doi.org/10.1016/j.bios.2020.112316; https://www.ncbi.nlm.nih.gov/pubmed/32553350/; https://www.sciencedirect.com/science/article/pii/S0956566320303110?v=s5; https://api.elsevier.com/content/article/pii/S0956566320303110,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to amplify target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ∼50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved qPCR assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",10.1016/j.bios.2020.112316,rhtpajoq,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'amplify', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
148094,Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group,2018-05-31,Journal of Clinical Virology,https://www.ncbi.nlm.nih.gov/pubmed/29494950/; https://api.elsevier.com/content/article/pii/S1386653218300465; https://www.sciencedirect.com/science/article/pii/S1386653218300465; https://doi.org/10.1016/j.jcv.2018.02.013,"Abstract Background Emergency Departments (ED) are challenged during influenza season by patients who present acutely during sporadic ED visits. ED management is largely empiric, often occurring without reliable diagnostics needed for targeted therapies, safe outpatient discharge, or hospital admissions. Objective To evaluate the impact of the influenza diagnosis on physician decision making during ED visits using the Cobas Liat® influenza A + B assay. Study design Prospective study assessing the impact of rapid (<30 min), reverse-transcriptase polymerase chain reaction (RT-PCR) influenza testing on physician decision making in the ED. Physician responses established pre-and post-diagnosis management courses which required confirmation via secondary documentation in the medical record. Changes in physician decision making were analyzed across four clinical touchpoints: (i) admission/discharge status, (ii) medical procedures, (iii) antiviral and antibiotic prescribing, and (iv) laboratory studies. Results An influenza diagnosis changed patient management courses, relative to empiric, pre-diagnosis plans, in in 61% of the cases resulting in cost savings of $49,420-to-$42,270 over 143 patients and 104 days during influenza season resulting in a cost savings of $200.40/ED visit. Evaluation over 2000 ED patient visits projects cost savings > $578,000 due to deferred admissions, and reduction in antiviral prescribing. Sensitivity of ED-based influenza testing using the Cobas Liat® assay was equivalent to centralized lab testing at 98.8% sensitivity and 98.5% specificity respectively. Conclusion Providing rapid, RT-PCR influenza testing to ED settings is actionable and used to guide patient care decisions. Understanding the cascade of events linked to the influenza diagnosis in the ED provides overall cost savings which offset the cost of providing ED-based testing.",10.1016/j.jcv.2018.02.013,v5qb41c1,"['Abstract', 'Background', 'Emergency', 'Departments', 'ED', 'are', 'challenged', 'during', 'influenza', 'season', 'by', 'patients', 'who', 'present', 'acutely', 'during', 'sporadic', 'ED', 'visits', 'ED', 'management', 'is', 'largely', 'empiric', 'often', 'occurring', 'without', 'reliable', 'diagnostics', 'needed', 'for', 'targeted', 'therapies', 'safe', 'outpatient', 'discharge', 'or', 'hospital', 'admissions', 'Objective', 'To', 'evaluate', 'the', 'impact', 'of', 'the', 'influenza', 'diagnosis', 'on', 'physician', 'decision', 'making', 'during', 'ED', 'visits', 'using', 'the', 'Cobas', 'Liat', 'influenza', 'A', 'B', 'assay', 'Study', 'design', 'Prospective', 'study', 'assessing', 'the', 'impact', 'of', 'rapid', '30', 'min', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'influenza', 'testing', 'on', 'physician', 'decision', 'making', 'in', 'the', 'ED', 'Physician', 'responses', 'established', 'pre', 'and', 'post', 'diagnosis', 'management', 'courses', 'which', 'required', 'confirmation', 'via', 'secondary', 'documentation', 'in', 'the', 'medical', 'record', 'Changes', 'in', 'physician', 'decision', 'making', 'were', 'analyzed', 'across', 'four', 'clinical', 'touchpoints', 'i', 'admission', 'discharge', 'status', 'ii', 'medical', 'procedures', 'iii', 'antiviral', 'and', 'antibiotic', 'prescribing', 'and', 'iv', 'laboratory', 'studies', 'Results', 'An', 'influenza', 'diagnosis', 'changed', 'patient', 'management', 'courses', 'relative', 'to', 'empiric', 'pre', 'diagnosis', 'plans', 'in', 'in', '61', 'of', 'the', 'cases', 'resulting', 'in', 'cost', 'savings', 'of', '49', '420', 'to', '42', '270', 'over', '143', 'patients', 'and', '104', 'days', 'during', 'influenza', 'season', 'resulting', 'in', 'a', 'cost', 'savings', 'of', '200', '40', 'ED', 'visit', 'Evaluation', 'over', '2000', 'ED', 'patient', 'visits', 'projects', 'cost', 'savings', '578', '000', 'due', 'to', 'deferred', 'admissions', 'and', 'reduction', 'in', 'antiviral', 'prescribing', 'Sensitivity', 'of', 'ED', 'based', 'influenza', 'testing', 'using', 'the', 'Cobas', 'Liat', 'assay', 'was', 'equivalent', 'to', 'centralized', 'lab', 'testing', 'at', '98', '8', 'sensitivity', 'and', '98', '5', 'specificity', 'respectively', 'Conclusion', 'Providing', 'rapid', 'RT', 'PCR', 'influenza', 'testing', 'to', 'ED', 'settings', 'is', 'actionable', 'and', 'used', 'to', 'guide', 'patient', 'care', 'decisions', 'Understanding', 'the', 'cascade', 'of', 'events', 'linked', 'to', 'the', 'influenza', 'diagnosis', 'in', 'the', 'ED', 'provides', 'overall', 'cost', 'savings', 'which', 'offset', 'the', 'cost', 'of', 'providing', 'ED', 'based', 'testing', '']"
148243,Comparison of commercial RT-PCR diagnostic kits for COVID-19,2020-05-08,J Clin Virol,https://api.elsevier.com/content/article/pii/S1386653220301542; https://www.sciencedirect.com/science/article/pii/S1386653220301542?v=s5; https://doi.org/10.1016/j.jcv.2020.104412; https://www.ncbi.nlm.nih.gov/pubmed/32416600/,"Abstract The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95% limit of detection (LOD95%). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was ≥96% for all assays and the estimated LOD95% varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",10.1016/j.jcv.2020.104412,7d7i3cc8,"['Abstract', 'The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
152105,Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context,2020-05-08,Front Med (Lausanne),https://www.ncbi.nlm.nih.gov/pubmed/32574326/; https://doi.org/10.3389/fmed.2020.00225,"Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine decisions. In this original research article, we describe the conception, the analytical and clinical performances as well as the risk management of implementing the COVID-19 Ag Respi-Strip in a diagnostic decision algorithm. Materials and Methods: Development of the COVID-19 Ag Respi-Strip resulted in a ready-to-use ICT assay based on a membrane technology with colloidal gold nanoparticles using monoclonal antibodies directed against the SARS-CoV and SARS-CoV-2 highly conserved nucleoprotein antigen. Four hundred observations were recorded for the analytical performance study and thirty tests were analyzed for the cross-reactivity study. The clinical performance study was performed in a retrospective multi-centric evaluation on aliquots of 328 nasopharyngeal samples. COVID-19 Ag Respi-Strip results were compared with qRT-PCR as golden standard for COVID-19 diagnostics. Results: In the analytical performance study, the reproducibility showed a between-observer disagreement of 1.7%, a robustness of 98%, an overall satisfying user friendliness and no cross-reactivity with other virus-infected nasopharyngeal samples. In the clinical performance study performed in three different clinical laboratories during the ascendant phase of the epidemiological curve, we found an overall sensitivity and specificity of 57.6 and 99.5%, respectively with an accuracy of 82.6%. The cut-off of the ICT was found at CT <22. User-friendliness analysis and risk management assessment through Ishikawa diagram demonstrate that COVID-19 Ag Respi-Strip may be implemented in clinical laboratories according to biosafety recommendations. Conclusion: The COVID-19 Ag Respi-Strip represents a promising rapid SARS-CoV-2 antigen assay for the first-line diagnosis of COVID-19 in 15 min at the peak of the pandemic. Its role in the proposed diagnostic algorithm is complementary to the currently-used molecular techniques.",10.3389/fmed.2020.00225,w3yoxhsg,"['Introduction', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'an', 'immunochromatographic', 'ICT', 'assay', 'for', 'the', 'rapid', 'detection', 'of', 'SARS', 'CoV', '2', 'antigen', 'on', 'nasopharyngeal', 'specimen', 'has', 'been', 'developed', 'to', 'identify', 'positive', 'COVID', '19', 'patients', 'allowing', 'prompt', 'clinical', 'and', 'quarantine', 'decisions', 'In', 'this', 'original', 'research', 'article', 'we', 'describe', 'the', 'conception', 'the', 'analytical', 'and', 'clinical', 'performances', 'as', 'well', 'as', 'the', 'risk', 'management', 'of', 'implementing', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'in', 'a', 'diagnostic', 'decision', 'algorithm', 'Materials', 'and', 'Methods', 'Development', 'of', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'resulted', 'in', 'a', 'ready', 'to', 'use', 'ICT', 'assay', 'based', 'on', 'a', 'membrane', 'technology', 'with', 'colloidal', 'gold', 'nanoparticles', 'using', 'monoclonal', 'antibodies', 'directed', 'against', 'the', 'SARS', 'CoV', 'and', 'SARS', 'CoV', '2', 'highly', 'conserved', 'nucleoprotein', 'antigen', 'Four', 'hundred', 'observations', 'were', 'recorded', 'for', 'the', 'analytical', 'performance', 'study', 'and', 'thirty', 'tests', 'were', 'analyzed', 'for', 'the', 'cross', 'reactivity', 'study', 'The', 'clinical', 'performance', 'study', 'was', 'performed', 'in', 'a', 'retrospective', 'multi', 'centric', 'evaluation', 'on', 'aliquots', 'of', '328', 'nasopharyngeal', 'samples', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'results', 'were', 'compared', 'with', 'qRT', 'PCR', 'as', 'golden', 'standard', 'for', 'COVID', '19', 'diagnostics', 'Results', 'In', 'the', 'analytical', 'performance', 'study', 'the', 'reproducibility', 'showed', 'a', 'between', 'observer', 'disagreement', 'of', '1', '7', 'a', 'robustness', 'of', '98', 'an', 'overall', 'satisfying', 'user', 'friendliness', 'and', 'no', 'cross', 'reactivity', 'with', 'other', 'virus', 'infected', 'nasopharyngeal', 'samples', 'In', 'the', 'clinical', 'performance', 'study', 'performed', 'in', 'three', 'different', 'clinical', 'laboratories', 'during', 'the', 'ascendant', 'phase', 'of', 'the', 'epidemiological', 'curve', 'we', 'found', 'an', 'overall', 'sensitivity', 'and', 'specificity', 'of', '57', '6', 'and', '99', '5', 'respectively', 'with', 'an', 'accuracy', 'of', '82', '6', 'The', 'cut', 'off', 'of', 'the', 'ICT', 'was', 'found', 'at', 'CT', '22', 'User', 'friendliness', 'analysis', 'and', 'risk', 'management', 'assessment', 'through', 'Ishikawa', 'diagram', 'demonstrate', 'that', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'may', 'be', 'implemented', 'in', 'clinical', 'laboratories', 'according', 'to', 'biosafety', 'recommendations', 'Conclusion', 'The', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'represents', 'a', 'promising', 'rapid', 'SARS', 'CoV', '2', 'antigen', 'assay', 'for', 'the', 'first', 'line', 'diagnosis', 'of', 'COVID', '19', 'in', '15', 'min', 'at', 'the', 'peak', 'of', 'the', 'pandemic', 'Its', 'role', 'in', 'the', 'proposed', 'diagnostic', 'algorithm', 'is', 'complementary', 'to', 'the', 'currently', 'used', 'molecular', 'techniques', '']"
153784,COVID-19 pandemic – A focused review for clinicians,2020-04-25,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/32344166/; https://www.sciencedirect.com/science/article/pii/S1198743X20302317?v=s5; https://api.elsevier.com/content/article/pii/S1198743X20302317; https://doi.org/10.1016/j.cmi.2020.04.023,"Abstract Background The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. Objectives Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. Sources We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. Content We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. Implications The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",10.1016/j.cmi.2020.04.023,x64tii2t,"['Abstract', 'Background', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'Objectives', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'about', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'Sources', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'Content', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'Implications', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'the', 'patient', 'density', 'However', 'accurate', 'diagnoses', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
154338,Transmissible gastroenteritis virus: Identification of M protein-binding peptide ligands with antiviral and diagnostic potential,2013-09-30,Antiviral Research,https://api.elsevier.com/content/article/pii/S0166354213001721; https://www.sciencedirect.com/science/article/pii/S0166354213001721; https://www.ncbi.nlm.nih.gov/pubmed/23830854/; https://doi.org/10.1016/j.antiviral.2013.06.015,"Abstract The membrane (M) protein is one of the major structural proteins of coronavirus particles. In this study, the M protein of transmissible gastroenteritis virus (TGEV) was used to biopan a 12-mer phage display random peptide library. Three phages expressing TGEV-M-binding peptides were identified and characterized in more depth. A phage-based immunosorbent assay (phage-ELISA) capable of differentiating TGEV from other coronaviruses was developed using one phage, phTGEV-M7, as antigen. When the phage-ELISA was compared to conventional antibody-based ELISA for detecting infections, phage-ELISA exhibited greater sensitivity. A chemically synthesized, TGEV-M7 peptide (pepTGEV-M7; HALTPIKYIPPG) was evaluated for antiviral activity. Plaque-reduction assays revealed that pepTGEV-M7 was able to prevent TGEV infection in vitro (p <0.01) following pretreatment of the virus with the peptide. Indirect immunofluorescence and real-time RT-PCR confirmed the inhibitory effects of the peptide. These results indicate that pepTGEV-M7 might be utilized for virus-specific diagnostics and treatment.",10.1016/j.antiviral.2013.06.015,59d4aojh,"['Abstract', 'The', 'membrane', 'M', 'protein', 'is', 'one', 'of', 'the', 'major', 'structural', 'proteins', 'of', 'coronavirus', 'particles', 'In', 'this', 'study', 'the', 'M', 'protein', 'of', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'was', 'used', 'to', 'biopan', 'a', '12', 'mer', 'phage', 'display', 'random', 'peptide', 'library', 'Three', 'phages', 'expressing', 'TGEV', 'M', 'binding', 'peptides', 'were', 'identified', 'and', 'characterized', 'in', 'more', 'depth', 'A', 'phage', 'based', 'immunosorbent', 'assay', 'phage', 'ELISA', 'capable', 'of', 'differentiating', 'TGEV', 'from', 'other', 'coronaviruses', 'was', 'developed', 'using', 'one', 'phage', 'phTGEV', 'M7', 'as', 'antigen', 'When', 'the', 'phage', 'ELISA', 'was', 'compared', 'to', 'conventional', 'antibody', 'based', 'ELISA', 'for', 'detecting', 'infections', 'phage', 'ELISA', 'exhibited', 'greater', 'sensitivity', 'A', 'chemically', 'synthesized', 'TGEV', 'M7', 'peptide', 'pepTGEV', 'M7', 'HALTPIKYIPPG', 'was', 'evaluated', 'for', 'antiviral', 'activity', 'Plaque', 'reduction', 'assays', 'revealed', 'that', 'pepTGEV', 'M7', 'was', 'able', 'to', 'prevent', 'TGEV', 'infection', 'in', 'vitro', 'p', '0', '01', 'following', 'pretreatment', 'of', 'the', 'virus', 'with', 'the', 'peptide', 'Indirect', 'immunofluorescence', 'and', 'real', 'time', 'RT', 'PCR', 'confirmed', 'the', 'inhibitory', 'effects', 'of', 'the', 'peptide', 'These', 'results', 'indicate', 'that', 'pepTGEV', 'M7', 'might', 'be', 'utilized', 'for', 'virus', 'specific', 'diagnostics', 'and', 'treatment', '']"
154518,"Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012–2015",2017-09-13,PLoS Negl Trop Dis,https://www.ncbi.nlm.nih.gov/pubmed/28902845/; https://doi.org/10.1371/journal.pntd.0005859,"Identifying etiologies of acute febrile illnesses (AFI) is challenging due to non-specific presentation and limited availability of diagnostics. Prospective AFI studies provide a methodology to describe the syndrome by age and etiology, findings that can be used to develop case definitions and multiplexed diagnostics to optimize management. We conducted a 3-year prospective AFI study in Puerto Rico. Patients with fever ≤7 days were offered enrollment, and clinical data and specimens were collected at enrollment and upon discharge or follow-up. Blood and oro-nasopharyngeal specimens were tested by RT-PCR and immunodiagnostic methods for infection with dengue viruses (DENV) 1–4, chikungunya virus (CHIKV), influenza A and B viruses (FLU A/B), 12 other respiratory viruses (ORV), enterovirus, Leptospira spp., and Burkholderia pseudomallei. Clinical presentation and laboratory findings of participants infected with DENV were compared to those infected with CHIKV, FLU A/B, and ORV. Clinical predictors of laboratory-positive dengue compared to all other AFI etiologies were determined by age and day post-illness onset (DPO) at presentation. Of 8,996 participants enrolled from May 7, 2012 through May 6, 2015, more than half (54.8%, 4,930) had a pathogen detected. Pathogens most frequently detected were CHIKV (1,635, 18.2%), FLU A/B (1,074, 11.9%), DENV 1–4 (970, 10.8%), and ORV (904, 10.3%). Participants with DENV infection presented later and a higher proportion were hospitalized than those with other diagnoses (46.7% versus 27.3% with ORV, 18.8% with FLU A/B, and 11.2% with CHIKV). Predictors of dengue in participants presenting <3 DPO included leukopenia, thrombocytopenia, headache, eye pain, nausea, and dizziness, while negative predictors were irritability and rhinorrhea. Predictors of dengue in participants presenting 3–5 DPO were leukopenia, thrombocytopenia, facial/neck erythema, nausea, eye pain, signs of poor circulation, and diarrhea; presence of rhinorrhea, cough, and red conjunctiva predicted non-dengue AFI. By enrolling febrile patients at clinical presentation, we identified unbiased predictors of laboratory-positive dengue as compared to other common causes of AFI. These findings can be used to assist in early identification of dengue patients, as well as direct anticipatory guidance and timely initiation of correct clinical management.",10.1371/journal.pntd.0005859,ded5t1ai,"['Identifying', 'etiologies', 'of', 'acute', 'febrile', 'illnesses', 'AFI', 'is', 'challenging', 'due', 'to', 'non', 'specific', 'presentation', 'and', 'limited', 'availability', 'of', 'diagnostics', 'Prospective', 'AFI', 'studies', 'provide', 'a', 'methodology', 'to', 'describe', 'the', 'syndrome', 'by', 'age', 'and', 'etiology', 'findings', 'that', 'can', 'be', 'used', 'to', 'develop', 'case', 'definitions', 'and', 'multiplexed', 'diagnostics', 'to', 'optimize', 'management', 'We', 'conducted', 'a', '3', 'year', 'prospective', 'AFI', 'study', 'in', 'Puerto', 'Rico', 'Patients', 'with', 'fever', '7', 'days', 'were', 'offered', 'enrollment', 'and', 'clinical', 'data', 'and', 'specimens', 'were', 'collected', 'at', 'enrollment', 'and', 'upon', 'discharge', 'or', 'follow', 'up', 'Blood', 'and', 'oro', 'nasopharyngeal', 'specimens', 'were', 'tested', 'by', 'RT', 'PCR', 'and', 'immunodiagnostic', 'methods', 'for', 'infection', 'with', 'dengue', 'viruses', 'DENV', '1', '4', 'chikungunya', 'virus', 'CHIKV', 'influenza', 'A', 'and', 'B', 'viruses', 'FLU', 'A', 'B', '12', 'other', 'respiratory', 'viruses', 'ORV', 'enterovirus', 'Leptospira', 'spp', 'and', 'Burkholderia', 'pseudomallei', 'Clinical', 'presentation', 'and', 'laboratory', 'findings', 'of', 'participants', 'infected', 'with', 'DENV', 'were', 'compared', 'to', 'those', 'infected', 'with', 'CHIKV', 'FLU', 'A', 'B', 'and', 'ORV', 'Clinical', 'predictors', 'of', 'laboratory', 'positive', 'dengue', 'compared', 'to', 'all', 'other', 'AFI', 'etiologies', 'were', 'determined', 'by', 'age', 'and', 'day', 'post', 'illness', 'onset', 'DPO', 'at', 'presentation', 'Of', '8', '996', 'participants', 'enrolled', 'from', 'May', '7', '2012', 'through', 'May', '6', '2015', 'more', 'than', 'half', '54', '8', '4', '930', 'had', 'a', 'pathogen', 'detected', 'Pathogens', 'most', 'frequently', 'detected', 'were', 'CHIKV', '1', '635', '18', '2', 'FLU', 'A', 'B', '1', '074', '11', '9', 'DENV', '1', '4', '970', '10', '8', 'and', 'ORV', '904', '10', '3', 'Participants', 'with', 'DENV', 'infection', 'presented', 'later', 'and', 'a', 'higher', 'proportion', 'were', 'hospitalized', 'than', 'those', 'with', 'other', 'diagnoses', '46', '7', 'versus', '27', '3', 'with', 'ORV', '18', '8', 'with', 'FLU', 'A', 'B', 'and', '11', '2', 'with', 'CHIKV', 'Predictors', 'of', 'dengue', 'in', 'participants', 'presenting', '3', 'DPO', 'included', 'leukopenia', 'thrombocytopenia', 'headache', 'eye', 'pain', 'nausea', 'and', 'dizziness', 'while', 'negative', 'predictors', 'were', 'irritability', 'and', 'rhinorrhea', 'Predictors', 'of', 'dengue', 'in', 'participants', 'presenting', '3', '5', 'DPO', 'were', 'leukopenia', 'thrombocytopenia', 'facial', 'neck', 'erythema', 'nausea', 'eye', 'pain', 'signs', 'of', 'poor', 'circulation', 'and', 'diarrhea', 'presence', 'of', 'rhinorrhea', 'cough', 'and', 'red', 'conjunctiva', 'predicted', 'non', 'dengue', 'AFI', 'By', 'enrolling', 'febrile', 'patients', 'at', 'clinical', 'presentation', 'we', 'identified', 'unbiased', 'predictors', 'of', 'laboratory', 'positive', 'dengue', 'as', 'compared', 'to', 'other', 'common', 'causes', 'of', 'AFI', 'These', 'findings', 'can', 'be', 'used', 'to', 'assist', 'in', 'early', 'identification', 'of', 'dengue', 'patients', 'as', 'well', 'as', 'direct', 'anticipatory', 'guidance', 'and', 'timely', 'initiation', 'of', 'correct', 'clinical', 'management', '']"
155611,Advances in Diagnostic Approaches for Viral Etiologies of Diarrhea: From the Lab to the Field,2019-09-13,Front Microbiol,https://www.ncbi.nlm.nih.gov/pubmed/31608017/; https://doi.org/10.3389/fmicb.2019.01957,"The applications of correct diagnostic approaches play a decisive role in timely containment of infectious diseases spread and mitigation of public health risks. Nevertheless, there is a need to update the diagnostics regularly to capture the new, emergent, and highly divergent viruses. Acute gastroenteritis of viral origin has been identified as a significant cause of mortality across the globe, with the more serious consequences seen at the extremes of age groups (young and elderly) and immune-compromised individuals. Therefore, significant advancements and efforts have been put in the development of enteric virus diagnostics to meet the WHO ASSURED criteria as a benchmark over the years. The Enzyme-Linked Immunosorbent (ELISA) and Polymerase Chain Reaction (PCR) are the basic assays that provided the platform for development of several efficient diagnostics such as real-time RT-PCR, loop-mediated isothermal amplification (LAMP), polymerase spiral reaction (PSR), biosensors, microarrays and next generation sequencing. Herein, we describe and discuss the applications of these advanced technologies in context to enteric virus detection by delineating their features, advantages and limitations.",10.3389/fmicb.2019.01957,h6zdbs28,"['The', 'applications', 'of', 'correct', 'diagnostic', 'approaches', 'play', 'a', 'decisive', 'role', 'in', 'timely', 'containment', 'of', 'infectious', 'diseases', 'spread', 'and', 'mitigation', 'of', 'public', 'health', 'risks', 'Nevertheless', 'there', 'is', 'a', 'need', 'to', 'update', 'the', 'diagnostics', 'regularly', 'to', 'capture', 'the', 'new', 'emergent', 'and', 'highly', 'divergent', 'viruses', 'Acute', 'gastroenteritis', 'of', 'viral', 'origin', 'has', 'been', 'identified', 'as', 'a', 'significant', 'cause', 'of', 'mortality', 'across', 'the', 'globe', 'with', 'the', 'more', 'serious', 'consequences', 'seen', 'at', 'the', 'extremes', 'of', 'age', 'groups', 'young', 'and', 'elderly', 'and', 'immune', 'compromised', 'individuals', 'Therefore', 'significant', 'advancements', 'and', 'efforts', 'have', 'been', 'put', 'in', 'the', 'development', 'of', 'enteric', 'virus', 'diagnostics', 'to', 'meet', 'the', 'WHO', 'ASSURED', 'criteria', 'as', 'a', 'benchmark', 'over', 'the', 'years', 'The', 'Enzyme', 'Linked', 'Immunosorbent', 'ELISA', 'and', 'Polymerase', 'Chain', 'Reaction', 'PCR', 'are', 'the', 'basic', 'assays', 'that', 'provided', 'the', 'platform', 'for', 'development', 'of', 'several', 'efficient', 'diagnostics', 'such', 'as', 'real', 'time', 'RT', 'PCR', 'loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'polymerase', 'spiral', 'reaction', 'PSR', 'biosensors', 'microarrays', 'and', 'next', 'generation', 'sequencing', 'Herein', 'we', 'describe', 'and', 'discuss', 'the', 'applications', 'of', 'these', 'advanced', 'technologies', 'in', 'context', 'to', 'enteric', 'virus', 'detection', 'by', 'delineating', 'their', 'features', 'advantages', 'and', 'limitations', '']"
156811,Reverse Transcription Loop-Mediated Isothermal Amplification for Rapid Detection of Transmissible Gastroenteritis Virus,2010-12-02,Curr Microbiol,https://doi.org/10.1007/s00284-010-9825-9; https://www.ncbi.nlm.nih.gov/pubmed/21127872/,"Transmissible gastroenteritis virus (TGEV) is the causative agent of porcine transmissible gastroenteritis, and sensitive detection methods are required for preventing the disease. In this article, reverse transcription-loop-mediated isothermal amplification (RT-LAMP) was developed to detect TGEV. Three pairs of primers targeting the nucleocapsid (N) gene of TGEV were synthesized and used in the RT-LAMP. The optimization, sensitivity, and specificity of the RT-LAMP were evaluated. Our results showed that the RT-LAMP amplified the N gene with high specificity, efficiency, and rapidity at isothermal condition. The optimal reaction condition was achieved at 60°C for 30 min. The RT-LAMP assay was more sensitive than gel-based RT-PCR and PCR. It had a higher sensitivity than enzyme-linked immunosorbent assay (ELISA) using the equal virus templates. In addition, the established RT-LAMP differentiated TGEV from porcine epidemic diarrhea virus, porcine rotavirus, porcine pseudorabies virus, porcine reproductive and respiratory syndrome virus, and avian infectious bronchitis virus. The approach is suitable for detecting TGEV for field diagnostics or in less-equipped laboratories due to its convenience and simplicity.",10.1007/s00284-010-9825-9,3vlctivn,"['Transmissible', 'gastroenteritis', 'virus', 'TGEV', 'is', 'the', 'causative', 'agent', 'of', 'porcine', 'transmissible', 'gastroenteritis', 'and', 'sensitive', 'detection', 'methods', 'are', 'required', 'for', 'preventing', 'the', 'disease', 'In', 'this', 'article', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'was', 'developed', 'to', 'detect', 'TGEV', 'Three', 'pairs', 'of', 'primers', 'targeting', 'the', 'nucleocapsid', 'N', 'gene', 'of', 'TGEV', 'were', 'synthesized', 'and', 'used', 'in', 'the', 'RT', 'LAMP', 'The', 'optimization', 'sensitivity', 'and', 'specificity', 'of', 'the', 'RT', 'LAMP', 'were', 'evaluated', 'Our', 'results', 'showed', 'that', 'the', 'RT', 'LAMP', 'amplified', 'the', 'N', 'gene', 'with', 'high', 'specificity', 'efficiency', 'and', 'rapidity', 'at', 'isothermal', 'condition', 'The', 'optimal', 'reaction', 'condition', 'was', 'achieved', 'at', '60', 'C', 'for', '30', 'min', 'The', 'RT', 'LAMP', 'assay', 'was', 'more', 'sensitive', 'than', 'gel', 'based', 'RT', 'PCR', 'and', 'PCR', 'It', 'had', 'a', 'higher', 'sensitivity', 'than', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'using', 'the', 'equal', 'virus', 'templates', 'In', 'addition', 'the', 'established', 'RT', 'LAMP', 'differentiated', 'TGEV', 'from', 'porcine', 'epidemic', 'diarrhea', 'virus', 'porcine', 'rotavirus', 'porcine', 'pseudorabies', 'virus', 'porcine', 'reproductive', 'and', 'respiratory', 'syndrome', 'virus', 'and', 'avian', 'infectious', 'bronchitis', 'virus', 'The', 'approach', 'is', 'suitable', 'for', 'detecting', 'TGEV', 'for', 'field', 'diagnostics', 'or', 'in', 'less', 'equipped', 'laboratories', 'due', 'to', 'its', 'convenience', 'and', 'simplicity', '']"
156832,Genome analysis of canine astroviruses reveals genetic heterogeneity and suggests possible inter-species transmission,2017-03-15,Virus Research,https://www.ncbi.nlm.nih.gov/pubmed/27965150/; https://www.sciencedirect.com/science/article/pii/S0168170216305731; https://api.elsevier.com/content/article/pii/S0168170216305731; https://doi.org/10.1016/j.virusres.2016.12.005,"Abstract Canine astrovirus RNA was detected in the stools of 17/63 (26.9%) samples, using either a broadly reactive consensus RT-PCR for astroviruses or random RT-PCR coupled with massive deep sequencing. The complete or nearly complete genome sequence of five canine astroviruses was reconstructed that allowed mapping the genome organization and to investigate the genetic diversity of these viruses. The genome was about 6.6kb in length and contained three open reading frames (ORFs) flanked by a 5′ UTR, and a 3′ UTR plus a poly-A tail. ORF1a and ORF1b overlapped by 43 nucleotides while the ORF2 overlapped by 8 nucleotides with the 3′ end of ORF1b. Upon genome comparison, four strains (HUN/2012/2, HUN/2012/6, HUN/2012/115, and HUN/2012/135) were more related genetically to each other and to UK canine astroviruses (88–96% nt identity), whilst strain HUN/2012/126 was more divergent (75–76% nt identity). In the ORF1b and ORF2, strains HUN/2012/2, HUN/2012/6, and HUN/2012/135 were related genetically to other canine astroviruses identified formerly in Europe and China, whereas strain HUN/2012/126 was related genetically to a divergent canine astrovirus strain, ITA/2010/Zoid. For one canine astrovirus, HUN/2012/8, only a 3.2kb portion of the genome, at the 3′ end, could be determined. Interestingly, this strain possessed unique genetic signatures (including a longer ORF1b/ORF2 overlap and a longer 3′UTR) and it was divergent in both ORF1b and ORF2 from all other canine astroviruses, with the highest nucleotide sequence identity (68% and 63%, respectively) to a mink astrovirus, thus suggesting a possible event of interspecies transmission. The genetic heterogeneity of canine astroviruses may pose a challenge for the diagnostics and for future prophylaxis strategies.",10.1016/j.virusres.2016.12.005,ilsenpus,"['Abstract', 'Canine', 'astrovirus', 'RNA', 'was', 'detected', 'in', 'the', 'stools', 'of', '17', '63', '26', '9', 'samples', 'using', 'either', 'a', 'broadly', 'reactive', 'consensus', 'RT', 'PCR', 'for', 'astroviruses', 'or', 'random', 'RT', 'PCR', 'coupled', 'with', 'massive', 'deep', 'sequencing', 'The', 'complete', 'or', 'nearly', 'complete', 'genome', 'sequence', 'of', 'five', 'canine', 'astroviruses', 'was', 'reconstructed', 'that', 'allowed', 'mapping', 'the', 'genome', 'organization', 'and', 'to', 'investigate', 'the', 'genetic', 'diversity', 'of', 'these', 'viruses', 'The', 'genome', 'was', 'about', '6', '6kb', 'in', 'length', 'and', 'contained', 'three', 'open', 'reading', 'frames', 'ORFs', 'flanked', 'by', 'a', '5', 'UTR', 'and', 'a', '3', 'UTR', 'plus', 'a', 'poly', 'A', 'tail', 'ORF1a', 'and', 'ORF1b', 'overlapped', 'by', '43', 'nucleotides', 'while', 'the', 'ORF2', 'overlapped', 'by', '8', 'nucleotides', 'with', 'the', '3', 'end', 'of', 'ORF1b', 'Upon', 'genome', 'comparison', 'four', 'strains', 'HUN', '2012', '2', 'HUN', '2012', '6', 'HUN', '2012', '115', 'and', 'HUN', '2012', '135', 'were', 'more', 'related', 'genetically', 'to', 'each', 'other', 'and', 'to', 'UK', 'canine', 'astroviruses', '88', '96', 'nt', 'identity', 'whilst', 'strain', 'HUN', '2012', '126', 'was', 'more', 'divergent', '75', '76', 'nt', 'identity', 'In', 'the', 'ORF1b', 'and', 'ORF2', 'strains', 'HUN', '2012', '2', 'HUN', '2012', '6', 'and', 'HUN', '2012', '135', 'were', 'related', 'genetically', 'to', 'other', 'canine', 'astroviruses', 'identified', 'formerly', 'in', 'Europe', 'and', 'China', 'whereas', 'strain', 'HUN', '2012', '126', 'was', 'related', 'genetically', 'to', 'a', 'divergent', 'canine', 'astrovirus', 'strain', 'ITA', '2010', 'Zoid', 'For', 'one', 'canine', 'astrovirus', 'HUN', '2012', '8', 'only', 'a', '3', '2kb', 'portion', 'of', 'the', 'genome', 'at', 'the', '3', 'end', 'could', 'be', 'determined', 'Interestingly', 'this', 'strain', 'possessed', 'unique', 'genetic', 'signatures', 'including', 'a', 'longer', 'ORF1b', 'ORF2', 'overlap', 'and', 'a', 'longer', '3', 'UTR', 'and', 'it', 'was', 'divergent', 'in', 'both', 'ORF1b', 'and', 'ORF2', 'from', 'all', 'other', 'canine', 'astroviruses', 'with', 'the', 'highest', 'nucleotide', 'sequence', 'identity', '68', 'and', '63', 'respectively', 'to', 'a', 'mink', 'astrovirus', 'thus', 'suggesting', 'a', 'possible', 'event', 'of', 'interspecies', 'transmission', 'The', 'genetic', 'heterogeneity', 'of', 'canine', 'astroviruses', 'may', 'pose', 'a', 'challenge', 'for', 'the', 'diagnostics', 'and', 'for', 'future', 'prophylaxis', 'strategies', '']"
157005,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020-06-20,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/32575728/; https://doi.org/10.3390/ijms21124396,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.3390/ijms21124396,d65njv7b,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
157088,SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses,2006-08-28,Arch Virol,https://www.ncbi.nlm.nih.gov/pubmed/16941059/,"Coronaviruses are etiologic agents of respiratory and enteric diseases in humans and in animals. In this study, a one-step real-time reverse transcription-polymerase chain reaction (RT-PCR) assay based on SYBR Green chemistry and degenerate primers was developed for the generic detection of coronaviruses. The primers, designed in the open reading frame 1b, enabled the detection of 32 animal coronaviruses including strains of canine coronavirus, feline coronavirus, transmissible gastroenteritis virus (TGEV), bovine coronavirus (BCoV), murine hepatitis virus (MHV) and infectious bronchitis virus (IBV). A specific amplification was also observed with the human coronaviruses (HCoV) HCoV-NL63, HCoV-OC43, HCoV-229E and severe acute respiratory syndrome coronavirus (SARS-CoV). The real-time RT-PCR detected down to 10 cRNA copies from TGEV, BCoV, SARS-CoV and IBV. In addition, the assay exhibited a high sensitivity and specificity on clinical samples from different animal species. The developed assay represents a potential tool for laboratory diagnostics and for detecting still uncharacterized coronaviruses.",10.1007/s00705-006-0840-x,ubg3mj4u,"['Coronaviruses', 'are', 'etiologic', 'agents', 'of', 'respiratory', 'and', 'enteric', 'diseases', 'in', 'humans', 'and', 'in', 'animals', 'In', 'this', 'study', 'a', 'one', 'step', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'assay', 'based', 'on', 'SYBR', 'Green', 'chemistry', 'and', 'degenerate', 'primers', 'was', 'developed', 'for', 'the', 'generic', 'detection', 'of', 'coronaviruses', 'The', 'primers', 'designed', 'in', 'the', 'open', 'reading', 'frame', '1b', 'enabled', 'the', 'detection', 'of', '32', 'animal', 'coronaviruses', 'including', 'strains', 'of', 'canine', 'coronavirus', 'feline', 'coronavirus', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'bovine', 'coronavirus', 'BCoV', 'murine', 'hepatitis', 'virus', 'MHV', 'and', 'infectious', 'bronchitis', 'virus', 'IBV', 'A', 'specific', 'amplification', 'was', 'also', 'observed', 'with', 'the', 'human', 'coronaviruses', 'HCoV', 'HCoV', 'NL63', 'HCoV', 'OC43', 'HCoV', '229E', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'The', 'real', 'time', 'RT', 'PCR', 'detected', 'down', 'to', '10', 'cRNA', 'copies', 'from', 'TGEV', 'BCoV', 'SARS', 'CoV', 'and', 'IBV', 'In', 'addition', 'the', 'assay', 'exhibited', 'a', 'high', 'sensitivity', 'and', 'specificity', 'on', 'clinical', 'samples', 'from', 'different', 'animal', 'species', 'The', 'developed', 'assay', 'represents', 'a', 'potential', 'tool', 'for', 'laboratory', 'diagnostics', 'and', 'for', 'detecting', 'still', 'uncharacterized', 'coronaviruses', '']"
157758,Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma,2020-06-08,Clin Chim Acta,https://www.sciencedirect.com/science/article/pii/S0009898120302588?v=s5; https://doi.org/10.1016/j.cca.2020.05.047; https://api.elsevier.com/content/article/pii/S0009898120302588; https://www.ncbi.nlm.nih.gov/pubmed/32526218/,"BACKGROUND: Besides SARS-CoV-2 RT-PCR testing, serological testing is emerging as additional option in COVID-19 diagnostics. Aim of this study was to evaluate novel immunoassays for detection of SARS-CoV-2 antibodies in human plasma. METHODS: Using EDI(TM) Novel Coronavirus COVID-19 Enzyme Linked Immunosorbent Assays (ELISAs), we measured SARS-CoV-2 IgM and IgG antibodies in 64 SARS-CoV-2 RT-PCR confirmed COVID-19 patients with serial blood samples (n=104) collected at different time points from symptom onset. Blood samples from 200 healthy blood donors and 256 intensive care unit (ICU) patients collected before the COVID-19 outbreak were also used. RESULTS: The positivity rates in the COVID-19 patients were 5.9% for IgM and 2.9% for IgG ≤5 days after symptom onset; Between day 5 and day 10 the positivity rates were 37.1% for IgM and 37.1% for IgG and rose to 76.4% for IgM and 82.4% for IgG after >10-15 days. After 15-22 days the “true” positivity rates were 94.4% for IgM and 100% for IgG. The “false” positivity rates were 0.5% for IgM and 1.0% for IgG in the healthy blood donors, 1.6% for IgM and 1.2% for IgG in ICU patients. CONCLUSIONS: This study shows high “true” vs. low “false” positivity rates for the EDI(TM) SARS-CoV-2 IgM and IgG ELISAs.",10.1016/j.cca.2020.05.047,uqg2xkie,"['BACKGROUND', 'Besides', 'SARS', 'CoV', '2', 'RT', 'PCR', 'testing', 'serological', 'testing', 'is', 'emerging', 'as', 'additional', 'option', 'in', 'COVID', '19', 'diagnostics', 'Aim', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'novel', 'immunoassays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'antibodies', 'in', 'human', 'plasma', 'METHODS', 'Using', 'EDI', 'TM', 'Novel', 'Coronavirus', 'COVID', '19', 'Enzyme', 'Linked', 'Immunosorbent', 'Assays', 'ELISAs', 'we', 'measured', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'in', '64', 'SARS', 'CoV', '2', 'RT', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'with', 'serial', 'blood', 'samples', 'n', '104', 'collected', 'at', 'different', 'time', 'points', 'from', 'symptom', 'onset', 'Blood', 'samples', 'from', '200', 'healthy', 'blood', 'donors', 'and', '256', 'intensive', 'care', 'unit', 'ICU', 'patients', 'collected', 'before', 'the', 'COVID', '19', 'outbreak', 'were', 'also', 'used', 'RESULTS', 'The', 'positivity', 'rates', 'in', 'the', 'COVID', '19', 'patients', 'were', '5', '9', 'for', 'IgM', 'and', '2', '9', 'for', 'IgG', '5', 'days', 'after', 'symptom', 'onset', 'Between', 'day', '5', 'and', 'day', '10', 'the', 'positivity', 'rates', 'were', '37', '1', 'for', 'IgM', 'and', '37', '1', 'for', 'IgG', 'and', 'rose', 'to', '76', '4', 'for', 'IgM', 'and', '82', '4', 'for', 'IgG', 'after', '10', '15', 'days', 'After', '15', '22', 'days', 'the', 'true', 'positivity', 'rates', 'were', '94', '4', 'for', 'IgM', 'and', '100', 'for', 'IgG', 'The', 'false', 'positivity', 'rates', 'were', '0', '5', 'for', 'IgM', 'and', '1', '0', 'for', 'IgG', 'in', 'the', 'healthy', 'blood', 'donors', '1', '6', 'for', 'IgM', 'and', '1', '2', 'for', 'IgG', 'in', 'ICU', 'patients', 'CONCLUSIONS', 'This', 'study', 'shows', 'high', 'true', 'vs', 'low', 'false', 'positivity', 'rates', 'for', 'the', 'EDI', 'TM', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'ELISAs', '']"
159817,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020-04-28,J Clin Virol,https://www.sciencedirect.com/science/article/pii/S1386653220301323?v=s5; https://api.elsevier.com/content/article/pii/S1386653220301323; https://www.ncbi.nlm.nih.gov/pubmed/32388471/; https://doi.org/10.1016/j.jcv.2020.104390,"Abstract Background The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for highly urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated device performing extraction and real-time PCR. Methods A publicly available SARS-CoV-2 RT-PCR assay was adapted for the automated system. Analytical performance was evaluated using in-vitro transcribed RNA and clinical performance was compared to the cobas 6800-based reference assay within the lab. Results The Envelope (E) Gene-LDT displayed good analytical performance with an LoD of 95.55 cp/ml and no false positives during evaluation of cross-reactivity. A total of 176 patient samples were tested with both the E-Gene-LDT and the reference assay. Positive and negative agreement were 100% and 99.2% respectively. Invalid-rate was 6.3%. Conclusion The E-Gene-LDT showed analytical and clinical performance comparable to the cobas6800-based reference assay. Due to its random-access workflow concept and rapid time-to-result of about 80 minutes, the system is very well suited for providing fast-tracked SARS-CoV-2 diagnostics for urgent clinical samples in the hospital setting.",10.1016/j.jcv.2020.104390,hzn6k9ru,"['Abstract', 'Background', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'highly', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'device', 'performing', 'extraction', 'and', 'real', 'time', 'PCR', 'Methods', 'A', 'publicly', 'available', 'SARS', 'CoV', '2', 'RT', 'PCR', 'assay', 'was', 'adapted', 'for', 'the', 'automated', 'system', 'Analytical', 'performance', 'was', 'evaluated', 'using', 'in', 'vitro', 'transcribed', 'RNA', 'and', 'clinical', 'performance', 'was', 'compared', 'to', 'the', 'cobas', '6800', 'based', 'reference', 'assay', 'within', 'the', 'lab', 'Results', 'The', 'Envelope', 'E', 'Gene', 'LDT', 'displayed', 'good', 'analytical', 'performance', 'with', 'an', 'LoD', 'of', '95', '55', 'cp', 'ml', 'and', 'no', 'false', 'positives', 'during', 'evaluation', 'of', 'cross', 'reactivity', 'A', 'total', 'of', '176', 'patient', 'samples', 'were', 'tested', 'with', 'both', 'the', 'E', 'Gene', 'LDT', 'and', 'the', 'reference', 'assay', 'Positive', 'and', 'negative', 'agreement', 'were', '100', 'and', '99', '2', 'respectively', 'Invalid', 'rate', 'was', '6', '3', 'Conclusion', 'The', 'E', 'Gene', 'LDT', 'showed', 'analytical', 'and', 'clinical', 'performance', 'comparable', 'to', 'the', 'cobas6800', 'based', 'reference', 'assay', 'Due', 'to', 'its', 'random', 'access', 'workflow', 'concept', 'and', 'rapid', 'time', 'to', 'result', 'of', 'about', '80', 'minutes', 'the', 'system', 'is', 'very', 'well', 'suited', 'for', 'providing', 'fast', 'tracked', 'SARS', 'CoV', '2', 'diagnostics', 'for', 'urgent', 'clinical', 'samples', 'in', 'the', 'hospital', 'setting', '']"
160371,Methods for Preparation of MS2 Phage-Like Particles and Their Utilization as Process Control Viruses in RT-PCR and qRT-PCR Detection of RNA Viruses From Food Matrices and Clinical Specimens,2015-02-25,Food Environ Virol,https://www.ncbi.nlm.nih.gov/pubmed/25711389/,"RNA viruses are pathogenic agents of many serious infectious diseases affecting humans and animals. The detection of pathogenic RNA viruses is based on modern molecular methods, of which the most widely used methods are the reverse transcription polymerase chain reaction (RT-PCR) and the real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). All steps of RT-PCR and qRT-PCR should be strictly controlled to ensure the validity of obtained results. False-negative results may be caused not only by inhibition of RT or/and PCR steps but also by failure of the nucleic acid extraction step, particularly in the case of viral RNA extraction. The control of nucleic acid extraction generally involves the utilization of a non-pathogenic virus (process control virus) of similar structural properties to those of the target virus. Although in clinical samples the use of such process control virus is only recommended, in other kinds of settings such as food matrices its use is necessary. Currently, several different process control viruses are used for these purposes. Process control viruses can also be constructed artificially using technology for production of MS2 phage-like particles, which have many advantages in comparison with other used controls and are especially suited for controlling the detection and quantification of certain types of RNA viruses. The technology for production of MS2 phage-like particles is theoretically well established, uses the knowledge gained from the study of the familiar bacteriophage MS2 and utilizes many different approaches for the construction of the various process control viruses. Nevertheless, the practical use of MS2 phage-like particles in routine diagnostics is relatively uncommon. The current situation with regard to the use of MS2 phage-like particles as process control viruses in detection of RNA viruses and different methods of their construction, purification and use are summarized and discussed in this review.",10.1007/s12560-015-9188-2,82iks0xf,"['RNA', 'viruses', 'are', 'pathogenic', 'agents', 'of', 'many', 'serious', 'infectious', 'diseases', 'affecting', 'humans', 'and', 'animals', 'The', 'detection', 'of', 'pathogenic', 'RNA', 'viruses', 'is', 'based', 'on', 'modern', 'molecular', 'methods', 'of', 'which', 'the', 'most', 'widely', 'used', 'methods', 'are', 'the', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'and', 'the', 'real', 'time', 'quantitative', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'qRT', 'PCR', 'All', 'steps', 'of', 'RT', 'PCR', 'and', 'qRT', 'PCR', 'should', 'be', 'strictly', 'controlled', 'to', 'ensure', 'the', 'validity', 'of', 'obtained', 'results', 'False', 'negative', 'results', 'may', 'be', 'caused', 'not', 'only', 'by', 'inhibition', 'of', 'RT', 'or', 'and', 'PCR', 'steps', 'but', 'also', 'by', 'failure', 'of', 'the', 'nucleic', 'acid', 'extraction', 'step', 'particularly', 'in', 'the', 'case', 'of', 'viral', 'RNA', 'extraction', 'The', 'control', 'of', 'nucleic', 'acid', 'extraction', 'generally', 'involves', 'the', 'utilization', 'of', 'a', 'non', 'pathogenic', 'virus', 'process', 'control', 'virus', 'of', 'similar', 'structural', 'properties', 'to', 'those', 'of', 'the', 'target', 'virus', 'Although', 'in', 'clinical', 'samples', 'the', 'use', 'of', 'such', 'process', 'control', 'virus', 'is', 'only', 'recommended', 'in', 'other', 'kinds', 'of', 'settings', 'such', 'as', 'food', 'matrices', 'its', 'use', 'is', 'necessary', 'Currently', 'several', 'different', 'process', 'control', 'viruses', 'are', 'used', 'for', 'these', 'purposes', 'Process', 'control', 'viruses', 'can', 'also', 'be', 'constructed', 'artificially', 'using', 'technology', 'for', 'production', 'of', 'MS2', 'phage', 'like', 'particles', 'which', 'have', 'many', 'advantages', 'in', 'comparison', 'with', 'other', 'used', 'controls', 'and', 'are', 'especially', 'suited', 'for', 'controlling', 'the', 'detection', 'and', 'quantification', 'of', 'certain', 'types', 'of', 'RNA', 'viruses', 'The', 'technology', 'for', 'production', 'of', 'MS2', 'phage', 'like', 'particles', 'is', 'theoretically', 'well', 'established', 'uses', 'the', 'knowledge', 'gained', 'from', 'the', 'study', 'of', 'the', 'familiar', 'bacteriophage', 'MS2', 'and', 'utilizes', 'many', 'different', 'approaches', 'for', 'the', 'construction', 'of', 'the', 'various', 'process', 'control', 'viruses', 'Nevertheless', 'the', 'practical', 'use', 'of', 'MS2', 'phage', 'like', 'particles', 'in', 'routine', 'diagnostics', 'is', 'relatively', 'uncommon', 'The', 'current', 'situation', 'with', 'regard', 'to', 'the', 'use', 'of', 'MS2', 'phage', 'like', 'particles', 'as', 'process', 'control', 'viruses', 'in', 'detection', 'of', 'RNA', 'viruses', 'and', 'different', 'methods', 'of', 'their', 'construction', 'purification', 'and', 'use', 'are', 'summarized', 'and', 'discussed', 'in', 'this', 'review', '']"
161002,First international external quality assessment of molecular diagnostics for Mers-CoV,2015-08-31,Journal of Clinical Virology,https://doi.org/10.1016/j.jcv.2015.05.022; https://www.sciencedirect.com/science/article/pii/S1386653215001675; https://www.ncbi.nlm.nih.gov/pubmed/26209385/; https://api.elsevier.com/content/article/pii/S1386653215001675,"Abstract Background Since the discovery of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, diagnostic protocols were quickly published and deployed globally. Objectives We set out to assess the quality of MERS-CoV molecular diagnostics worldwide. Study design Both sensitivity and specificity were assessed using 12 samples containing different viral loads of MERS-CoV or common coronaviruses (OC43, 229E, NL63, HKU1). Results The panel was sent to more than 106 participants, of which 99 laboratories from 6 continents returned 189 panel results.Scores ranged from 100% (84 laboratories) to 33% (1 laboratory). 15% of respondents reported quantitative results, 61% semi-quantitative (Ct-values or time to positivity) and 24% reported qualitative results. The major specific technique used was real-time RT-PCR using the WHO recommended targets upE, ORF1a and ORF1b. The evaluation confirmed that RT-PCRs targeting the ORF1b are less sensitive, and therefore not advised for primary diagnostics. Conclusions The first external quality assessment MERS-CoV panel gives a good insight in molecular diagnostic techniques and their performances for sensitive and specific detection of MERS-CoV RNA globally. Overall, all laboratories were capable of detecting MERS-CoV with some differences in sensitivity. The observation that 8% of laboratories reported false MERS-CoV positive single assay results shows room for improvement, and the importance of using confirmatory targets.",10.1016/j.jcv.2015.05.022,s95ryhiu,"['Abstract', 'Background', 'Since', 'the', 'discovery', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'in', '2012', 'diagnostic', 'protocols', 'were', 'quickly', 'published', 'and', 'deployed', 'globally', 'Objectives', 'We', 'set', 'out', 'to', 'assess', 'the', 'quality', 'of', 'MERS', 'CoV', 'molecular', 'diagnostics', 'worldwide', 'Study', 'design', 'Both', 'sensitivity', 'and', 'specificity', 'were', 'assessed', 'using', '12', 'samples', 'containing', 'different', 'viral', 'loads', 'of', 'MERS', 'CoV', 'or', 'common', 'coronaviruses', 'OC43', '229E', 'NL63', 'HKU1', 'Results', 'The', 'panel', 'was', 'sent', 'to', 'more', 'than', '106', 'participants', 'of', 'which', '99', 'laboratories', 'from', '6', 'continents', 'returned', '189', 'panel', 'results', 'Scores', 'ranged', 'from', '100', '84', 'laboratories', 'to', '33', '1', 'laboratory', '15', 'of', 'respondents', 'reported', 'quantitative', 'results', '61', 'semi', 'quantitative', 'Ct', 'values', 'or', 'time', 'to', 'positivity', 'and', '24', 'reported', 'qualitative', 'results', 'The', 'major', 'specific', 'technique', 'used', 'was', 'real', 'time', 'RT', 'PCR', 'using', 'the', 'WHO', 'recommended', 'targets', 'upE', 'ORF1a', 'and', 'ORF1b', 'The', 'evaluation', 'confirmed', 'that', 'RT', 'PCRs', 'targeting', 'the', 'ORF1b', 'are', 'less', 'sensitive', 'and', 'therefore', 'not', 'advised', 'for', 'primary', 'diagnostics', 'Conclusions', 'The', 'first', 'external', 'quality', 'assessment', 'MERS', 'CoV', 'panel', 'gives', 'a', 'good', 'insight', 'in', 'molecular', 'diagnostic', 'techniques', 'and', 'their', 'performances', 'for', 'sensitive', 'and', 'specific', 'detection', 'of', 'MERS', 'CoV', 'RNA', 'globally', 'Overall', 'all', 'laboratories', 'were', 'capable', 'of', 'detecting', 'MERS', 'CoV', 'with', 'some', 'differences', 'in', 'sensitivity', 'The', 'observation', 'that', '8', 'of', 'laboratories', 'reported', 'false', 'MERS', 'CoV', 'positive', 'single', 'assay', 'results', 'shows', 'room', 'for', 'improvement', 'and', 'the', 'importance', 'of', 'using', 'confirmatory', 'targets', '']"
161087,The use of next generation sequencing in the diagnosis and typing of respiratory infections,2015-08-31,Journal of Clinical Virology,https://doi.org/10.1016/j.jcv.2015.06.082; https://www.ncbi.nlm.nih.gov/pubmed/26209388/; https://api.elsevier.com/content/article/pii/S138665321500267X; https://www.sciencedirect.com/science/article/pii/S138665321500267X,"Abstract Background Molecular assays are the gold standard methods used to diagnose viral respiratory pathogens. Pitfalls associated with this technique include limits to the number of targeted pathogens, the requirement for continuous monitoring to ensure sensitivity/specificity is maintained and the need to evolve to include emerging pathogens. Introducing target independent next generation sequencing (NGS) could resolve these issues and revolutionise respiratory viral diagnostics. Objectives To compare the sensitivity and specificity of target independent NGS against the current standard diagnostic test. Study design Diagnostic RT-PCR of clinical samples was carried out in parallel with target independent NGS. NGS sequences were analyzed to determine the proportion with viral origin and consensus sequences were used to establish viral genotypes and serotypes where applicable. Results 89 nasopharyngeal swabs were tested. A viral pathogen was detected in 43% of samples by NGS and 54% by RT-PCR. All NGS viral detections were confirmed by RT-PCR. Conclusions Target independent NGS can detect viral pathogens in clinical samples. Where viruses were detected by RT-PCR alone the Ct value was higher than those detected by both assays, suggesting an NGS detection cut-off – Ct=32. The sensitivity and specificity of NGS compared with RT-PCR was 78% and 80% respectively. This is lower than current diagnostic assays but NGS provided full genome sequences in some cases, allowing determination of viral subtype and serotype. Sequencing technology is improving rapidly and it is likely that within a short period of time sequencing depth will increase in-turn improving test sensitivity.",10.1016/j.jcv.2015.06.082,q7jp224a,"['Abstract', 'Background', 'Molecular', 'assays', 'are', 'the', 'gold', 'standard', 'methods', 'used', 'to', 'diagnose', 'viral', 'respiratory', 'pathogens', 'Pitfalls', 'associated', 'with', 'this', 'technique', 'include', 'limits', 'to', 'the', 'number', 'of', 'targeted', 'pathogens', 'the', 'requirement', 'for', 'continuous', 'monitoring', 'to', 'ensure', 'sensitivity', 'specificity', 'is', 'maintained', 'and', 'the', 'need', 'to', 'evolve', 'to', 'include', 'emerging', 'pathogens', 'Introducing', 'target', 'independent', 'next', 'generation', 'sequencing', 'NGS', 'could', 'resolve', 'these', 'issues', 'and', 'revolutionise', 'respiratory', 'viral', 'diagnostics', 'Objectives', 'To', 'compare', 'the', 'sensitivity', 'and', 'specificity', 'of', 'target', 'independent', 'NGS', 'against', 'the', 'current', 'standard', 'diagnostic', 'test', 'Study', 'design', 'Diagnostic', 'RT', 'PCR', 'of', 'clinical', 'samples', 'was', 'carried', 'out', 'in', 'parallel', 'with', 'target', 'independent', 'NGS', 'NGS', 'sequences', 'were', 'analyzed', 'to', 'determine', 'the', 'proportion', 'with', 'viral', 'origin', 'and', 'consensus', 'sequences', 'were', 'used', 'to', 'establish', 'viral', 'genotypes', 'and', 'serotypes', 'where', 'applicable', 'Results', '89', 'nasopharyngeal', 'swabs', 'were', 'tested', 'A', 'viral', 'pathogen', 'was', 'detected', 'in', '43', 'of', 'samples', 'by', 'NGS', 'and', '54', 'by', 'RT', 'PCR', 'All', 'NGS', 'viral', 'detections', 'were', 'confirmed', 'by', 'RT', 'PCR', 'Conclusions', 'Target', 'independent', 'NGS', 'can', 'detect', 'viral', 'pathogens', 'in', 'clinical', 'samples', 'Where', 'viruses', 'were', 'detected', 'by', 'RT', 'PCR', 'alone', 'the', 'Ct', 'value', 'was', 'higher', 'than', 'those', 'detected', 'by', 'both', 'assays', 'suggesting', 'an', 'NGS', 'detection', 'cut', 'off', 'Ct', '32', 'The', 'sensitivity', 'and', 'specificity', 'of', 'NGS', 'compared', 'with', 'RT', 'PCR', 'was', '78', 'and', '80', 'respectively', 'This', 'is', 'lower', 'than', 'current', 'diagnostic', 'assays', 'but', 'NGS', 'provided', 'full', 'genome', 'sequences', 'in', 'some', 'cases', 'allowing', 'determination', 'of', 'viral', 'subtype', 'and', 'serotype', 'Sequencing', 'technology', 'is', 'improving', 'rapidly', 'and', 'it', 'is', 'likely', 'that', 'within', 'a', 'short', 'period', 'of', 'time', 'sequencing', 'depth', 'will', 'increase', 'in', 'turn', 'improving', 'test', 'sensitivity', '']"
167221,Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2,2020-05-21,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511358/; https://doi.org/10.1101/2020.05.21.108381,"The COVID-19 pandemic provides an urgent example where a gap exists between availability of state-of-the-art diagnostics and current needs. As assay details and primer sequences become widely known, many laboratories could perform diagnostic tests using methods such as RT-PCR or isothermal RT-LAMP amplification. A key advantage of RT-LAMP based approaches compared to RT-PCR is that RT-LAMP is known to be robust in detecting targets from unprocessed samples. In addition, RT-LAMP assays are performed at a constant temperature enabling speed, simplicity, and point-of-use testing. Here, we provide the details of an RT-LAMP isothermal assay for the detection of SARS-CoV-2 virus with performance comparable to currently approved tests using RT-PCR. We characterize the assay by introducing swabs in virus spiked synthetic nasal fluids, moving the swab to viral transport medium (VTM), and using a volume of that VTM for performing the amplification without an RNA extraction kit. The assay has a Limit-of-Detection (LOD) of 50 RNA copies/μL in the VTM solution within 20 minutes, and LOD of 5000 RNA copies/μL in the nasal solution. Additionally, we show the utility of this assay for real-time point-of-use testing by demonstrating detection of SARS-CoV-2 virus in less than 40 minutes using an additively manufactured cartridge and a smartphone-based reader. Finally, we explore the speed and cost advantages by comparing the required resources and workflows with RT-PCR. This work could accelerate the development and availability of SARS-CoV-2 diagnostics by proving alternatives to conventional laboratory benchtop tests.",10.1101/2020.05.21.108381,6epdh88j,"['The', 'COVID', '19', 'pandemic', 'provides', 'an', 'urgent', 'example', 'where', 'a', 'gap', 'exists', 'between', 'availability', 'of', 'state', 'of', 'the', 'art', 'diagnostics', 'and', 'current', 'needs', 'As', 'assay', 'details', 'and', 'primer', 'sequences', 'become', 'widely', 'known', 'many', 'laboratories', 'could', 'perform', 'diagnostic', 'tests', 'using', 'methods', 'such', 'as', 'RT', 'PCR', 'or', 'isothermal', 'RT', 'LAMP', 'amplification', 'A', 'key', 'advantage', 'of', 'RT', 'LAMP', 'based', 'approaches', 'compared', 'to', 'RT', 'PCR', 'is', 'that', 'RT', 'LAMP', 'is', 'known', 'to', 'be', 'robust', 'in', 'detecting', 'targets', 'from', 'unprocessed', 'samples', 'In', 'addition', 'RT', 'LAMP', 'assays', 'are', 'performed', 'at', 'a', 'constant', 'temperature', 'enabling', 'speed', 'simplicity', 'and', 'point', 'of', 'use', 'testing', 'Here', 'we', 'provide', 'the', 'details', 'of', 'an', 'RT', 'LAMP', 'isothermal', 'assay', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'with', 'performance', 'comparable', 'to', 'currently', 'approved', 'tests', 'using', 'RT', 'PCR', 'We', 'characterize', 'the', 'assay', 'by', 'introducing', 'swabs', 'in', 'virus', 'spiked', 'synthetic', 'nasal', 'fluids', 'moving', 'the', 'swab', 'to', 'viral', 'transport', 'medium', 'VTM', 'and', 'using', 'a', 'volume', 'of', 'that', 'VTM', 'for', 'performing', 'the', 'amplification', 'without', 'an', 'RNA', 'extraction', 'kit', 'The', 'assay', 'has', 'a', 'Limit', 'of', 'Detection', 'LOD', 'of', '50', 'RNA', 'copies', 'μL', 'in', 'the', 'VTM', 'solution', 'within', '20', 'minutes', 'and', 'LOD', 'of', '5000', 'RNA', 'copies', 'μL', 'in', 'the', 'nasal', 'solution', 'Additionally', 'we', 'show', 'the', 'utility', 'of', 'this', 'assay', 'for', 'real', 'time', 'point', 'of', 'use', 'testing', 'by', 'demonstrating', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'in', 'less', 'than', '40', 'minutes', 'using', 'an', 'additively', 'manufactured', 'cartridge', 'and', 'a', 'smartphone', 'based', 'reader', 'Finally', 'we', 'explore', 'the', 'speed', 'and', 'cost', 'advantages', 'by', 'comparing', 'the', 'required', 'resources', 'and', 'workflows', 'with', 'RT', 'PCR', 'This', 'work', 'could', 'accelerate', 'the', 'development', 'and', 'availability', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'by', 'proving', 'alternatives', 'to', 'conventional', 'laboratory', 'benchtop', 'tests', '']"
176293,A Rapid and Low-Cost PCR Thermal Cycler for Infectious Disease Diagnostics,2016-02-12,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/26872358/; https://doi.org/10.1371/journal.pone.0149150,"The ability to make rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a great step forward in global health. Many molecular diagnostic assays are developed based on using thermal cyclers to carry out polymerase chain reaction (PCR) and reverse-transcription PCR for DNA and RNA amplification and detection, respectively. Unfortunately, most commercial thermal cyclers are expensive and need continuous electrical power supply, so they are not suitable for uses in low-resource settings. We have previously reported a low-cost and simple approach to amplify DNA using vacuum insulated stainless steel thermoses food cans, which we have named it thermos thermal cycler or TTC. Here, we describe the use of an improved set up to enable the detection of viral RNA targets by reverse-transcription PCR (RT-PCR), thus expanding the TTC’s ability to identify highly infectious, RNA virus-based diseases in low resource settings. The TTC was successful in demonstrating high-speed and sensitive detection of DNA or RNA targets of sexually transmitted diseases, HIV/AIDS, Ebola hemorrhagic fever, and dengue fever. Our innovative TTC costs less than $200 to build and has a capacity of at least eight tubes. In terms of speed, the TTC’s performance exceeded that of commercial thermal cyclers tested. When coupled with low-cost endpoint detection technologies such as nucleic acid lateral-flow assay or a cell-phone-based fluorescence detector, the TTC will increase the availability of on-site molecular diagnostics in low-resource settings.",10.1371/journal.pone.0149150,pt4jsr6d,"['The', 'ability', 'to', 'make', 'rapid', 'diagnosis', 'of', 'infectious', 'diseases', 'broadly', 'available', 'in', 'a', 'portable', 'low', 'cost', 'format', 'would', 'mark', 'a', 'great', 'step', 'forward', 'in', 'global', 'health', 'Many', 'molecular', 'diagnostic', 'assays', 'are', 'developed', 'based', 'on', 'using', 'thermal', 'cyclers', 'to', 'carry', 'out', 'polymerase', 'chain', 'reaction', 'PCR', 'and', 'reverse', 'transcription', 'PCR', 'for', 'DNA', 'and', 'RNA', 'amplification', 'and', 'detection', 'respectively', 'Unfortunately', 'most', 'commercial', 'thermal', 'cyclers', 'are', 'expensive', 'and', 'need', 'continuous', 'electrical', 'power', 'supply', 'so', 'they', 'are', 'not', 'suitable', 'for', 'uses', 'in', 'low', 'resource', 'settings', 'We', 'have', 'previously', 'reported', 'a', 'low', 'cost', 'and', 'simple', 'approach', 'to', 'amplify', 'DNA', 'using', 'vacuum', 'insulated', 'stainless', 'steel', 'thermoses', 'food', 'cans', 'which', 'we', 'have', 'named', 'it', 'thermos', 'thermal', 'cycler', 'or', 'TTC', 'Here', 'we', 'describe', 'the', 'use', 'of', 'an', 'improved', 'set', 'up', 'to', 'enable', 'the', 'detection', 'of', 'viral', 'RNA', 'targets', 'by', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'thus', 'expanding', 'the', 'TTC', 's', 'ability', 'to', 'identify', 'highly', 'infectious', 'RNA', 'virus', 'based', 'diseases', 'in', 'low', 'resource', 'settings', 'The', 'TTC', 'was', 'successful', 'in', 'demonstrating', 'high', 'speed', 'and', 'sensitive', 'detection', 'of', 'DNA', 'or', 'RNA', 'targets', 'of', 'sexually', 'transmitted', 'diseases', 'HIV', 'AIDS', 'Ebola', 'hemorrhagic', 'fever', 'and', 'dengue', 'fever', 'Our', 'innovative', 'TTC', 'costs', 'less', 'than', '200', 'to', 'build', 'and', 'has', 'a', 'capacity', 'of', 'at', 'least', 'eight', 'tubes', 'In', 'terms', 'of', 'speed', 'the', 'TTC', 's', 'performance', 'exceeded', 'that', 'of', 'commercial', 'thermal', 'cyclers', 'tested', 'When', 'coupled', 'with', 'low', 'cost', 'endpoint', 'detection', 'technologies', 'such', 'as', 'nucleic', 'acid', 'lateral', 'flow', 'assay', 'or', 'a', 'cell', 'phone', 'based', 'fluorescence', 'detector', 'the', 'TTC', 'will', 'increase', 'the', 'availability', 'of', 'on', 'site', 'molecular', 'diagnostics', 'in', 'low', 'resource', 'settings', '']"
177282,Multifunctional nano-magnetic particles assisted viral RNA-extraction protocol for potential detection of COVID-19,2020-05-18,Mater. Res. Innov.,https://doi.org/10.1080/14328917.2020.1769350,"The enduring outbreak of the corona virus disease (COVID-19) originated from China illustrates global concerns owing to their infective nature and time-consuming incubation. Even though diagnostic tools based on RT-PCR are being extensively employed at present, well-timed and precise diagnostics are still restricted because of the long-period and exhaustive man-power requirement. To tackle this problem, we herewith report the fabrication of the surface functionalised magnetic nanoparticles (MNP’s) and viral RNA-extraction protocol for potential detection of COVID-19. The zinc ferrite nanoparticles were prepared by combustion synthesis and its surface was functionalised by silica and carboxyl-modified polyvinyl alcohol. The MNP’s were characterized to confirm the nano-scale appearance and functionalization. The proposed model may provide the ability to extract the viral RNA from several specimens through automation process. In light of ease and proficiency, this protocol may significantly lessen the operation period and necessities for the present molecular-level diagnostic of COVID-19.",10.1080/14328917.2020.1769350,2v1pqnjt,"['The', 'enduring', 'outbreak', 'of', 'the', 'corona', 'virus', 'disease', 'COVID', '19', 'originated', 'from', 'China', 'illustrates', 'global', 'concerns', 'owing', 'to', 'their', 'infective', 'nature', 'and', 'time', 'consuming', 'incubation', 'Even', 'though', 'diagnostic', 'tools', 'based', 'on', 'RT', 'PCR', 'are', 'being', 'extensively', 'employed', 'at', 'present', 'well', 'timed', 'and', 'precise', 'diagnostics', 'are', 'still', 'restricted', 'because', 'of', 'the', 'long', 'period', 'and', 'exhaustive', 'man', 'power', 'requirement', 'To', 'tackle', 'this', 'problem', 'we', 'herewith', 'report', 'the', 'fabrication', 'of', 'the', 'surface', 'functionalised', 'magnetic', 'nanoparticles', 'MNP', 's', 'and', 'viral', 'RNA', 'extraction', 'protocol', 'for', 'potential', 'detection', 'of', 'COVID', '19', 'The', 'zinc', 'ferrite', 'nanoparticles', 'were', 'prepared', 'by', 'combustion', 'synthesis', 'and', 'its', 'surface', 'was', 'functionalised', 'by', 'silica', 'and', 'carboxyl', 'modified', 'polyvinyl', 'alcohol', 'The', 'MNP', 's', 'were', 'characterized', 'to', 'confirm', 'the', 'nano', 'scale', 'appearance', 'and', 'functionalization', 'The', 'proposed', 'model', 'may', 'provide', 'the', 'ability', 'to', 'extract', 'the', 'viral', 'RNA', 'from', 'several', 'specimens', 'through', 'automation', 'process', 'In', 'light', 'of', 'ease', 'and', 'proficiency', 'this', 'protocol', 'may', 'significantly', 'lessen', 'the', 'operation', 'period', 'and', 'necessities', 'for', 'the', 'present', 'molecular', 'level', 'diagnostic', 'of', 'COVID', '19', '']"
177294,A novel enterovirus and parechovirus multiplex one-step real-time PCR-validation and clinical experience,2013-11-30,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2013.06.038; https://www.sciencedirect.com/science/article/pii/S0166093413002528; https://api.elsevier.com/content/article/pii/S0166093413002528; https://www.ncbi.nlm.nih.gov/pubmed/23845901/,"Abstract As the number of new enteroviruses and human parechoviruses seems ever growing, the necessity for updated diagnostics is relevant. We have updated an enterovirus assay and combined it with a previously published assay for human parechovirus resulting in a multiplex one-step RT-PCR assay. The multiplex assay was validated by analysing the sensitivity and specificity of the assay compared to the respective monoplex assays, and a good concordance was found. Furthermore, the enterovirus assay was able to detect 42 reference strains from all 4 species, and an additional 9 genotypes during panel testing and routine usage. During 15 months of routine use, from October 2008 to December 2009, we received and analysed 2187 samples (stool samples, cerebrospinal fluids, blood samples, respiratory samples and autopsy samples) were tested, from 1546 patients and detected enteroviruses and parechoviruses in 171 (8%) and 66 (3%) of the samples, respectively. 180 of the positive samples could be genotyped by PCR and sequencing and the most common genotypes found were human parechovirus type 3, echovirus 9, enterovirus 71, Coxsackievirus A16, and echovirus 25. During 2009 in Denmark, both enterovirus and human parechovirus type 3 had a similar seasonal pattern with a peak during the summer and autumn. Human parechovirus type 3 was almost invariably found in children less than 4 months of age. In conclusion, a multiplex assay was developed allowing simultaneous detection of 2 viruses, which can cause similar clinical symptoms.",10.1016/j.jviromet.2013.06.038,rldr8om0,"['Abstract', 'As', 'the', 'number', 'of', 'new', 'enteroviruses', 'and', 'human', 'parechoviruses', 'seems', 'ever', 'growing', 'the', 'necessity', 'for', 'updated', 'diagnostics', 'is', 'relevant', 'We', 'have', 'updated', 'an', 'enterovirus', 'assay', 'and', 'combined', 'it', 'with', 'a', 'previously', 'published', 'assay', 'for', 'human', 'parechovirus', 'resulting', 'in', 'a', 'multiplex', 'one', 'step', 'RT', 'PCR', 'assay', 'The', 'multiplex', 'assay', 'was', 'validated', 'by', 'analysing', 'the', 'sensitivity', 'and', 'specificity', 'of', 'the', 'assay', 'compared', 'to', 'the', 'respective', 'monoplex', 'assays', 'and', 'a', 'good', 'concordance', 'was', 'found', 'Furthermore', 'the', 'enterovirus', 'assay', 'was', 'able', 'to', 'detect', '42', 'reference', 'strains', 'from', 'all', '4', 'species', 'and', 'an', 'additional', '9', 'genotypes', 'during', 'panel', 'testing', 'and', 'routine', 'usage', 'During', '15', 'months', 'of', 'routine', 'use', 'from', 'October', '2008', 'to', 'December', '2009', 'we', 'received', 'and', 'analysed', '2187', 'samples', 'stool', 'samples', 'cerebrospinal', 'fluids', 'blood', 'samples', 'respiratory', 'samples', 'and', 'autopsy', 'samples', 'were', 'tested', 'from', '1546', 'patients', 'and', 'detected', 'enteroviruses', 'and', 'parechoviruses', 'in', '171', '8', 'and', '66', '3', 'of', 'the', 'samples', 'respectively', '180', 'of', 'the', 'positive', 'samples', 'could', 'be', 'genotyped', 'by', 'PCR', 'and', 'sequencing', 'and', 'the', 'most', 'common', 'genotypes', 'found', 'were', 'human', 'parechovirus', 'type', '3', 'echovirus', '9', 'enterovirus', '71', 'Coxsackievirus', 'A16', 'and', 'echovirus', '25', 'During', '2009', 'in', 'Denmark', 'both', 'enterovirus', 'and', 'human', 'parechovirus', 'type', '3', 'had', 'a', 'similar', 'seasonal', 'pattern', 'with', 'a', 'peak', 'during', 'the', 'summer', 'and', 'autumn', 'Human', 'parechovirus', 'type', '3', 'was', 'almost', 'invariably', 'found', 'in', 'children', 'less', 'than', '4', 'months', 'of', 'age', 'In', 'conclusion', 'a', 'multiplex', 'assay', 'was', 'developed', 'allowing', 'simultaneous', 'detection', 'of', '2', 'viruses', 'which', 'can', 'cause', 'similar', 'clinical', 'symptoms', '']"
177579,Immunochromatographic test for detection of adenovirus from respiratory samples: Is it a real solution for pediatric emergency department?,2014-01-31,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2013.09.002; https://api.elsevier.com/content/article/pii/S0166093413003893; https://www.ncbi.nlm.nih.gov/pubmed/24096271/; https://www.sciencedirect.com/science/article/pii/S0166093413003893,"Abstract Rapid diagnosis of adenoviral respiratory infections is required in order to decide optimal treatment strategies. The adenovirus antigen immunochromatography Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain), was evaluated versus the shell-vial culture and multiplex PCR (Clart Pneumovir Version 3.0, Genomica, Madrid, Spain), in nasopharyngeal washes and oropharyngeal swabs specimens from subjects with respiratory tract infections. Between April 2011 and November 2012, 224 patients were included. The IC Adeno Respiratory Card Letitest was positive for 77.9% (74 of 95) of patients diagnosed at bedside. Using multiplex-PCR as the reference standard, the overall sensitivity was 77.9% and the specificity was 73.6%. Taking shell-viral culture as the reference method, the Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain) sensitivity and specificity values were 80.0% and 60.9%, respectively. Using RT-PCR (Clart Pneumovir Version 3.0, Genomica, Madrid, Spain) as the reference standard, the viral culture sensitivity was 53.2% and the specificity was 100%. The Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain) assay could be a simple and rapid method for antigenic detection of adenovirus in pediatric respiratory samples although it would be necessary to improve the specificity and sensitivity of the test.",10.1016/j.jviromet.2013.09.002,0oos87b1,"['Abstract', 'Rapid', 'diagnosis', 'of', 'adenoviral', 'respiratory', 'infections', 'is', 'required', 'in', 'order', 'to', 'decide', 'optimal', 'treatment', 'strategies', 'The', 'adenovirus', 'antigen', 'immunochromatography', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'was', 'evaluated', 'versus', 'the', 'shell', 'vial', 'culture', 'and', 'multiplex', 'PCR', 'Clart', 'Pneumovir', 'Version', '3', '0', 'Genomica', 'Madrid', 'Spain', 'in', 'nasopharyngeal', 'washes', 'and', 'oropharyngeal', 'swabs', 'specimens', 'from', 'subjects', 'with', 'respiratory', 'tract', 'infections', 'Between', 'April', '2011', 'and', 'November', '2012', '224', 'patients', 'were', 'included', 'The', 'IC', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'was', 'positive', 'for', '77', '9', '74', 'of', '95', 'of', 'patients', 'diagnosed', 'at', 'bedside', 'Using', 'multiplex', 'PCR', 'as', 'the', 'reference', 'standard', 'the', 'overall', 'sensitivity', 'was', '77', '9', 'and', 'the', 'specificity', 'was', '73', '6', 'Taking', 'shell', 'viral', 'culture', 'as', 'the', 'reference', 'method', 'the', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'sensitivity', 'and', 'specificity', 'values', 'were', '80', '0', 'and', '60', '9', 'respectively', 'Using', 'RT', 'PCR', 'Clart', 'Pneumovir', 'Version', '3', '0', 'Genomica', 'Madrid', 'Spain', 'as', 'the', 'reference', 'standard', 'the', 'viral', 'culture', 'sensitivity', 'was', '53', '2', 'and', 'the', 'specificity', 'was', '100', 'The', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'assay', 'could', 'be', 'a', 'simple', 'and', 'rapid', 'method', 'for', 'antigenic', 'detection', 'of', 'adenovirus', 'in', 'pediatric', 'respiratory', 'samples', 'although', 'it', 'would', 'be', 'necessary', 'to', 'improve', 'the', 'specificity', 'and', 'sensitivity', 'of', 'the', 'test', '']"
177883,Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses,2017-10-31,Molecular and Cellular Probes,https://www.sciencedirect.com/science/article/pii/S0890850817300658; https://doi.org/10.1016/j.mcp.2017.06.005; https://www.ncbi.nlm.nih.gov/pubmed/28652020/; https://api.elsevier.com/content/article/pii/S0890850817300658,"Abstract Influenza and other acute respiratory infections are of great concern for public health, causing excessive morbidity and mortality throughout the world. Influenza virus A(H2N2), which caused a pandemic of so called “Asian flu” in 1957 was expelled from the human population by the new pandemic virus subtype H3N2 in 1968, however, influenza A(H2) viruses continue to circulate in wild birds and poultry. The lack of immunity in human population and the continued circulation of influenza A(H2) among animals makes emergence of a new pandemic virus possible. One of the basic techniques of molecular diagnostics of infectious diseases is the realtime polymerase chain reaction (PCR). The aim of this work was to design oligonucleotide primers and probes for the rapid detection of influenza A virus subtype H2 by realtime reverse transcription - polymerase chain reaction (rRT-PCR). Analysis of 539 sequences of influenza A(H2N2) virus hemagglutinin gene from GISAID EpiFlu database revealed conservative regions suitable for use as binding sites for primers and probes. 191 probes were designed and 2 sets of primers and probes (H2-1 and H2-2) were selected for further experimental evaluation. Detection limit of RT-PCR system was 50 copies of DNA per 25 μl reaction when 10-fold dilutions of pCI-neo-H2 plasmid used as template. Analytical specificity of selected sets of primers and probes were tested on wide range of influenza strains and non-influenza respiratory viruses. H2-2 set found to have insufficient specificity detecting seasonal influenza A(H1N1) viruses and was excluded from further analysis. Analytical sensitivity was further tested on vaccine strain A/17/California/66/395 (H2N2) and A/Japan/305/1957 (H2N2), limit of detection for primers-probe set H2-1 was 3.2 (CI95%: 3.07–3.48) lg EID50/ml. Designed primers and probes for the realtime RT-PCR universal detection of influenza A(H2) viruses could be used in clinical trials of vaccines against influenza A(H2) and screening for H2 in cases of unsubtypeable influenza A in humans.",10.1016/j.mcp.2017.06.005,ozv0zp7r,"['Abstract', 'Influenza', 'and', 'other', 'acute', 'respiratory', 'infections', 'are', 'of', 'great', 'concern', 'for', 'public', 'health', 'causing', 'excessive', 'morbidity', 'and', 'mortality', 'throughout', 'the', 'world', 'Influenza', 'virus', 'A', 'H2N2', 'which', 'caused', 'a', 'pandemic', 'of', 'so', 'called', 'Asian', 'flu', 'in', '1957', 'was', 'expelled', 'from', 'the', 'human', 'population', 'by', 'the', 'new', 'pandemic', 'virus', 'subtype', 'H3N2', 'in', '1968', 'however', 'influenza', 'A', 'H2', 'viruses', 'continue', 'to', 'circulate', 'in', 'wild', 'birds', 'and', 'poultry', 'The', 'lack', 'of', 'immunity', 'in', 'human', 'population', 'and', 'the', 'continued', 'circulation', 'of', 'influenza', 'A', 'H2', 'among', 'animals', 'makes', 'emergence', 'of', 'a', 'new', 'pandemic', 'virus', 'possible', 'One', 'of', 'the', 'basic', 'techniques', 'of', 'molecular', 'diagnostics', 'of', 'infectious', 'diseases', 'is', 'the', 'realtime', 'polymerase', 'chain', 'reaction', 'PCR', 'The', 'aim', 'of', 'this', 'work', 'was', 'to', 'design', 'oligonucleotide', 'primers', 'and', 'probes', 'for', 'the', 'rapid', 'detection', 'of', 'influenza', 'A', 'virus', 'subtype', 'H2', 'by', 'realtime', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'Analysis', 'of', '539', 'sequences', 'of', 'influenza', 'A', 'H2N2', 'virus', 'hemagglutinin', 'gene', 'from', 'GISAID', 'EpiFlu', 'database', 'revealed', 'conservative', 'regions', 'suitable', 'for', 'use', 'as', 'binding', 'sites', 'for', 'primers', 'and', 'probes', '191', 'probes', 'were', 'designed', 'and', '2', 'sets', 'of', 'primers', 'and', 'probes', 'H2', '1', 'and', 'H2', '2', 'were', 'selected', 'for', 'further', 'experimental', 'evaluation', 'Detection', 'limit', 'of', 'RT', 'PCR', 'system', 'was', '50', 'copies', 'of', 'DNA', 'per', '25', 'μl', 'reaction', 'when', '10', 'fold', 'dilutions', 'of', 'pCI', 'neo', 'H2', 'plasmid', 'used', 'as', 'template', 'Analytical', 'specificity', 'of', 'selected', 'sets', 'of', 'primers', 'and', 'probes', 'were', 'tested', 'on', 'wide', 'range', 'of', 'influenza', 'strains', 'and', 'non', 'influenza', 'respiratory', 'viruses', 'H2', '2', 'set', 'found', 'to', 'have', 'insufficient', 'specificity', 'detecting', 'seasonal', 'influenza', 'A', 'H1N1', 'viruses', 'and', 'was', 'excluded', 'from', 'further', 'analysis', 'Analytical', 'sensitivity', 'was', 'further', 'tested', 'on', 'vaccine', 'strain', 'A', '17', 'California', '66', '395', 'H2N2', 'and', 'A', 'Japan', '305', '1957', 'H2N2', 'limit', 'of', 'detection', 'for', 'primers', 'probe', 'set', 'H2', '1', 'was', '3', '2', 'CI95', '3', '07', '3', '48', 'lg', 'EID50', 'ml', 'Designed', 'primers', 'and', 'probes', 'for', 'the', 'realtime', 'RT', 'PCR', 'universal', 'detection', 'of', 'influenza', 'A', 'H2', 'viruses', 'could', 'be', 'used', 'in', 'clinical', 'trials', 'of', 'vaccines', 'against', 'influenza', 'A', 'H2', 'and', 'screening', 'for', 'H2', 'in', 'cases', 'of', 'unsubtypeable', 'influenza', 'A', 'in', 'humans', '']"
179444,28 New and Emerging Infections of the Lung,2019-12-31,Kendig's Disorders of the Respiratory Tract in Children,https://www.sciencedirect.com/science/article/pii/B9780323448871000286; https://api.elsevier.com/content/article/pii/B9780323448871000286,"Abstract In this era of rapid globalization and frequent travel, emerging viral infections have gained an immense potential to spread at an unprecedented speed and scale compared with the past. This poses a significant challenge to coordinated international efforts in global surveillance and infection control. Significantly, respiratory viral infections, spread mostly via droplet transmission, are extremely contagious and have caused significant morbidity and mortality during outbreaks in the last decade. Molecular diagnostics via reverse transcriptase polymerase chain reaction (RT-PCR) have been key in the rapid diagnosis of most of these viral infections. However, a high index of suspicion and early institution of appropriate isolation measures remain as the mainstay in the control and containment of the spread of these viral infections. Although treatment for most of the viral infections remains supportive, efficacious antiviral agents against influenza infections exist. The infections discussed in this chapter include those first described in the 2000s: Middle East respiratory syndrome coronavirus (MERS-CoV) and metapneumovirus and rhinovirus C as well as those that have been described in the past but have reemerged in the last decade in outbreaks resulting in significant morbidity and mortality, including adenovirus, influenza virus, and enterovirus D68 (EV-D68).",10.1016/b978-0-323-44887-1.00028-6,vbdb0x3m,"['Abstract', 'In', 'this', 'era', 'of', 'rapid', 'globalization', 'and', 'frequent', 'travel', 'emerging', 'viral', 'infections', 'have', 'gained', 'an', 'immense', 'potential', 'to', 'spread', 'at', 'an', 'unprecedented', 'speed', 'and', 'scale', 'compared', 'with', 'the', 'past', 'This', 'poses', 'a', 'significant', 'challenge', 'to', 'coordinated', 'international', 'efforts', 'in', 'global', 'surveillance', 'and', 'infection', 'control', 'Significantly', 'respiratory', 'viral', 'infections', 'spread', 'mostly', 'via', 'droplet', 'transmission', 'are', 'extremely', 'contagious', 'and', 'have', 'caused', 'significant', 'morbidity', 'and', 'mortality', 'during', 'outbreaks', 'in', 'the', 'last', 'decade', 'Molecular', 'diagnostics', 'via', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'key', 'in', 'the', 'rapid', 'diagnosis', 'of', 'most', 'of', 'these', 'viral', 'infections', 'However', 'a', 'high', 'index', 'of', 'suspicion', 'and', 'early', 'institution', 'of', 'appropriate', 'isolation', 'measures', 'remain', 'as', 'the', 'mainstay', 'in', 'the', 'control', 'and', 'containment', 'of', 'the', 'spread', 'of', 'these', 'viral', 'infections', 'Although', 'treatment', 'for', 'most', 'of', 'the', 'viral', 'infections', 'remains', 'supportive', 'efficacious', 'antiviral', 'agents', 'against', 'influenza', 'infections', 'exist', 'The', 'infections', 'discussed', 'in', 'this', 'chapter', 'include', 'those', 'first', 'described', 'in', 'the', '2000s', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'and', 'metapneumovirus', 'and', 'rhinovirus', 'C', 'as', 'well', 'as', 'those', 'that', 'have', 'been', 'described', 'in', 'the', 'past', 'but', 'have', 'reemerged', 'in', 'the', 'last', 'decade', 'in', 'outbreaks', 'resulting', 'in', 'significant', 'morbidity', 'and', 'mortality', 'including', 'adenovirus', 'influenza', 'virus', 'and', 'enterovirus', 'D68', 'EV', 'D68', '']"
180028,Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2,2020-04-14,Infect Ecol Epidemiol,https://www.ncbi.nlm.nih.gov/pubmed/32363011/; https://doi.org/10.1080/20008686.2020.1754538,"COVID-19 is the most rapidly growing pandemic in modern time, and the need for serological testing is most urgent. Although the diagnostics of acute patients by RT-PCR is both efficient and specific, we are also crucially in need of serological tools for investigating antibody responses and assessing individual and potential herd immunity. We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. The results revealed a sensitivity of 69% and 93.1% for IgM and IgG, respectively, based solely on PCR-positivity due to the absence of a serological gold standard. The assay specificities were shown to be 100% for IgM and 99.2% for IgG. This indicates that the test is suitable for assessing previous virus exposure, although negative results may be unreliable during the first weeks after infection. More detailed studies on antibody responses during and post infection are urgently needed.",10.1080/20008686.2020.1754538,knc0ruou,"['COVID', '19', 'is', 'the', 'most', 'rapidly', 'growing', 'pandemic', 'in', 'modern', 'time', 'and', 'the', 'need', 'for', 'serological', 'testing', 'is', 'most', 'urgent', 'Although', 'the', 'diagnostics', 'of', 'acute', 'patients', 'by', 'RT', 'PCR', 'is', 'both', 'efficient', 'and', 'specific', 'we', 'are', 'also', 'crucially', 'in', 'need', 'of', 'serological', 'tools', 'for', 'investigating', 'antibody', 'responses', 'and', 'assessing', 'individual', 'and', 'potential', 'herd', 'immunity', 'We', 'evaluated', 'a', 'commercially', 'available', 'test', 'developed', 'for', 'rapid', 'within', '15', 'minutes', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'IgM', 'and', 'IgG', 'by', '29', 'PCR', 'confirmed', 'COVID', '19', 'cases', 'and', '124', 'negative', 'controls', 'The', 'results', 'revealed', 'a', 'sensitivity', 'of', '69', 'and', '93', '1', 'for', 'IgM', 'and', 'IgG', 'respectively', 'based', 'solely', 'on', 'PCR', 'positivity', 'due', 'to', 'the', 'absence', 'of', 'a', 'serological', 'gold', 'standard', 'The', 'assay', 'specificities', 'were', 'shown', 'to', 'be', '100', 'for', 'IgM', 'and', '99', '2', 'for', 'IgG', 'This', 'indicates', 'that', 'the', 'test', 'is', 'suitable', 'for', 'assessing', 'previous', 'virus', 'exposure', 'although', 'negative', 'results', 'may', 'be', 'unreliable', 'during', 'the', 'first', 'weeks', 'after', 'infection', 'More', 'detailed', 'studies', 'on', 'antibody', 'responses', 'during', 'and', 'post', 'infection', 'are', 'urgently', 'needed', '']"
180098,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020-05-18,Emerg Microbes Infect,https://www.ncbi.nlm.nih.gov/pubmed/32306853/; https://doi.org/10.1080/22221751.2020.1756698,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 10(2) RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30 min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",10.1080/22221751.2020.1756698,sdde8bgd,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '10', '2', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
182022,Thermostable DNA Polymerase from a Viral Metagenome Is a Potent RT-PCR Enzyme,2012-06-04,PLoS One,https://doi.org/10.1371/journal.pone.0038371; https://www.ncbi.nlm.nih.gov/pubmed/22675552/,"Viral metagenomic libraries are a promising but previously untapped source of new reagent enzymes. Deep sequencing and functional screening of viral metagenomic DNA from a near-boiling thermal pool identified clones expressing thermostable DNA polymerase (Pol) activity. Among these, 3173 Pol demonstrated both high thermostability and innate reverse transcriptase (RT) activity. We describe the biochemistry of 3173 Pol and report its use in single-enzyme reverse transcription PCR (RT-PCR). Wild-type 3173 Pol contains a proofreading 3′-5′ exonuclease domain that confers high fidelity in PCR. An easier-to-use exonuclease-deficient derivative was incorporated into a PyroScript RT-PCR master mix and compared to one-enzyme (Tth) and two-enzyme (MMLV RT/Taq) RT-PCR systems for quantitative detection of MS2 RNA, influenza A RNA, and mRNA targets. Specificity and sensitivity of 3173 Pol-based RT-PCR were higher than Tth Pol and comparable to three common two-enzyme systems. The performance and simplified set-up make this enzyme a potential alternative for research and molecular diagnostics.",10.1371/journal.pone.0038371,c31xsyeo,"['Viral', 'metagenomic', 'libraries', 'are', 'a', 'promising', 'but', 'previously', 'untapped', 'source', 'of', 'new', 'reagent', 'enzymes', 'Deep', 'sequencing', 'and', 'functional', 'screening', 'of', 'viral', 'metagenomic', 'DNA', 'from', 'a', 'near', 'boiling', 'thermal', 'pool', 'identified', 'clones', 'expressing', 'thermostable', 'DNA', 'polymerase', 'Pol', 'activity', 'Among', 'these', '3173', 'Pol', 'demonstrated', 'both', 'high', 'thermostability', 'and', 'innate', 'reverse', 'transcriptase', 'RT', 'activity', 'We', 'describe', 'the', 'biochemistry', 'of', '3173', 'Pol', 'and', 'report', 'its', 'use', 'in', 'single', 'enzyme', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'Wild', 'type', '3173', 'Pol', 'contains', 'a', 'proofreading', '3', '5', 'exonuclease', 'domain', 'that', 'confers', 'high', 'fidelity', 'in', 'PCR', 'An', 'easier', 'to', 'use', 'exonuclease', 'deficient', 'derivative', 'was', 'incorporated', 'into', 'a', 'PyroScript', 'RT', 'PCR', 'master', 'mix', 'and', 'compared', 'to', 'one', 'enzyme', 'Tth', 'and', 'two', 'enzyme', 'MMLV', 'RT', 'Taq', 'RT', 'PCR', 'systems', 'for', 'quantitative', 'detection', 'of', 'MS2', 'RNA', 'influenza', 'A', 'RNA', 'and', 'mRNA', 'targets', 'Specificity', 'and', 'sensitivity', 'of', '3173', 'Pol', 'based', 'RT', 'PCR', 'were', 'higher', 'than', 'Tth', 'Pol', 'and', 'comparable', 'to', 'three', 'common', 'two', 'enzyme', 'systems', 'The', 'performance', 'and', 'simplified', 'set', 'up', 'make', 'this', 'enzyme', 'a', 'potential', 'alternative', 'for', 'research', 'and', 'molecular', 'diagnostics', '']"
182689,"Identification of viral agents associated with diarrhea in young children during a winter season in Beijing, China",2006-01-31,Journal of Clinical Virology,https://api.elsevier.com/content/article/pii/S1386653205001368; https://www.sciencedirect.com/science/article/pii/S1386653205001368,"Abstract Background Viral diarrhea remains a major cause of childhood morbidity and mortality worldwide. Although rotavirus was extensively studied in China, few comprehensive studies of all viral agents related to diarrhea in children have been conducted. Objectives Our study was performed to investigate the role of enteric viruses in acute diarrhea in our country and to evaluate methods that could be used in routine diagnostics. Study design One hundred stool samples were collected from children under 5 years of age seeking medical care for acute diarrhea during the winter season 2000/2001 in Beijing Children's Hospital. All specimens were initially screened microscopically for leucocytes/red blood cells. Samples with negative results were analyzed for virus presence using commercial EIAs and/or in-house RT-PCRs. Results At least one viral agent was found in 67% of the specimens. The frequency of rotavirus, astrovirus, norovirus and enteric adenovirus was 59%, 8%, 6% and 2%, respectively. Dual infections were found in 9.0% (6/67) of the positive samples. The results from rotavirus and astrovirus EIAs were concordant with those of rotavirus and astrovirus RT-PCRs. Conclusions Enteric viruses play an important role in pediatric diarrhea during the winter season in China. A combination of microscopic examination of stool samples with specific EIA assays to detect virus antigen in stool specimens may be suitable for routine diagnostics.",10.1016/j.jcv.2005.04.007,w0gf3d08,"['Abstract', 'Background', 'Viral', 'diarrhea', 'remains', 'a', 'major', 'cause', 'of', 'childhood', 'morbidity', 'and', 'mortality', 'worldwide', 'Although', 'rotavirus', 'was', 'extensively', 'studied', 'in', 'China', 'few', 'comprehensive', 'studies', 'of', 'all', 'viral', 'agents', 'related', 'to', 'diarrhea', 'in', 'children', 'have', 'been', 'conducted', 'Objectives', 'Our', 'study', 'was', 'performed', 'to', 'investigate', 'the', 'role', 'of', 'enteric', 'viruses', 'in', 'acute', 'diarrhea', 'in', 'our', 'country', 'and', 'to', 'evaluate', 'methods', 'that', 'could', 'be', 'used', 'in', 'routine', 'diagnostics', 'Study', 'design', 'One', 'hundred', 'stool', 'samples', 'were', 'collected', 'from', 'children', 'under', '5', 'years', 'of', 'age', 'seeking', 'medical', 'care', 'for', 'acute', 'diarrhea', 'during', 'the', 'winter', 'season', '2000', '2001', 'in', 'Beijing', 'Children', 's', 'Hospital', 'All', 'specimens', 'were', 'initially', 'screened', 'microscopically', 'for', 'leucocytes', 'red', 'blood', 'cells', 'Samples', 'with', 'negative', 'results', 'were', 'analyzed', 'for', 'virus', 'presence', 'using', 'commercial', 'EIAs', 'and', 'or', 'in', 'house', 'RT', 'PCRs', 'Results', 'At', 'least', 'one', 'viral', 'agent', 'was', 'found', 'in', '67', 'of', 'the', 'specimens', 'The', 'frequency', 'of', 'rotavirus', 'astrovirus', 'norovirus', 'and', 'enteric', 'adenovirus', 'was', '59', '8', '6', 'and', '2', 'respectively', 'Dual', 'infections', 'were', 'found', 'in', '9', '0', '6', '67', 'of', 'the', 'positive', 'samples', 'The', 'results', 'from', 'rotavirus', 'and', 'astrovirus', 'EIAs', 'were', 'concordant', 'with', 'those', 'of', 'rotavirus', 'and', 'astrovirus', 'RT', 'PCRs', 'Conclusions', 'Enteric', 'viruses', 'play', 'an', 'important', 'role', 'in', 'pediatric', 'diarrhea', 'during', 'the', 'winter', 'season', 'in', 'China', 'A', 'combination', 'of', 'microscopic', 'examination', 'of', 'stool', 'samples', 'with', 'specific', 'EIA', 'assays', 'to', 'detect', 'virus', 'antigen', 'in', 'stool', 'specimens', 'may', 'be', 'suitable', 'for', 'routine', 'diagnostics', '']"
182816,The role of interleukin-12 in the heavy metal-elicited immunomodulation: relevance of various evaluation methods,2008-11-06,J Occup Med Toxicol,https://www.ncbi.nlm.nih.gov/pubmed/18990205/; https://doi.org/10.1186/1745-6673-3-25,"BACKGROUND: Increasing evidence exists that heavy metals modulate T helper cell (Th) responses and thereby elicit various pathological manifestation. Interleukin (IL)-12, a crucial innate cytokine, was found to be regulated by such xenobiotic agents. This study aimed at testing whether IL-12 profiles may be indicative of heavy metals-induced immunomodulation. METHODS: Human immunocompetent cells, activated either by monoclonal antibodies or heat-killed Salmonella enterica, were cultured in the absence or presence of cadmium (Cd) acetate or mercuric (Hg) chloride. In vivo experiments were set up where BALB/c mice were exposed to sub-lethal doses of Cd or Hg salts for 3 or 5 weeks. Cytotoxicity was assessed by MTT-reduction assay. Modulation of cytokine profiles was evaluated by enzyme-linked immunosorbent assay (ELISA), cytometric bead-based array (CBA) and real-time polymerase chain reaction (RT-PCR); the relevance of these methods of cytokine quantification was explored. RESULTS: Modulation of IL-12 profiles in Cd- or Hg-exposed human PBMC was dose-dependent and significantly related to IFN-γ levels as well as to the Th1- or Th2-polarized responses. Similarly, skewing the Th1/Th2 ratios in vivo correlated significantly with up- or down-regulation of IL-12 levels in both cases of investigated metals. CONCLUSION: It can be inferred that: (i) IL-12 profiles alone may represent a relevant indicator of heavy metal-induced immune modulation; (ii) evaluating cytokine profiles by CBA is relevant and can adequately replace other methods such as ELISA and RT-PCR in basic research as well as in immune diagnostics; and (iii) targeting IL-12 in therapeutic approaches may be promising to modify Th1/Th2-associated immune disorders.",10.1186/1745-6673-3-25,j74a3j5w,"['BACKGROUND', 'Increasing', 'evidence', 'exists', 'that', 'heavy', 'metals', 'modulate', 'T', 'helper', 'cell', 'Th', 'responses', 'and', 'thereby', 'elicit', 'various', 'pathological', 'manifestation', 'Interleukin', 'IL', '12', 'a', 'crucial', 'innate', 'cytokine', 'was', 'found', 'to', 'be', 'regulated', 'by', 'such', 'xenobiotic', 'agents', 'This', 'study', 'aimed', 'at', 'testing', 'whether', 'IL', '12', 'profiles', 'may', 'be', 'indicative', 'of', 'heavy', 'metals', 'induced', 'immunomodulation', 'METHODS', 'Human', 'immunocompetent', 'cells', 'activated', 'either', 'by', 'monoclonal', 'antibodies', 'or', 'heat', 'killed', 'Salmonella', 'enterica', 'were', 'cultured', 'in', 'the', 'absence', 'or', 'presence', 'of', 'cadmium', 'Cd', 'acetate', 'or', 'mercuric', 'Hg', 'chloride', 'In', 'vivo', 'experiments', 'were', 'set', 'up', 'where', 'BALB', 'c', 'mice', 'were', 'exposed', 'to', 'sub', 'lethal', 'doses', 'of', 'Cd', 'or', 'Hg', 'salts', 'for', '3', 'or', '5', 'weeks', 'Cytotoxicity', 'was', 'assessed', 'by', 'MTT', 'reduction', 'assay', 'Modulation', 'of', 'cytokine', 'profiles', 'was', 'evaluated', 'by', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'cytometric', 'bead', 'based', 'array', 'CBA', 'and', 'real', 'time', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'the', 'relevance', 'of', 'these', 'methods', 'of', 'cytokine', 'quantification', 'was', 'explored', 'RESULTS', 'Modulation', 'of', 'IL', '12', 'profiles', 'in', 'Cd', 'or', 'Hg', 'exposed', 'human', 'PBMC', 'was', 'dose', 'dependent', 'and', 'significantly', 'related', 'to', 'IFN', 'γ', 'levels', 'as', 'well', 'as', 'to', 'the', 'Th1', 'or', 'Th2', 'polarized', 'responses', 'Similarly', 'skewing', 'the', 'Th1', 'Th2', 'ratios', 'in', 'vivo', 'correlated', 'significantly', 'with', 'up', 'or', 'down', 'regulation', 'of', 'IL', '12', 'levels', 'in', 'both', 'cases', 'of', 'investigated', 'metals', 'CONCLUSION', 'It', 'can', 'be', 'inferred', 'that', 'i', 'IL', '12', 'profiles', 'alone', 'may', 'represent', 'a', 'relevant', 'indicator', 'of', 'heavy', 'metal', 'induced', 'immune', 'modulation', 'ii', 'evaluating', 'cytokine', 'profiles', 'by', 'CBA', 'is', 'relevant', 'and', 'can', 'adequately', 'replace', 'other', 'methods', 'such', 'as', 'ELISA', 'and', 'RT', 'PCR', 'in', 'basic', 'research', 'as', 'well', 'as', 'in', 'immune', 'diagnostics', 'and', 'iii', 'targeting', 'IL', '12', 'in', 'therapeutic', 'approaches', 'may', 'be', 'promising', 'to', 'modify', 'Th1', 'Th2', 'associated', 'immune', 'disorders', '']"
183164,Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet Nam 1997–2010,2018-04-12,Virol J,https://doi.org/10.1186/s12985-018-0980-0; https://www.ncbi.nlm.nih.gov/pubmed/29650033/,"BACKGROUND: Enteroviruses are the most common causative agents of human illness. Enteroviruses have been associated with regional and global epidemics, recently, including with severe disease (Enterovirus A71 and D68), and are of interest as emerging viruses. Here, we typed Enterovirus A-D (EV) from central nervous system (CNS) and respiratory infections in Viet Nam. METHODS: Data and specimens from prospective observational clinical studies conducted between 1997 and 2010 were used. Species and serotypes were determined using type-specific RT-PCR and viral protein 1 or 4 (VP1, VP4) sequencing. RESULTS: Samples from patients with CNS infection (51 children – 10 CSF and 41 respiratory/rectal swabs) and 28 adults (28 CSF) and respiratory infection (124 children – 124 respiratory swabs) were analysed. Twenty-six different serotypes of the four Enterovirus species (A-D) were identified, including EV-A71 and EV-D68. Enterovirus B was associated with viral meningitis in children and adults. Hand, foot and mouth disease associated Enteroviruses A (EV-A71 and Coxsackievirus [CV] A10) were detected in children with encephalitis. Diverse serotypes of all four Enterovirus species were found in respiratory samples, including 2 polio-vaccine viruses, but also 8 CV-A24 and 8 EV-D68. With the exception of EV-D68, the relevance of these viruses in respiratory infection remains unknown. CONCLUSION: We describe the diverse spectrum of enteroviruses from patients with CNS and respiratory infections in Viet Nam between 1997 and 2010. These data confirm the global circulation of Enterovirus genera and their associations and are important for clinical diagnostics, patient management, and outbreak response. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-0980-0) contains supplementary material, which is available to authorized users.",10.1186/s12985-018-0980-0,ucm7wx8b,"['BACKGROUND', 'Enteroviruses', 'are', 'the', 'most', 'common', 'causative', 'agents', 'of', 'human', 'illness', 'Enteroviruses', 'have', 'been', 'associated', 'with', 'regional', 'and', 'global', 'epidemics', 'recently', 'including', 'with', 'severe', 'disease', 'Enterovirus', 'A71', 'and', 'D68', 'and', 'are', 'of', 'interest', 'as', 'emerging', 'viruses', 'Here', 'we', 'typed', 'Enterovirus', 'A', 'D', 'EV', 'from', 'central', 'nervous', 'system', 'CNS', 'and', 'respiratory', 'infections', 'in', 'Viet', 'Nam', 'METHODS', 'Data', 'and', 'specimens', 'from', 'prospective', 'observational', 'clinical', 'studies', 'conducted', 'between', '1997', 'and', '2010', 'were', 'used', 'Species', 'and', 'serotypes', 'were', 'determined', 'using', 'type', 'specific', 'RT', 'PCR', 'and', 'viral', 'protein', '1', 'or', '4', 'VP1', 'VP4', 'sequencing', 'RESULTS', 'Samples', 'from', 'patients', 'with', 'CNS', 'infection', '51', 'children', '10', 'CSF', 'and', '41', 'respiratory', 'rectal', 'swabs', 'and', '28', 'adults', '28', 'CSF', 'and', 'respiratory', 'infection', '124', 'children', '124', 'respiratory', 'swabs', 'were', 'analysed', 'Twenty', 'six', 'different', 'serotypes', 'of', 'the', 'four', 'Enterovirus', 'species', 'A', 'D', 'were', 'identified', 'including', 'EV', 'A71', 'and', 'EV', 'D68', 'Enterovirus', 'B', 'was', 'associated', 'with', 'viral', 'meningitis', 'in', 'children', 'and', 'adults', 'Hand', 'foot', 'and', 'mouth', 'disease', 'associated', 'Enteroviruses', 'A', 'EV', 'A71', 'and', 'Coxsackievirus', 'CV', 'A10', 'were', 'detected', 'in', 'children', 'with', 'encephalitis', 'Diverse', 'serotypes', 'of', 'all', 'four', 'Enterovirus', 'species', 'were', 'found', 'in', 'respiratory', 'samples', 'including', '2', 'polio', 'vaccine', 'viruses', 'but', 'also', '8', 'CV', 'A24', 'and', '8', 'EV', 'D68', 'With', 'the', 'exception', 'of', 'EV', 'D68', 'the', 'relevance', 'of', 'these', 'viruses', 'in', 'respiratory', 'infection', 'remains', 'unknown', 'CONCLUSION', 'We', 'describe', 'the', 'diverse', 'spectrum', 'of', 'enteroviruses', 'from', 'patients', 'with', 'CNS', 'and', 'respiratory', 'infections', 'in', 'Viet', 'Nam', 'between', '1997', 'and', '2010', 'These', 'data', 'confirm', 'the', 'global', 'circulation', 'of', 'Enterovirus', 'genera', 'and', 'their', 'associations', 'and', 'are', 'important', 'for', 'clinical', 'diagnostics', 'patient', 'management', 'and', 'outbreak', 'response', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', '10', '1186', 's12985', '018', '0980', '0', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
183339,"Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017",2019-04-11,PeerJ,https://doi.org/10.7717/peerj.6748; https://www.ncbi.nlm.nih.gov/pubmed/30997293/,"Children and adults residing in densely populated urban centers around the world are at risk of seasonal influenza-like illness caused by respiratory viruses such as influenza virus, human metapneumovirus (hMPV), and respiratory syncytial virus (RSV). In a large metropolitan of Thailand’s capital city Bangkok, most respiratory infections are rarely confirmed by molecular diagnostics. We therefore examined the frequency of RSV, hMPV, and influenza virus in 8,842 patients who presented influenza-like illness and sought medical care at a large hospital in Bangkok between 2016 and 2017. Using a multiplex real-time reverse-transcription polymerase chain reaction (RT-PCR), 30.5% (2,699/8,842) of nasopharyngeal (NP) swab samples tested positive for one or more of these viruses. Influenza virus comprised 17.3% (1,528/8,842), of which the majority were influenza A/H3N2. Such infection was most prevalent among adults and the elderly. RSV was identified in 11.4% (1,011/8,842) and were mostly ON1 and BA9 genotypes. Of the hMPV-positive samples (3.6%, 318/8,842), genotypes A2, B1, and B2 were detected. A small number of individuals experienced co-infections (1.8%, 155/8,842), most commonly between RSV and influenza A/H3N2. RSV and hMPV co-infections were also found, but mainly in young children. Viral respiratory tract infection peaked locally in the rainy season (June to September). These findings support the utility of rapid nucleic acid testing of RSV, hMPV, and influenza virus in patients with ILI.",10.7717/peerj.6748,vt706f26,"['Children', 'and', 'adults', 'residing', 'in', 'densely', 'populated', 'urban', 'centers', 'around', 'the', 'world', 'are', 'at', 'risk', 'of', 'seasonal', 'influenza', 'like', 'illness', 'caused', 'by', 'respiratory', 'viruses', 'such', 'as', 'influenza', 'virus', 'human', 'metapneumovirus', 'hMPV', 'and', 'respiratory', 'syncytial', 'virus', 'RSV', 'In', 'a', 'large', 'metropolitan', 'of', 'Thailand', 's', 'capital', 'city', 'Bangkok', 'most', 'respiratory', 'infections', 'are', 'rarely', 'confirmed', 'by', 'molecular', 'diagnostics', 'We', 'therefore', 'examined', 'the', 'frequency', 'of', 'RSV', 'hMPV', 'and', 'influenza', 'virus', 'in', '8', '842', 'patients', 'who', 'presented', 'influenza', 'like', 'illness', 'and', 'sought', 'medical', 'care', 'at', 'a', 'large', 'hospital', 'in', 'Bangkok', 'between', '2016', 'and', '2017', 'Using', 'a', 'multiplex', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', '30', '5', '2', '699', '8', '842', 'of', 'nasopharyngeal', 'NP', 'swab', 'samples', 'tested', 'positive', 'for', 'one', 'or', 'more', 'of', 'these', 'viruses', 'Influenza', 'virus', 'comprised', '17', '3', '1', '528', '8', '842', 'of', 'which', 'the', 'majority', 'were', 'influenza', 'A', 'H3N2', 'Such', 'infection', 'was', 'most', 'prevalent', 'among', 'adults', 'and', 'the', 'elderly', 'RSV', 'was', 'identified', 'in', '11', '4', '1', '011', '8', '842', 'and', 'were', 'mostly', 'ON1', 'and', 'BA9', 'genotypes', 'Of', 'the', 'hMPV', 'positive', 'samples', '3', '6', '318', '8', '842', 'genotypes', 'A2', 'B1', 'and', 'B2', 'were', 'detected', 'A', 'small', 'number', 'of', 'individuals', 'experienced', 'co', 'infections', '1', '8', '155', '8', '842', 'most', 'commonly', 'between', 'RSV', 'and', 'influenza', 'A', 'H3N2', 'RSV', 'and', 'hMPV', 'co', 'infections', 'were', 'also', 'found', 'but', 'mainly', 'in', 'young', 'children', 'Viral', 'respiratory', 'tract', 'infection', 'peaked', 'locally', 'in', 'the', 'rainy', 'season', 'June', 'to', 'September', 'These', 'findings', 'support', 'the', 'utility', 'of', 'rapid', 'nucleic', 'acid', 'testing', 'of', 'RSV', 'hMPV', 'and', 'influenza', 'virus', 'in', 'patients', 'with', 'ILI', '']"
183706,Verification and diagnostic evaluation of the RealStar(®) Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0,2019-07-02,Future microbiology,https://www.ncbi.nlm.nih.gov/pubmed/31271059/; https://doi.org/10.2217/fmb-2019-0067,"AIM: We report the diagnostic evaluation of a confirmatory reverse transcription-PCR (RT-PCR) kit targeting the Middle East respiratory syndrome coronavirus (MERS-CoV) N gene. MATERIAL & METHODS: 33 patient samples from two collections sites in Riyadh, Saudi Arabia, which were pre-characterized via real-time RT-PCR targeting MERS-CoV orf1a and upE, and were tested using the MERS-CoV N gene, as a confirmatory assay. This diagnostic procedure follows a two-step diagnostics scheme, recommended by the WHO. RESULTS: 18/33 samples tested positive, 11/33 tested negative for MERS-CoV RNA and 2/33 showed uncertain results. CONCLUSION: The results suggest, that the RealStar(®) MERS-CoV (N gene) RT-PCR kit 1.0 can be considered a suitable and reliable confirmatory assay in combination with the RealStar MERS-CoV RT-PCR kit 1.0 according to the diagnostic scheme recommended by WHO.",10.2217/fmb-2019-0067,qj45jefm,"['AIM', 'We', 'report', 'the', 'diagnostic', 'evaluation', 'of', 'a', 'confirmatory', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'kit', 'targeting', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'N', 'gene', 'MATERIAL', 'METHODS', '33', 'patient', 'samples', 'from', 'two', 'collections', 'sites', 'in', 'Riyadh', 'Saudi', 'Arabia', 'which', 'were', 'pre', 'characterized', 'via', 'real', 'time', 'RT', 'PCR', 'targeting', 'MERS', 'CoV', 'orf1a', 'and', 'upE', 'and', 'were', 'tested', 'using', 'the', 'MERS', 'CoV', 'N', 'gene', 'as', 'a', 'confirmatory', 'assay', 'This', 'diagnostic', 'procedure', 'follows', 'a', 'two', 'step', 'diagnostics', 'scheme', 'recommended', 'by', 'the', 'WHO', 'RESULTS', '18', '33', 'samples', 'tested', 'positive', '11', '33', 'tested', 'negative', 'for', 'MERS', 'CoV', 'RNA', 'and', '2', '33', 'showed', 'uncertain', 'results', 'CONCLUSION', 'The', 'results', 'suggest', 'that', 'the', 'RealStar', 'MERS', 'CoV', 'N', 'gene', 'RT', 'PCR', 'kit', '1', '0', 'can', 'be', 'considered', 'a', 'suitable', 'and', 'reliable', 'confirmatory', 'assay', 'in', 'combination', 'with', 'the', 'RealStar', 'MERS', 'CoV', 'RT', 'PCR', 'kit', '1', '0', 'according', 'to', 'the', 'diagnostic', 'scheme', 'recommended', 'by', 'WHO', '']"
185952,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020-02-26,J Clin Med,https://doi.org/10.3390/jcm9030623; https://www.ncbi.nlm.nih.gov/pubmed/32110875/,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",10.3390/jcm9030623,8gncbgot,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
186344,SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro,2020-07-13,Mem Inst Oswaldo Cruz,https://doi.org/10.1590/0074-02760200200; https://www.ncbi.nlm.nih.gov/pubmed/32667461/,"Corona virus disease (COVID-19) presents a serious threat to global health. A historical timeline of early molecular diagnostics from government alert (January 22) (D) was presented. After in silico analysis, Brazilian Army Institute of Biology (IBEx-RJ) tested samples in house using real-time reverse transcriptase polymerase chain reaction (RT-PCR) (fast mode) based on Centers for Disease Control and Prevention (CDC) recommendations. First cases from Brazil, Rio de Janeiro, IBEx, and diagnosis team were reported in D36, D44, D66, and D74 respectively. Therefore, after 1300 tests, we recommend N1/N2 primer sets (CDC) for preliminary and Charité protocol confirmation in case of positive results. Moreover, every professional should be tested before starting work, in addition to weekly tests for everyone involved.",10.1590/0074-02760200200,13s3ozv5,"['Corona', 'virus', 'disease', 'COVID', '19', 'presents', 'a', 'serious', 'threat', 'to', 'global', 'health', 'A', 'historical', 'timeline', 'of', 'early', 'molecular', 'diagnostics', 'from', 'government', 'alert', 'January', '22', 'D', 'was', 'presented', 'After', 'in', 'silico', 'analysis', 'Brazilian', 'Army', 'Institute', 'of', 'Biology', 'IBEx', 'RJ', 'tested', 'samples', 'in', 'house', 'using', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'fast', 'mode', 'based', 'on', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommendations', 'First', 'cases', 'from', 'Brazil', 'Rio', 'de', 'Janeiro', 'IBEx', 'and', 'diagnosis', 'team', 'were', 'reported', 'in', 'D36', 'D44', 'D66', 'and', 'D74', 'respectively', 'Therefore', 'after', '1300', 'tests', 'we', 'recommend', 'N1', 'N2', 'primer', 'sets', 'CDC', 'for', 'preliminary', 'and', 'Charité', 'protocol', 'confirmation', 'in', 'case', 'of', 'positive', 'results', 'Moreover', 'every', 'professional', 'should', 'be', 'tested', 'before', 'starting', 'work', 'in', 'addition', 'to', 'weekly', 'tests', 'for', 'everyone', 'involved', '']"
186363,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020-04-01,Biosensors and Bioelectronics,https://api.elsevier.com/content/article/pii/S0956566320300385; https://www.ncbi.nlm.nih.gov/pubmed/31999560/; https://doi.org/10.1016/j.bios.2020.112041; https://www.sciencedirect.com/science/article/pii/S0956566320300385,"Abstract The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",10.1016/j.bios.2020.112041,zwbn44gz,"['Abstract', 'The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
186454,LOMA: A fast method to generate efficient tagged-random primers despite amplification bias of random PCR on pathogens,2008-09-10,BMC Bioinformatics,https://www.ncbi.nlm.nih.gov/pubmed/18783594/; https://doi.org/10.1186/1471-2105-9-368,"BACKGROUND: Pathogen detection using DNA microarrays has the potential to become a fast and comprehensive diagnostics tool. However, since pathogen detection chips currently utilize random primers rather than specific primers for the RT-PCR step, bias inherent in random PCR amplification becomes a serious problem that causes large inaccuracies in hybridization signals. RESULTS: In this paper, we study how the efficiency of random PCR amplification affects hybridization signals. We describe a model that predicts the amplification efficiency of a given random primer on a target viral genome. The prediction allows us to filter false-negative probes of the genome that lie in regions of poor random PCR amplification and improves the accuracy of pathogen detection. Subsequently, we propose LOMA, an algorithm to generate random primers that have good amplification efficiency. Wet-lab validation showed that the generated random primers improve the amplification efficiency significantly. CONCLUSION: The blind use of a random primer with attached universal tag (random-tagged primer) in a PCR reaction on a pathogen sample may not lead to a successful amplification. Thus, the design of random-tagged primers is an important consideration when performing PCR.",10.1186/1471-2105-9-368,8xe7cg8q,"['BACKGROUND', 'Pathogen', 'detection', 'using', 'DNA', 'microarrays', 'has', 'the', 'potential', 'to', 'become', 'a', 'fast', 'and', 'comprehensive', 'diagnostics', 'tool', 'However', 'since', 'pathogen', 'detection', 'chips', 'currently', 'utilize', 'random', 'primers', 'rather', 'than', 'specific', 'primers', 'for', 'the', 'RT', 'PCR', 'step', 'bias', 'inherent', 'in', 'random', 'PCR', 'amplification', 'becomes', 'a', 'serious', 'problem', 'that', 'causes', 'large', 'inaccuracies', 'in', 'hybridization', 'signals', 'RESULTS', 'In', 'this', 'paper', 'we', 'study', 'how', 'the', 'efficiency', 'of', 'random', 'PCR', 'amplification', 'affects', 'hybridization', 'signals', 'We', 'describe', 'a', 'model', 'that', 'predicts', 'the', 'amplification', 'efficiency', 'of', 'a', 'given', 'random', 'primer', 'on', 'a', 'target', 'viral', 'genome', 'The', 'prediction', 'allows', 'us', 'to', 'filter', 'false', 'negative', 'probes', 'of', 'the', 'genome', 'that', 'lie', 'in', 'regions', 'of', 'poor', 'random', 'PCR', 'amplification', 'and', 'improves', 'the', 'accuracy', 'of', 'pathogen', 'detection', 'Subsequently', 'we', 'propose', 'LOMA', 'an', 'algorithm', 'to', 'generate', 'random', 'primers', 'that', 'have', 'good', 'amplification', 'efficiency', 'Wet', 'lab', 'validation', 'showed', 'that', 'the', 'generated', 'random', 'primers', 'improve', 'the', 'amplification', 'efficiency', 'significantly', 'CONCLUSION', 'The', 'blind', 'use', 'of', 'a', 'random', 'primer', 'with', 'attached', 'universal', 'tag', 'random', 'tagged', 'primer', 'in', 'a', 'PCR', 'reaction', 'on', 'a', 'pathogen', 'sample', 'may', 'not', 'lead', 'to', 'a', 'successful', 'amplification', 'Thus', 'the', 'design', 'of', 'random', 'tagged', 'primers', 'is', 'an', 'important', 'consideration', 'when', 'performing', 'PCR', '']"
186705,Evaluation of custom multiplex real - time RT - PCR in comparison to fast - track diagnostics respiratory 21 pathogens kit for detection of multiple respiratory viruses,2016-06-06,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/27267595/; https://doi.org/10.1186/s12985-016-0549-8,"BACKGROUND: Severe acute respiratory infections in children can be fatal, rapid identification of the causative agent and timely treatment can be life saving. Multiplex real time RT-PCR helps in simultaneous detection of multiple viruses saving cost, time and labour. Commercially available multiplex real time RT-PCR kits are very expensive. Therefore the aim of the present study was to develop a cost effective multiplex real time RT-PCR for the detection of 18 respiratory viruses and compare it with an in-vitro diagnostics approved Fast Track Diagnostic Respiratory Pathogens 21 Kit (FTD). METHODS: Nasopharyngeal aspirates and throat swabs were collected and processed for extraction of nucleic acid using an automated extraction system and multiplex real time RT-PCR was performed using the FTD kit and a custom assay on 356 samples. RESULTS: Custom and FTD assays detected one or more respiratory viruses in 268 (75.29 %) and 262 (73.60 %) samples respectively. The concordance between the custom assay and the FTD assay was 100 % for HCoV OC43, HCoV 229E, HPIV-1, HPIV-2, HBoV, HPeV, Flu A, and Influenza A(H1N1)pdm09 and 94.66 – 99.71 % for the remaining viruses; Flu B (99.71 %), HRV (99.71 %), HPIV-3 (98.87 %), HPIV-4 (99.43 %), HCoV NL63 (99.71 %), HMPV A/B (99.71 %), RSV A/B (94.66 %), EV (98.31 %), HCoV HKU1 (99.71 %), HAdV (99.71 %). Major discrepancy was observed for RSV A/B, which was over detected in 18 samples by the custom assay as compared to the FTD assay. The custom assay was much cheaper than the FTD assay and the time taken was only 29 min more. CONCLUSION: The custom primer and probe mix was found to be comparable to the FTD assay with good concordance but was much cheaper and the time taken for reporting was only 29 min more. The low cost custom multiplex RT-PCR can be a useful alternative to the costly FTD kit for rapid identification of viral aetiology in resource limited settings.",10.1186/s12985-016-0549-8,5ca2e6wm,"['BACKGROUND', 'Severe', 'acute', 'respiratory', 'infections', 'in', 'children', 'can', 'be', 'fatal', 'rapid', 'identification', 'of', 'the', 'causative', 'agent', 'and', 'timely', 'treatment', 'can', 'be', 'life', 'saving', 'Multiplex', 'real', 'time', 'RT', 'PCR', 'helps', 'in', 'simultaneous', 'detection', 'of', 'multiple', 'viruses', 'saving', 'cost', 'time', 'and', 'labour', 'Commercially', 'available', 'multiplex', 'real', 'time', 'RT', 'PCR', 'kits', 'are', 'very', 'expensive', 'Therefore', 'the', 'aim', 'of', 'the', 'present', 'study', 'was', 'to', 'develop', 'a', 'cost', 'effective', 'multiplex', 'real', 'time', 'RT', 'PCR', 'for', 'the', 'detection', 'of', '18', 'respiratory', 'viruses', 'and', 'compare', 'it', 'with', 'an', 'in', 'vitro', 'diagnostics', 'approved', 'Fast', 'Track', 'Diagnostic', 'Respiratory', 'Pathogens', '21', 'Kit', 'FTD', 'METHODS', 'Nasopharyngeal', 'aspirates', 'and', 'throat', 'swabs', 'were', 'collected', 'and', 'processed', 'for', 'extraction', 'of', 'nucleic', 'acid', 'using', 'an', 'automated', 'extraction', 'system', 'and', 'multiplex', 'real', 'time', 'RT', 'PCR', 'was', 'performed', 'using', 'the', 'FTD', 'kit', 'and', 'a', 'custom', 'assay', 'on', '356', 'samples', 'RESULTS', 'Custom', 'and', 'FTD', 'assays', 'detected', 'one', 'or', 'more', 'respiratory', 'viruses', 'in', '268', '75', '29', 'and', '262', '73', '60', 'samples', 'respectively', 'The', 'concordance', 'between', 'the', 'custom', 'assay', 'and', 'the', 'FTD', 'assay', 'was', '100', 'for', 'HCoV', 'OC43', 'HCoV', '229E', 'HPIV', '1', 'HPIV', '2', 'HBoV', 'HPeV', 'Flu', 'A', 'and', 'Influenza', 'A', 'H1N1', 'pdm09', 'and', '94', '66', '99', '71', 'for', 'the', 'remaining', 'viruses', 'Flu', 'B', '99', '71', 'HRV', '99', '71', 'HPIV', '3', '98', '87', 'HPIV', '4', '99', '43', 'HCoV', 'NL63', '99', '71', 'HMPV', 'A', 'B', '99', '71', 'RSV', 'A', 'B', '94', '66', 'EV', '98', '31', 'HCoV', 'HKU1', '99', '71', 'HAdV', '99', '71', 'Major', 'discrepancy', 'was', 'observed', 'for', 'RSV', 'A', 'B', 'which', 'was', 'over', 'detected', 'in', '18', 'samples', 'by', 'the', 'custom', 'assay', 'as', 'compared', 'to', 'the', 'FTD', 'assay', 'The', 'custom', 'assay', 'was', 'much', 'cheaper', 'than', 'the', 'FTD', 'assay', 'and', 'the', 'time', 'taken', 'was', 'only', '29', 'min', 'more', 'CONCLUSION', 'The', 'custom', 'primer', 'and', 'probe', 'mix', 'was', 'found', 'to', 'be', 'comparable', 'to', 'the', 'FTD', 'assay', 'with', 'good', 'concordance', 'but', 'was', 'much', 'cheaper', 'and', 'the', 'time', 'taken', 'for', 'reporting', 'was', 'only', '29', 'min', 'more', 'The', 'low', 'cost', 'custom', 'multiplex', 'RT', 'PCR', 'can', 'be', 'a', 'useful', 'alternative', 'to', 'the', 'costly', 'FTD', 'kit', 'for', 'rapid', 'identification', 'of', 'viral', 'aetiology', 'in', 'resource', 'limited', 'settings', '']"
187149,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020-05-11,J Clin Virol,https://www.ncbi.nlm.nih.gov/pubmed/32417674/; https://www.sciencedirect.com/science/article/pii/S1386653220301682?v=s5; https://api.elsevier.com/content/article/pii/S1386653220301682; https://doi.org/10.1016/j.jcv.2020.104426,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",10.1016/j.jcv.2020.104426,shdg4l3r,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
189024,Association of targeted multiplex PCR with resequencing microarray for the detection of multiple respiratory pathogens,2015-05-28,Front Microbiol,https://doi.org/10.3389/fmicb.2015.00532; https://www.ncbi.nlm.nih.gov/pubmed/26074910/,"A large number of viral and bacterial organisms are responsible for community-acquired pneumonia (CAP) which contributes to substantial burden on health management. A new resequencing microarray (RPM-IVDC1) associated with targeted multiplex PCR was recently developed and validated for multiple respiratory viruses detection and discrimination. In this study, we evaluated the capability of RPM-IVDC1 for simultaneous identification of multiple viral and bacterial organisms. The nasopharyngeal aspirates (NPAs) of 110 consecutive CAP patients, aged from 1 month to 96 years old, were collected from five distinct general hospitals in Beijing during 1-year period. The samples were subjected to the RPM-IVDC1 established protocol as compared to a real-time PCR (qRT-PCR), which was used as standard. The results of virus detection were consistent with those previously described. A total of 37 of Streptococcus pneumoniae, 14 of Haemophilus influenzae, 10 of Mycoplasma pneumoniae, two of Klebsiella pneumoniae and one of Moraxella catarrhalis were detected by RPM-IVDC1. The sensitivities and specificities were compared with those of qRT-PCR for S. pneumoniae (100, 100%, respectively), H. influenzae (92.3, 97.9%, respectively), M. pneumoniae (69.2, 99.0%, respectively), K. pneumoniae (100, 100%, respectively), and M. catarrhalis (100, 100%, respectively). Additional 22 of Streptococcus spp., 24 of Haemophilus spp. and 16 of Neisseria spp. were identified. In addition, methicillin-resistant and carbapenemases allele were also found in nine of Staphylococcus spp. and one of K. pneumoniae, respectively. These results demonstrated the capability of RPM-IVDC1 for simultaneous detection of broad-spectrum respiratory pathogens in complex backgrounds and the advantage of accessing to the actual sequences, showing great potential use of epidemic outbreak investigation. The detection results should be carefully interpreted when introducing this technique in the clinical diagnostics.",10.3389/fmicb.2015.00532,byqph47j,"['A', 'large', 'number', 'of', 'viral', 'and', 'bacterial', 'organisms', 'are', 'responsible', 'for', 'community', 'acquired', 'pneumonia', 'CAP', 'which', 'contributes', 'to', 'substantial', 'burden', 'on', 'health', 'management', 'A', 'new', 'resequencing', 'microarray', 'RPM', 'IVDC1', 'associated', 'with', 'targeted', 'multiplex', 'PCR', 'was', 'recently', 'developed', 'and', 'validated', 'for', 'multiple', 'respiratory', 'viruses', 'detection', 'and', 'discrimination', 'In', 'this', 'study', 'we', 'evaluated', 'the', 'capability', 'of', 'RPM', 'IVDC1', 'for', 'simultaneous', 'identification', 'of', 'multiple', 'viral', 'and', 'bacterial', 'organisms', 'The', 'nasopharyngeal', 'aspirates', 'NPAs', 'of', '110', 'consecutive', 'CAP', 'patients', 'aged', 'from', '1', 'month', 'to', '96', 'years', 'old', 'were', 'collected', 'from', 'five', 'distinct', 'general', 'hospitals', 'in', 'Beijing', 'during', '1', 'year', 'period', 'The', 'samples', 'were', 'subjected', 'to', 'the', 'RPM', 'IVDC1', 'established', 'protocol', 'as', 'compared', 'to', 'a', 'real', 'time', 'PCR', 'qRT', 'PCR', 'which', 'was', 'used', 'as', 'standard', 'The', 'results', 'of', 'virus', 'detection', 'were', 'consistent', 'with', 'those', 'previously', 'described', 'A', 'total', 'of', '37', 'of', 'Streptococcus', 'pneumoniae', '14', 'of', 'Haemophilus', 'influenzae', '10', 'of', 'Mycoplasma', 'pneumoniae', 'two', 'of', 'Klebsiella', 'pneumoniae', 'and', 'one', 'of', 'Moraxella', 'catarrhalis', 'were', 'detected', 'by', 'RPM', 'IVDC1', 'The', 'sensitivities', 'and', 'specificities', 'were', 'compared', 'with', 'those', 'of', 'qRT', 'PCR', 'for', 'S', 'pneumoniae', '100', '100', 'respectively', 'H', 'influenzae', '92', '3', '97', '9', 'respectively', 'M', 'pneumoniae', '69', '2', '99', '0', 'respectively', 'K', 'pneumoniae', '100', '100', 'respectively', 'and', 'M', 'catarrhalis', '100', '100', 'respectively', 'Additional', '22', 'of', 'Streptococcus', 'spp', '24', 'of', 'Haemophilus', 'spp', 'and', '16', 'of', 'Neisseria', 'spp', 'were', 'identified', 'In', 'addition', 'methicillin', 'resistant', 'and', 'carbapenemases', 'allele', 'were', 'also', 'found', 'in', 'nine', 'of', 'Staphylococcus', 'spp', 'and', 'one', 'of', 'K', 'pneumoniae', 'respectively', 'These', 'results', 'demonstrated', 'the', 'capability', 'of', 'RPM', 'IVDC1', 'for', 'simultaneous', 'detection', 'of', 'broad', 'spectrum', 'respiratory', 'pathogens', 'in', 'complex', 'backgrounds', 'and', 'the', 'advantage', 'of', 'accessing', 'to', 'the', 'actual', 'sequences', 'showing', 'great', 'potential', 'use', 'of', 'epidemic', 'outbreak', 'investigation', 'The', 'detection', 'results', 'should', 'be', 'carefully', 'interpreted', 'when', 'introducing', 'this', 'technique', 'in', 'the', 'clinical', 'diagnostics', '']"
189043,CRISPR/dCas9-mediated biosensor for detection of tick-borne diseases,2018-11-10,Sensors and Actuators B: Chemical,https://www.ncbi.nlm.nih.gov/pubmed/32288252/; https://doi.org/10.1016/j.snb.2018.06.069; https://www.sciencedirect.com/science/article/pii/S0925400518311742; https://api.elsevier.com/content/article/pii/S0925400518311742,"Abstract Rapid and highly sensitive detection of biomolecules is greatly needed for pathogen diagnosis in clinical samples, but the method needs to be significantly improved in terms of sensitivity and specificity for actual use in clinical settings. Here, we report the development of an improved molecular diagnostics tool that utilizes CRISPR/dCas9-mediated biosensor that couples a nuclease inactivated Cas9 (dCas9) and single microring resonator biosensor, enables label-free and real-time detection of pathogenic DNA and RNA. We addressed the clinical utility of this CRISPR/dCas9-mediated biosensor in tick-borne illnesses including scrub typhus (ST) and severe fever with thrombocytopenia syndrome (SFTS), whose clinical presentations are too similar to be easily differentiated. By using CRISPR/dCas9-mediated biosensor, we achieved single molecule sensitivity for the detection of ST (0.54 aM) and SFTS (0.63 aM); this detection sensitivity is 100 times more sensitive than that of RT-PCR assay. Finally, CRISPR/dCas9-mediated biosensor was able to clearly distinguish between ST and SFTS in serum samples within 20 min. We believe that CRISPR/dCas9-mediated biosensor will be useful for rapid and accurate molecular diagnostic tool that is suitable for immediate clinical applications.",10.1016/j.snb.2018.06.069,kgzbd6w3,"['Abstract', 'Rapid', 'and', 'highly', 'sensitive', 'detection', 'of', 'biomolecules', 'is', 'greatly', 'needed', 'for', 'pathogen', 'diagnosis', 'in', 'clinical', 'samples', 'but', 'the', 'method', 'needs', 'to', 'be', 'significantly', 'improved', 'in', 'terms', 'of', 'sensitivity', 'and', 'specificity', 'for', 'actual', 'use', 'in', 'clinical', 'settings', 'Here', 'we', 'report', 'the', 'development', 'of', 'an', 'improved', 'molecular', 'diagnostics', 'tool', 'that', 'utilizes', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'that', 'couples', 'a', 'nuclease', 'inactivated', 'Cas9', 'dCas9', 'and', 'single', 'microring', 'resonator', 'biosensor', 'enables', 'label', 'free', 'and', 'real', 'time', 'detection', 'of', 'pathogenic', 'DNA', 'and', 'RNA', 'We', 'addressed', 'the', 'clinical', 'utility', 'of', 'this', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'in', 'tick', 'borne', 'illnesses', 'including', 'scrub', 'typhus', 'ST', 'and', 'severe', 'fever', 'with', 'thrombocytopenia', 'syndrome', 'SFTS', 'whose', 'clinical', 'presentations', 'are', 'too', 'similar', 'to', 'be', 'easily', 'differentiated', 'By', 'using', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'we', 'achieved', 'single', 'molecule', 'sensitivity', 'for', 'the', 'detection', 'of', 'ST', '0', '54', 'aM', 'and', 'SFTS', '0', '63', 'aM', 'this', 'detection', 'sensitivity', 'is', '100', 'times', 'more', 'sensitive', 'than', 'that', 'of', 'RT', 'PCR', 'assay', 'Finally', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'was', 'able', 'to', 'clearly', 'distinguish', 'between', 'ST', 'and', 'SFTS', 'in', 'serum', 'samples', 'within', '20', 'min', 'We', 'believe', 'that', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'will', 'be', 'useful', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostic', 'tool', 'that', 'is', 'suitable', 'for', 'immediate', 'clinical', 'applications', '']"
192013,The Use of NanoTrap Particles as a Sample Enrichment Method to Enhance the Detection of Rift Valley Fever Virus,2013-07-04,PLoS Negl Trop Dis,https://doi.org/10.1371/journal.pntd.0002296; https://www.ncbi.nlm.nih.gov/pubmed/23861988/,"BACKGROUND: Rift Valley Fever Virus (RVFV) is a zoonotic virus that is not only an emerging pathogen but is also considered a biodefense pathogen due to the threat it may cause to public health and national security. The current state of diagnosis has led to misdiagnosis early on in infection. Here we describe the use of a novel sample preparation technology, NanoTrap particles, to enhance the detection of RVFV. Previous studies demonstrated that NanoTrap particles lead to both 100 percent capture of protein analytes as well as an improvement of more than 100-fold in sensitivity compared to existing methods. Here we extend these findings by demonstrating the capture and enrichment of viruses. RESULTS: Screening of NanoTrap particles indicated that one particle, NT53, was the most efficient at RVFV capture as demonstrated by both qRT-PCR and plaque assays. Importantly, NT53 capture of RVFV resulted in greater than 100-fold enrichment from low viral titers when other diagnostics assays may produce false negatives. NT53 was also capable of capturing and enhancing RVFV detection from serum samples. RVFV that was inactivated through either detergent or heat treatment was still found bound to NT53, indicating the ability to use NanoTrap particles for viral capture prior to transport to a BSL-2 environment. Furthermore, both NP-40-lysed virus and purified RVFV RNA were bound by NT53. Importantly, NT53 protected viral RNA from RNase A degradation, which was not observed with other commercially available beads. Incubation of RVFV samples with NT53 also resulted in increased viral stability as demonstrated through preservation of infectivity at elevated temperatures. Finally, NanoTrap particles were capable of capturing VEEV and HIV, demonstrating the broad applicability of NanoTrap particles for viral diagnostics. CONCLUSION: This study demonstrates NanoTrap particles are capable of capturing, enriching, and protecting RVFV virions. Furthermore, the use of NanoTrap particles can be extended to a variety of viruses, including VEEV and HIV.",10.1371/journal.pntd.0002296,qgwzgazd,"['BACKGROUND', 'Rift', 'Valley', 'Fever', 'Virus', 'RVFV', 'is', 'a', 'zoonotic', 'virus', 'that', 'is', 'not', 'only', 'an', 'emerging', 'pathogen', 'but', 'is', 'also', 'considered', 'a', 'biodefense', 'pathogen', 'due', 'to', 'the', 'threat', 'it', 'may', 'cause', 'to', 'public', 'health', 'and', 'national', 'security', 'The', 'current', 'state', 'of', 'diagnosis', 'has', 'led', 'to', 'misdiagnosis', 'early', 'on', 'in', 'infection', 'Here', 'we', 'describe', 'the', 'use', 'of', 'a', 'novel', 'sample', 'preparation', 'technology', 'NanoTrap', 'particles', 'to', 'enhance', 'the', 'detection', 'of', 'RVFV', 'Previous', 'studies', 'demonstrated', 'that', 'NanoTrap', 'particles', 'lead', 'to', 'both', '100', 'percent', 'capture', 'of', 'protein', 'analytes', 'as', 'well', 'as', 'an', 'improvement', 'of', 'more', 'than', '100', 'fold', 'in', 'sensitivity', 'compared', 'to', 'existing', 'methods', 'Here', 'we', 'extend', 'these', 'findings', 'by', 'demonstrating', 'the', 'capture', 'and', 'enrichment', 'of', 'viruses', 'RESULTS', 'Screening', 'of', 'NanoTrap', 'particles', 'indicated', 'that', 'one', 'particle', 'NT53', 'was', 'the', 'most', 'efficient', 'at', 'RVFV', 'capture', 'as', 'demonstrated', 'by', 'both', 'qRT', 'PCR', 'and', 'plaque', 'assays', 'Importantly', 'NT53', 'capture', 'of', 'RVFV', 'resulted', 'in', 'greater', 'than', '100', 'fold', 'enrichment', 'from', 'low', 'viral', 'titers', 'when', 'other', 'diagnostics', 'assays', 'may', 'produce', 'false', 'negatives', 'NT53', 'was', 'also', 'capable', 'of', 'capturing', 'and', 'enhancing', 'RVFV', 'detection', 'from', 'serum', 'samples', 'RVFV', 'that', 'was', 'inactivated', 'through', 'either', 'detergent', 'or', 'heat', 'treatment', 'was', 'still', 'found', 'bound', 'to', 'NT53', 'indicating', 'the', 'ability', 'to', 'use', 'NanoTrap', 'particles', 'for', 'viral', 'capture', 'prior', 'to', 'transport', 'to', 'a', 'BSL', '2', 'environment', 'Furthermore', 'both', 'NP', '40', 'lysed', 'virus', 'and', 'purified', 'RVFV', 'RNA', 'were', 'bound', 'by', 'NT53', 'Importantly', 'NT53', 'protected', 'viral', 'RNA', 'from', 'RNase', 'A', 'degradation', 'which', 'was', 'not', 'observed', 'with', 'other', 'commercially', 'available', 'beads', 'Incubation', 'of', 'RVFV', 'samples', 'with', 'NT53', 'also', 'resulted', 'in', 'increased', 'viral', 'stability', 'as', 'demonstrated', 'through', 'preservation', 'of', 'infectivity', 'at', 'elevated', 'temperatures', 'Finally', 'NanoTrap', 'particles', 'were', 'capable', 'of', 'capturing', 'VEEV', 'and', 'HIV', 'demonstrating', 'the', 'broad', 'applicability', 'of', 'NanoTrap', 'particles', 'for', 'viral', 'diagnostics', 'CONCLUSION', 'This', 'study', 'demonstrates', 'NanoTrap', 'particles', 'are', 'capable', 'of', 'capturing', 'enriching', 'and', 'protecting', 'RVFV', 'virions', 'Furthermore', 'the', 'use', 'of', 'NanoTrap', 'particles', 'can', 'be', 'extended', 'to', 'a', 'variety', 'of', 'viruses', 'including', 'VEEV', 'and', 'HIV', '']"
192037,Hot start reverse transcriptase: an approach for improved real-time RT-PCR performance,2015-06-21,J Anal Sci Technol,https://www.ncbi.nlm.nih.gov/pubmed/32226638/; https://doi.org/10.1186/s40543-015-0063-4,"BACKGROUND: Reverse transcriptase is an indispensable enzyme for real-time reverse transcriptase (RT)-PCR, a standard method in molecular diagnostics for detection and quantification of defined RNA molecules. The prevention of non-specific products due to elongation of misprimed oligonucleotides by the enzyme at temperatures beneath the specific annealing temperature is one of the biggest challenges in real-time RT-PCR. In the present study, an aptamer directed against the reverse transcriptase was analyzed for its potential to attain a temperature-dependent reverse transcriptase (“hot start” RT). FINDINGS: The hot start effect was investigated in a one-step real-time RT-PCR assay for the detection of Middle East respiratory syndrome coronavirus (MERS-CoV). Results with aptamer revealed a reduced RT activity at low temperatures while achieving full activity at the specific annealing temperature of 55 °C. Sensitivity (limit of detection (LoD) 95 %) of the MERS-CoV assay was increased by about two times in the presence of aptamer. CONCLUSIONS: The study demonstrates the potential of aptamer-dependent hot start RT for the improvement of diagnostic real-time RT-PCR assays.",10.1186/s40543-015-0063-4,wlhmcdcn,"['BACKGROUND', 'Reverse', 'transcriptase', 'is', 'an', 'indispensable', 'enzyme', 'for', 'real', 'time', 'reverse', 'transcriptase', 'RT', 'PCR', 'a', 'standard', 'method', 'in', 'molecular', 'diagnostics', 'for', 'detection', 'and', 'quantification', 'of', 'defined', 'RNA', 'molecules', 'The', 'prevention', 'of', 'non', 'specific', 'products', 'due', 'to', 'elongation', 'of', 'misprimed', 'oligonucleotides', 'by', 'the', 'enzyme', 'at', 'temperatures', 'beneath', 'the', 'specific', 'annealing', 'temperature', 'is', 'one', 'of', 'the', 'biggest', 'challenges', 'in', 'real', 'time', 'RT', 'PCR', 'In', 'the', 'present', 'study', 'an', 'aptamer', 'directed', 'against', 'the', 'reverse', 'transcriptase', 'was', 'analyzed', 'for', 'its', 'potential', 'to', 'attain', 'a', 'temperature', 'dependent', 'reverse', 'transcriptase', 'hot', 'start', 'RT', 'FINDINGS', 'The', 'hot', 'start', 'effect', 'was', 'investigated', 'in', 'a', 'one', 'step', 'real', 'time', 'RT', 'PCR', 'assay', 'for', 'the', 'detection', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'Results', 'with', 'aptamer', 'revealed', 'a', 'reduced', 'RT', 'activity', 'at', 'low', 'temperatures', 'while', 'achieving', 'full', 'activity', 'at', 'the', 'specific', 'annealing', 'temperature', 'of', '55', 'C', 'Sensitivity', 'limit', 'of', 'detection', 'LoD', '95', 'of', 'the', 'MERS', 'CoV', 'assay', 'was', 'increased', 'by', 'about', 'two', 'times', 'in', 'the', 'presence', 'of', 'aptamer', 'CONCLUSIONS', 'The', 'study', 'demonstrates', 'the', 'potential', 'of', 'aptamer', 'dependent', 'hot', 'start', 'RT', 'for', 'the', 'improvement', 'of', 'diagnostic', 'real', 'time', 'RT', 'PCR', 'assays', '']"
192695,Imagerie de la pneumonie COVID-19,2020-05-07,Journal d&#039;imagerie diagnostique et interventionnelle,https://api.elsevier.com/content/article/pii/S2543343120300774; https://www.sciencedirect.com/science/article/pii/S2543343120300774?v=s5; https://doi.org/10.1016/j.jidi.2020.04.011,"Résumé La pandémie de COVID-19 est une crise sanitaire sans précédent. Compte-tenu des délais d’obtention des résultats de la RT-PCR, technique diagnostique de référence, le scanner thoracique joue un rôle pivot dans le triage des patients arrivant aux urgences, permettant de les hospitaliser en services « COVID » ou « non-COVID ». Le scanner initial doit être réalisé sans injection mais une injection est nécessaire en cas de suspicion d’embolie pulmonaire, dont la prévalence pourrait être assez élevée dans cette maladie. L’atteinte scanographique typique de la pneumonie COVID-19 consiste en des plages de verre dépoli bilatérales, périphériques sous-pleurales, souvent postérieures et basales. L’extension lésionnelle en scanner est corrélée à la sévérité clinique de la maladie et doit être mentionnée dans le compte-rendu d’examen. Au vu du nombre considérable de scanners thoraciques réalisés pendant cette épidémie, il est important de connaitre la gamme des diagnostics différentiels devant une dyspnée aiguë. Les techniques d’intelligence artificielle vont permettre de faire des diagnostics automatiques fiables et de quantifier l’étendue lésionnelle. Summary The COVID-19 pandemic is an unprecedented global health crisis. Given the long turnaround of RT-PCR, the gold standard diagnostic technique, chest CT plays a pivotal role in the triage of patients presenting at the emergency department, allowing them to be hospitalized in ""COVID"" or ""non-COVID"" units. Baseline CT scan must be performed without contrast, but injection is necessary in case of suspected pulmonary embolism, which could be quite frequent in this disease. The typical CT appearance of COVID-19 pneumonia consists of bilateral, peripheral, posterior and basal ground-glass opacities. CT extent of pulmonary lesions correlates with clinical disease severity and should be mentioned in the radiologic report. Given the considerable number of chest CT scans performed during this epidemic, it is important to be aware of the differential diagnosis of acute dyspnea. AI techniques could allow for reliable automated diagnosis and quantification of disease extent.",10.1016/j.jidi.2020.04.011,hehc5ri7,"['Résumé', 'La', 'pandémie', 'de', 'COVID', '19', 'est', 'une', 'crise', 'sanitaire', 'sans', 'précédent', 'Compte', 'tenu', 'des', 'délais', 'd', 'obtention', 'des', 'résultats', 'de', 'la', 'RT', 'PCR', 'technique', 'diagnostique', 'de', 'référence', 'le', 'scanner', 'thoracique', 'joue', 'un', 'rôle', 'pivot', 'dans', 'le', 'triage', 'des', 'patients', 'arrivant', 'aux', 'urgences', 'permettant', 'de', 'les', 'hospitaliser', 'en', 'services', 'COVID', 'ou', 'non', 'COVID', 'Le', 'scanner', 'initial', 'doit', 'être', 'réalisé', 'sans', 'injection', 'mais', 'une', 'injection', 'est', 'nécessaire', 'en', 'cas', 'de', 'suspicion', 'd', 'embolie', 'pulmonaire', 'dont', 'la', 'prévalence', 'pourrait', 'être', 'assez', 'élevée', 'dans', 'cette', 'maladie', 'L', 'atteinte', 'scanographique', 'typique', 'de', 'la', 'pneumonie', 'COVID', '19', 'consiste', 'en', 'des', 'plages', 'de', 'verre', 'dépoli', 'bilatérales', 'périphériques', 'sous', 'pleurales', 'souvent', 'postérieures', 'et', 'basales', 'L', 'extension', 'lésionnelle', 'en', 'scanner', 'est', 'corrélée', 'à', 'la', 'sévérité', 'clinique', 'de', 'la', 'maladie', 'et', 'doit', 'être', 'mentionnée', 'dans', 'le', 'compte', 'rendu', 'd', 'examen', 'Au', 'vu', 'du', 'nombre', 'considérable', 'de', 'scanners', 'thoraciques', 'réalisés', 'pendant', 'cette', 'épidémie', 'il', 'est', 'important', 'de', 'connaitre', 'la', 'gamme', 'des', 'diagnostics', 'différentiels', 'devant', 'une', 'dyspnée', 'aiguë', 'Les', 'techniques', 'd', 'intelligence', 'artificielle', 'vont', 'permettre', 'de', 'faire', 'des', 'diagnostics', 'automatiques', 'fiables', 'et', 'de', 'quantifier', 'l', 'étendue', 'lésionnelle', 'Summary', 'The', 'COVID', '19', 'pandemic', 'is', 'an', 'unprecedented', 'global', 'health', 'crisis', 'Given', 'the', 'long', 'turnaround', 'of', 'RT', 'PCR', 'the', 'gold', 'standard', 'diagnostic', 'technique', 'chest', 'CT', 'plays', 'a', 'pivotal', 'role', 'in', 'the', 'triage', 'of', 'patients', 'presenting', 'at', 'the', 'emergency', 'department', 'allowing', 'them', 'to', 'be', 'hospitalized', 'in', 'COVID', 'or', 'non', 'COVID', 'units', 'Baseline', 'CT', 'scan', 'must', 'be', 'performed', 'without', 'contrast', 'but', 'injection', 'is', 'necessary', 'in', 'case', 'of', 'suspected', 'pulmonary', 'embolism', 'which', 'could', 'be', 'quite', 'frequent', 'in', 'this', 'disease', 'The', 'typical', 'CT', 'appearance', 'of', 'COVID', '19', 'pneumonia', 'consists', 'of', 'bilateral', 'peripheral', 'posterior', 'and', 'basal', 'ground', 'glass', 'opacities', 'CT', 'extent', 'of', 'pulmonary', 'lesions', 'correlates', 'with', 'clinical', 'disease', 'severity', 'and', 'should', 'be', 'mentioned', 'in', 'the', 'radiologic', 'report', 'Given', 'the', 'considerable', 'number', 'of', 'chest', 'CT', 'scans', 'performed', 'during', 'this', 'epidemic', 'it', 'is', 'important', 'to', 'be', 'aware', 'of', 'the', 'differential', 'diagnosis', 'of', 'acute', 'dyspnea', 'AI', 'techniques', 'could', 'allow', 'for', 'reliable', 'automated', 'diagnosis', 'and', 'quantification', 'of', 'disease', 'extent', '']"
194041,Protein based biomarkers for non-invasive Covid-19 detection,2020-07-01,Sens Biosensing Res,https://api.elsevier.com/content/article/pii/S2214180420301252; https://doi.org/10.1016/j.sbsr.2020.100362; https://www.sciencedirect.com/science/article/pii/S2214180420301252?v=s5,"COVID-19 has become a substantial lethal disease worldwide, and early diagnosis is a significant concern for this virus. Currently, RT-PCR is being used worldwide for the detection of this virus with human to human transmission. Furthermore, the recent develop biosensor leading to others diagnosis approach but being invasive are painful and time taking. Another possibility can be protein-based biomarkers as an application of biosensors for detection and early diagnostics. Considering the other approach, that is, microfluidics-based biosensor, though being a non-invasive method, will be restricting virus transmission. This review commences with the recent develop biosensor for Covid-19 detection and listing down the available biomarkers with their secretion range comparison of normal to COVID-19 patients through clinical analysis in china and concludes with the future approach for the diagnosis.",10.1016/j.sbsr.2020.100362,kej8zeon,"['COVID', '19', 'has', 'become', 'a', 'substantial', 'lethal', 'disease', 'worldwide', 'and', 'early', 'diagnosis', 'is', 'a', 'significant', 'concern', 'for', 'this', 'virus', 'Currently', 'RT', 'PCR', 'is', 'being', 'used', 'worldwide', 'for', 'the', 'detection', 'of', 'this', 'virus', 'with', 'human', 'to', 'human', 'transmission', 'Furthermore', 'the', 'recent', 'develop', 'biosensor', 'leading', 'to', 'others', 'diagnosis', 'approach', 'but', 'being', 'invasive', 'are', 'painful', 'and', 'time', 'taking', 'Another', 'possibility', 'can', 'be', 'protein', 'based', 'biomarkers', 'as', 'an', 'application', 'of', 'biosensors', 'for', 'detection', 'and', 'early', 'diagnostics', 'Considering', 'the', 'other', 'approach', 'that', 'is', 'microfluidics', 'based', 'biosensor', 'though', 'being', 'a', 'non', 'invasive', 'method', 'will', 'be', 'restricting', 'virus', 'transmission', 'This', 'review', 'commences', 'with', 'the', 'recent', 'develop', 'biosensor', 'for', 'Covid', '19', 'detection', 'and', 'listing', 'down', 'the', 'available', 'biomarkers', 'with', 'their', 'secretion', 'range', 'comparison', 'of', 'normal', 'to', 'COVID', '19', 'patients', 'through', 'clinical', 'analysis', 'in', 'china', 'and', 'concludes', 'with', 'the', 'future', 'approach', 'for', 'the', 'diagnosis', '']"
195716,Navigating the Diagnostics of COVID-19,2020-07-25,SN Compr Clin Med,https://doi.org/10.1007/s42399-020-00408-8,"The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance. This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of 2019 novel coronavirus disease (COVID-19) patient. An electronic literature search was performed for peer-reviewed articles published from January 1, 2020, until June 19, 2020. Published articles were then reviewed and included based on the applicability to the topic. The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages. They could potentially be used as triage tests to rapidly identify patients who are very likely to have COVID-19 in combination with other accurate diagnostic methods, such as diagnostic imaging. A combination of the disease history, clinical manifestations, laboratory diagnostic testing, and diagnostic imaging is crucial for making an accurate and useful diagnosis for COVID-19. Hopefully, the continuous development and use of rapid diagnostic tests and the implementation of public health measures will help control the spread of the disease.",10.1007/s42399-020-00408-8,bqibelvc,"['The', 'recent', 'outbreak', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'began', 'in', 'Hubei', 'province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'worldwide', 'at', 'an', 'alarming', 'rate', 'With', 'over', 'eight', 'million', 'individuals', 'infected', 'and', 'exceeding', '400', '000', 'deaths', 'globally', 'the', 'necessity', 'to', 'develop', 'fast', 'and', 'efficient', 'diagnostic', 'methods', 'is', 'of', 'high', 'importance', 'This', 'paper', 'reports', 'on', 'currently', 'available', 'diagnostic', 'screening', 'methods', 'for', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'to', 'guide', 'frontline', 'healthcare', 'workers', 'involved', 'with', 'the', 'diagnosis', 'of', '2019', 'novel', 'coronavirus', 'disease', 'COVID', '19', 'patient', 'An', 'electronic', 'literature', 'search', 'was', 'performed', 'for', 'peer', 'reviewed', 'articles', 'published', 'from', 'January', '1', '2020', 'until', 'June', '19', '2020', 'Published', 'articles', 'were', 'then', 'reviewed', 'and', 'included', 'based', 'on', 'the', 'applicability', 'to', 'the', 'topic', 'The', 'preferred', 'diagnostic', 'approach', 'is', 'the', 'reverse', 'transcription', 'RT', 'of', 'the', 'virus', 'ribonucleic', 'acid', 'RNA', 'followed', 'by', 'polymerase', 'chain', 'reaction', 'PCR', 'amplification', 'RT', 'PCR', 'However', 'this', 'method', 'has', 'been', 'proven', 'to', 'be', 'time', 'consuming', 'In', 'improving', 'the', 'speed', 'and', 'efficiency', 'of', 'diagnostics', 'newer', 'rapid', 'diagnostic', 'serological', 'tests', 'are', 'in', 'development', 'for', 'testing', 'SARS', 'CoV', '2', 'each', 'with', 'its', 'unique', 'advantages', 'and', 'disadvantages', 'They', 'could', 'potentially', 'be', 'used', 'as', 'triage', 'tests', 'to', 'rapidly', 'identify', 'patients', 'who', 'are', 'very', 'likely', 'to', 'have', 'COVID', '19', 'in', 'combination', 'with', 'other', 'accurate', 'diagnostic', 'methods', 'such', 'as', 'diagnostic', 'imaging', 'A', 'combination', 'of', 'the', 'disease', 'history', 'clinical', 'manifestations', 'laboratory', 'diagnostic', 'testing', 'and', 'diagnostic', 'imaging', 'is', 'crucial', 'for', 'making', 'an', 'accurate', 'and', 'useful', 'diagnosis', 'for', 'COVID', '19', 'Hopefully', 'the', 'continuous', 'development', 'and', 'use', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'will', 'help', 'control', 'the', 'spread', 'of', 'the', 'disease', '']"
196782,"All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus",2020-03-21,bioRxiv,https://doi.org/10.1101/2020.03.19.998724; https://www.ncbi.nlm.nih.gov/pubmed/32511323/,"A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an All-In-One Dual CRISPR-Cas12a (termed “AIOD-CRISPR”) assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.",10.1101/2020.03.19.998724,vlqd192g,"['A', 'recent', 'outbreak', 'of', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'the', 'causative', 'agent', 'of', 'COVID', '19', 'has', 'spread', 'rapidly', 'all', 'over', 'the', 'world', 'Human', 'immunodeficiency', 'virus', 'HIV', 'is', 'another', 'deadly', 'virus', 'and', 'causes', 'acquired', 'immunodeficiency', 'syndrome', 'AIDS', 'Rapid', 'and', 'early', 'detection', 'of', 'these', 'viruses', 'will', 'facilitate', 'early', 'intervention', 'and', 'reduce', 'disease', 'transmission', 'risk', 'Here', 'we', 'present', 'an', 'All', 'In', 'One', 'Dual', 'CRISPR', 'Cas12a', 'termed', 'AIOD', 'CRISPR', 'assay', 'method', 'for', 'simple', 'rapid', 'ultrasensitive', 'one', 'pot', 'and', 'visual', 'detection', 'of', 'coronavirus', 'SARS', 'CoV', '2', 'and', 'HIV', 'virus', 'In', 'our', 'AIOD', 'CRISPR', 'assay', 'a', 'pair', 'of', 'crRNAs', 'was', 'introduced', 'to', 'initiate', 'dual', 'CRISPR', 'Cas12a', 'detection', 'and', 'improve', 'detection', 'sensitivity', 'The', 'AIOD', 'CRISPR', 'assay', 'system', 'was', 'successfully', 'utilized', 'to', 'detect', 'nucleic', 'acids', 'DNA', 'and', 'RNA', 'of', 'SARS', 'CoV', '2', 'and', 'HIV', 'with', 'a', 'sensitivity', 'of', 'few', 'copies', 'Also', 'it', 'was', 'evaluated', 'by', 'detecting', 'HIV', '1', 'RNA', 'extracted', 'from', 'human', 'plasma', 'samples', 'achieving', 'a', 'comparable', 'sensitivity', 'with', 'real', 'time', 'RT', 'PCR', 'method', 'Thus', 'our', 'method', 'has', 'a', 'great', 'potential', 'for', 'developing', 'next', 'generation', 'point', 'of', 'care', 'molecular', 'diagnostics', '']"
197760,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020-04-23,J Clin Microbiol,https://doi.org/10.1128/jcm.00310-20; https://www.ncbi.nlm.nih.gov/pubmed/32132196/,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID(50)]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 10(4) RNA copies/ml (range, 2.21 × 10(2) to 4.71 × 10(5) RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",10.1128/jcm.00310-20,njne526i,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID', '50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '10', '4', 'RNA', 'copies', 'ml', 'range', '2', '21', '10', '2', 'to', '4', '71', '10', '5', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
198094,Evaluation of the Luminex xTAG Respiratory Viral Panel FAST v2 assay for detection of multiple respiratory viral pathogens in nasal and throat swabs in Vietnam,2018-04-30,Wellcome Open Res,https://doi.org/10.12688/wellcomeopenres.12429.2; https://www.ncbi.nlm.nih.gov/pubmed/29503874/,"Background: Acute respiratory infections (ARI) are among the leading causes of hospitalization in children ≤5 years old. Rapid diagnostics of viral pathogens is essential to avoid unnecessary antibiotic treatment, thereby slowing down antibiotic-resistance. We evaluated the diagnostic performance of the Luminex xTAG Respiratory Viral Panel FAST v2 against viral specific PCR as reference assays for ARI in Vietnam. Methods: Four hundred and forty two nose and throat swabs were collected in viral transport medium, and were tested with Luminex xTAG Respiratory Viral Panel FAST v2. Multiplex RT-PCR and single RT-PCR were used as references. Results: Overall, sensitivity of the Luminex against reference assays was 91.8%, 95% CI 88.1-94.7 (270/294), whilst 112/6336 (1.8%, 95% CI, 1.4-2.1) of pathogens were detected by the Luminex, but not by reference assays. Frequency of pathogens detected by Luminex and reference assays was 379 and 292, respectively. The diagnostic yield was 66.7% (295/442, 95%CI 62.1-71.1%) for the Luminex assay and 54.1% (239/442, 95% CI, 49.3-58.8%) for reference assays. The Luminex kit had higher yields for all viruses except influenza B virus, respiratory syncytial virus, and human bocavirus. High agreements between both methods [mean (range): 0.91 (0.83-1.00)] were found for 10/15 viral agents. Conclusions: The Luminex assay is a high throughput multiplex platform for rapid detection of common viral pathogens causing ARI. Although the current high cost may prevent Luminex assays from being widely used, especially in limited resource settings where ARI are felt most, its introduction in clinical diagnostics may help reduce unnecessary use of antibiotic prescription.",10.12688/wellcomeopenres.12429.2,5lcfxjkc,"['Background', 'Acute', 'respiratory', 'infections', 'ARI', 'are', 'among', 'the', 'leading', 'causes', 'of', 'hospitalization', 'in', 'children', '5', 'years', 'old', 'Rapid', 'diagnostics', 'of', 'viral', 'pathogens', 'is', 'essential', 'to', 'avoid', 'unnecessary', 'antibiotic', 'treatment', 'thereby', 'slowing', 'down', 'antibiotic', 'resistance', 'We', 'evaluated', 'the', 'diagnostic', 'performance', 'of', 'the', 'Luminex', 'xTAG', 'Respiratory', 'Viral', 'Panel', 'FAST', 'v2', 'against', 'viral', 'specific', 'PCR', 'as', 'reference', 'assays', 'for', 'ARI', 'in', 'Vietnam', 'Methods', 'Four', 'hundred', 'and', 'forty', 'two', 'nose', 'and', 'throat', 'swabs', 'were', 'collected', 'in', 'viral', 'transport', 'medium', 'and', 'were', 'tested', 'with', 'Luminex', 'xTAG', 'Respiratory', 'Viral', 'Panel', 'FAST', 'v2', 'Multiplex', 'RT', 'PCR', 'and', 'single', 'RT', 'PCR', 'were', 'used', 'as', 'references', 'Results', 'Overall', 'sensitivity', 'of', 'the', 'Luminex', 'against', 'reference', 'assays', 'was', '91', '8', '95', 'CI', '88', '1', '94', '7', '270', '294', 'whilst', '112', '6336', '1', '8', '95', 'CI', '1', '4', '2', '1', 'of', 'pathogens', 'were', 'detected', 'by', 'the', 'Luminex', 'but', 'not', 'by', 'reference', 'assays', 'Frequency', 'of', 'pathogens', 'detected', 'by', 'Luminex', 'and', 'reference', 'assays', 'was', '379', 'and', '292', 'respectively', 'The', 'diagnostic', 'yield', 'was', '66', '7', '295', '442', '95', 'CI', '62', '1', '71', '1', 'for', 'the', 'Luminex', 'assay', 'and', '54', '1', '239', '442', '95', 'CI', '49', '3', '58', '8', 'for', 'reference', 'assays', 'The', 'Luminex', 'kit', 'had', 'higher', 'yields', 'for', 'all', 'viruses', 'except', 'influenza', 'B', 'virus', 'respiratory', 'syncytial', 'virus', 'and', 'human', 'bocavirus', 'High', 'agreements', 'between', 'both', 'methods', 'mean', 'range', '0', '91', '0', '83', '1', '00', 'were', 'found', 'for', '10', '15', 'viral', 'agents', 'Conclusions', 'The', 'Luminex', 'assay', 'is', 'a', 'high', 'throughput', 'multiplex', 'platform', 'for', 'rapid', 'detection', 'of', 'common', 'viral', 'pathogens', 'causing', 'ARI', 'Although', 'the', 'current', 'high', 'cost', 'may', 'prevent', 'Luminex', 'assays', 'from', 'being', 'widely', 'used', 'especially', 'in', 'limited', 'resource', 'settings', 'where', 'ARI', 'are', 'felt', 'most', 'its', 'introduction', 'in', 'clinical', 'diagnostics', 'may', 'help', 'reduce', 'unnecessary', 'use', 'of', 'antibiotic', 'prescription', '']"
200288,Coronaviren als Ursache respiratorischer Infektionen,2019-08-27,Internist (Berl),https://doi.org/10.1007/s00108-019-00671-5; https://www.ncbi.nlm.nih.gov/pubmed/31455974/,"BACKGROUND: There are six human pathogenic coronaviruses (CoV), which mainly cause infections of the respiratory system. In everyday clinical practice, it is helpful to know the relevance and characteristics of these pathogens. OBJECTIVE: To present the epidemiology, clinical picture and differences of human pathogenic CoV and to provide information on the diagnostics and treatment of patients suspected of having CoV infections. MATERIAL AND METHODS: Selective literature search, presentation of results and discussion of fundamental works and expert recommendations, including publications by the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC) and the Robert Koch Institute. RESULTS: The four endemic human CoVs (HCoV-NL63, HCoV-229E, HCoV-OC43 and HCoV-HKU1) mainly cause mild respiratory tract infections. In addition to these four endemic HCoV, the two epidemic CoV, severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV can cause severe pneumonia. The SARS-CoV has not been detected in humans in the last 15 years and MERS-CoV has been circulating mainly on the Arabian Peninsula since 2012; however, neither a specific treatment nor approved vaccines exist for any of the six human pathogenic CoVs. CONCLUSION: All six human CoVs can be diagnosed using RT-PCR on respiratory specimens but this is rarely necessary for the four endemic strains. In current clinical practice SARS-CoV has no importance as it has not been detected in humans for 15 years; however, a possible MERS-CoV infection should be taken into account in patients with typical symptoms and travel history to endemic regions. In this case, rapid diagnostic and general hygiene practices are important to prevent further transmission.",10.1007/s00108-019-00671-5,hi3fjne4,"['BACKGROUND', 'There', 'are', 'six', 'human', 'pathogenic', 'coronaviruses', 'CoV', 'which', 'mainly', 'cause', 'infections', 'of', 'the', 'respiratory', 'system', 'In', 'everyday', 'clinical', 'practice', 'it', 'is', 'helpful', 'to', 'know', 'the', 'relevance', 'and', 'characteristics', 'of', 'these', 'pathogens', 'OBJECTIVE', 'To', 'present', 'the', 'epidemiology', 'clinical', 'picture', 'and', 'differences', 'of', 'human', 'pathogenic', 'CoV', 'and', 'to', 'provide', 'information', 'on', 'the', 'diagnostics', 'and', 'treatment', 'of', 'patients', 'suspected', 'of', 'having', 'CoV', 'infections', 'MATERIAL', 'AND', 'METHODS', 'Selective', 'literature', 'search', 'presentation', 'of', 'results', 'and', 'discussion', 'of', 'fundamental', 'works', 'and', 'expert', 'recommendations', 'including', 'publications', 'by', 'the', 'World', 'Health', 'Organization', 'WHO', 'the', 'European', 'Centre', 'for', 'Disease', 'Prevention', 'and', 'Control', 'ECDC', 'and', 'the', 'Robert', 'Koch', 'Institute', 'RESULTS', 'The', 'four', 'endemic', 'human', 'CoVs', 'HCoV', 'NL63', 'HCoV', '229E', 'HCoV', 'OC43', 'and', 'HCoV', 'HKU1', 'mainly', 'cause', 'mild', 'respiratory', 'tract', 'infections', 'In', 'addition', 'to', 'these', 'four', 'endemic', 'HCoV', 'the', 'two', 'epidemic', 'CoV', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'CoV', 'can', 'cause', 'severe', 'pneumonia', 'The', 'SARS', 'CoV', 'has', 'not', 'been', 'detected', 'in', 'humans', 'in', 'the', 'last', '15', 'years', 'and', 'MERS', 'CoV', 'has', 'been', 'circulating', 'mainly', 'on', 'the', 'Arabian', 'Peninsula', 'since', '2012', 'however', 'neither', 'a', 'specific', 'treatment', 'nor', 'approved', 'vaccines', 'exist', 'for', 'any', 'of', 'the', 'six', 'human', 'pathogenic', 'CoVs', 'CONCLUSION', 'All', 'six', 'human', 'CoVs', 'can', 'be', 'diagnosed', 'using', 'RT', 'PCR', 'on', 'respiratory', 'specimens', 'but', 'this', 'is', 'rarely', 'necessary', 'for', 'the', 'four', 'endemic', 'strains', 'In', 'current', 'clinical', 'practice', 'SARS', 'CoV', 'has', 'no', 'importance', 'as', 'it', 'has', 'not', 'been', 'detected', 'in', 'humans', 'for', '15', 'years', 'however', 'a', 'possible', 'MERS', 'CoV', 'infection', 'should', 'be', 'taken', 'into', 'account', 'in', 'patients', 'with', 'typical', 'symptoms', 'and', 'travel', 'history', 'to', 'endemic', 'regions', 'In', 'this', 'case', 'rapid', 'diagnostic', 'and', 'general', 'hygiene', 'practices', 'are', 'important', 'to', 'prevent', 'further', 'transmission', '']"
204163,Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape,2020-07-18,Biosens Bioelectron,https://www.sciencedirect.com/science/article/pii/S0956566320304486?v=s5; https://doi.org/10.1016/j.bios.2020.112454; https://api.elsevier.com/content/article/pii/S0956566320304486,"The rapidly spreading outbreak of COVID-19 disease is caused by the SARS-CoV-2 virus, first reported in December 2019 in Wuhan, China. As of June 17, 2020, this virus has infected over 8.2 million people but ranges in symptom severity, making it difficult to assess its overall infection rate. There is a need for rapid and accurate diagnostics to better monitor and prevent the spread of COVID-19. In this review, we present and evaluate two main types of diagnostics with FDA-EUA status for COVID-19: nucleic acid testing for detection of SARS-CoV-2 RNA, and serological assays for detection of SARS-CoV-2 specific IgG and IgM patient antibodies, along with the necessary sample preparation for accurate diagnoses. In particular, we cover and compare tests such as the CDC 2019-nCoV RT-PCR Diagnostic Panel, Cellex's qSARS-CoV-2 IgG/IgM Rapid Test, and point-of-care tests such as Abbott's ID NOW COVID-19 Test. Antibody testing is especially important in understanding the prevalence of the virus in the community and to identify those who have gained immunity. We conclude by highlighting the future of COVID-19 diagnostics, which include the need for quantitative testing and the development of emerging biosensors as point-of-care tests.",10.1016/j.bios.2020.112454,3ejychjf,"['The', 'rapidly', 'spreading', 'outbreak', 'of', 'COVID', '19', 'disease', 'is', 'caused', 'by', 'the', 'SARS', 'CoV', '2', 'virus', 'first', 'reported', 'in', 'December', '2019', 'in', 'Wuhan', 'China', 'As', 'of', 'June', '17', '2020', 'this', 'virus', 'has', 'infected', 'over', '8', '2', 'million', 'people', 'but', 'ranges', 'in', 'symptom', 'severity', 'making', 'it', 'difficult', 'to', 'assess', 'its', 'overall', 'infection', 'rate', 'There', 'is', 'a', 'need', 'for', 'rapid', 'and', 'accurate', 'diagnostics', 'to', 'better', 'monitor', 'and', 'prevent', 'the', 'spread', 'of', 'COVID', '19', 'In', 'this', 'review', 'we', 'present', 'and', 'evaluate', 'two', 'main', 'types', 'of', 'diagnostics', 'with', 'FDA', 'EUA', 'status', 'for', 'COVID', '19', 'nucleic', 'acid', 'testing', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'and', 'serological', 'assays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'IgG', 'and', 'IgM', 'patient', 'antibodies', 'along', 'with', 'the', 'necessary', 'sample', 'preparation', 'for', 'accurate', 'diagnoses', 'In', 'particular', 'we', 'cover', 'and', 'compare', 'tests', 'such', 'as', 'the', 'CDC', '2019', 'nCoV', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Cellex', 's', 'qSARS', 'CoV', '2', 'IgG', 'IgM', 'Rapid', 'Test', 'and', 'point', 'of', 'care', 'tests', 'such', 'as', 'Abbott', 's', 'ID', 'NOW', 'COVID', '19', 'Test', 'Antibody', 'testing', 'is', 'especially', 'important', 'in', 'understanding', 'the', 'prevalence', 'of', 'the', 'virus', 'in', 'the', 'community', 'and', 'to', 'identify', 'those', 'who', 'have', 'gained', 'immunity', 'We', 'conclude', 'by', 'highlighting', 'the', 'future', 'of', 'COVID', '19', 'diagnostics', 'which', 'include', 'the', 'need', 'for', 'quantitative', 'testing', 'and', 'the', 'development', 'of', 'emerging', 'biosensors', 'as', 'point', 'of', 'care', 'tests', '']"
